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ABSTRACT 
Human biomonitoring is an analytical challenge to find environmental organic 
chemicals of varying polarity, persistency, and potential toxicity in a suitable, ideally 
non-invasive matrix at ppb levels that are significantly above method blanks.  Compared 
with more traditional matrices of adipose tissue, serum, and urine, toenail clippings 
samples are non-invasive, compact, can be shipped without refrigeration, stored 
indefinitely at room temperature, and processed without concerns for biohazards.  With 
both hydrophilic and hydrophobic layers, toenails contain 1-2% lipid, which is several 
times higher than serum.  Toenails grow slowly and are trimmed every 2-3 months, 
which offers the potential to integrate both chronic and pulsed episodic exposures.  
Using toenail samples (65 to 340 mg) donated from four individuals and an indoor house 
cat, the hypothesis that toenails are a suitable biomonitoring matrix was tested by 
analyzing for persistent pesticides, over 50 PCB congeners, moderately persistent 
PBDEs, and transient compounds of triclosan and bisphenol A by using GC/High 
Resolution MS (GC/HRMS) analysis and for unsuspected compounds using GC/full scan 
MS.  Although not fully digested and dissolved, toenails averaged 1.22% lipid (sd 0.20%, 
n=10).  Lipid was separated and determined using a new small single-use 2-g S-X3 gel 
permeation chromatography flash column with high purity nitrogen.  Multiple toenail 
samples from one individual were collected for over a year for replicate analysis, p,p’-
DDE averaged 0.82 ng/g-nail, sd 0.28, n=5 and 65.2 ng/g-lipid, sd 15.3, n=5 on lipid-
adjusted basis.  Trans-nonachlor averaged 3.08 ng/g-nail, sd 1.03, n=5; mean 254 ng/g-
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lipid, sd 97, n=5.  PBDE 28 averaged 0.29 ng/g-nail, sd 0.10, n=5; mean 24.8 ng/g-lipid, 
sd 13.3, n=5.  PBDE 85 averaged 0.25 ng/g-nail, sd 0.06, n=5; mean 20.8 ng/g-lipid, sd 
6.2, n=5.  PBDE 153 averaged 1.82 ng/g-nail, sd 0.51, n=6; mean 150 ng/g-lipid, sd 49.3, 
n=6.  Most effectively biomonitored in toenails were normally transient triclosan (mean 
58.3 ng/g-nail, sd 6.6, n=2), chlordanes, DDT, PBDEs, and PCBs including congeners with 
2,5- or 2,3,6-chlorine substitution (PCBs 52, 49, 44, 70, 95, 101, 87, and 110), which are 
suspect neurotoxins, but are rarely found in extant serum biomonitoring data.   Toenail 
soap wash samples indicated little (< 4%) or no exogenous contamination, except for the 
musks galaxolide and tonalide in most samples, which ranged up to 30%, likely from 
topical application.  The one cat toenail sample had elevated concentrations of PBDEs 
and especially chlordanes.  Unsuspected tentatively identified compounds included a UV 
Filter compound, octocrylene, a hydroxyl-methyl benzothiazole, and several compounds 
used in flavors or fragrances.
CHAPTER 1.  INTRODUCTION 
Human Health Biomonitoring 
The Centers for Disease Control and Prevention (CDC) defines “biomonitoring” 
as: 
“the assessment of human exposure to an environmental chemical via 
the measurement of that chemical, its metabolite(s), or reaction 
product(s) in human blood, urine, milk, saliva, adipose, or other tissue in 
individuals taken separately but generally taken together to constitute a 
population.1” 
“Blood, serum, and urine levels reflect the amount of a chemical that 
actually gets into the body by all routes of exposure, including ingestion, 
inhalation, and dermal absorption.  The measurement of an 
environmental chemical in a person’s blood or urine is an indication of 
exposure; it does not by itself mean that the chemical causes disease or 
an adverse effect.2” 
  
Human biomonitoring began gradually in the 1930s and 1940s when 
investigations of people dying from toxic substances implicated exposure to toxic metals 
lead and mercury.  With the invention of gas chromatography (GC) in 1952 and an 
electron capture detector in 1958, organochlorine pesticides, e.g. 
dichlorodiphenyltrichloroethane or DDT, became detectable in various sample extracts.  
In 1962, the ecologist Rachel Carson in her book, Silent Spring3 warned about toxicity 
and long-term reproduction failures in animals (and likely humans) from widespread use 
of pesticides like DDT.  Thus, federal agencies like the CDC and some state agencies 
began human health monitoring for not only toxic metals but also pesticides. 
By directly measuring the elements or compounds in human samples, human 
biomonitoring inherently considers all sources and exposure routes instead of 
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estimating exposure by separately measuring concentrations in air, water, food, house 
dust, and other possible sources.  Human biomonitoring can identify new chemical 
exposures, trends and changes in exposure, and vulnerable populations linked to certain 
contaminated sites.4  For example in the US, the CDC’s National Health and Nutrition 
Examination Survey (NHANES) effectively targeted lead in human blood samples and 
showed a concomitant drop of lead in blood concentrations during 1976-1980, when 
the US reduced lead in gasoline and other products.1   
For organic compound analyses of human samples, early investigations for DDT 
and other pesticides led to measurements of polychlorinated biphenyls (PCBs), which as 
industrial chemicals and not pesticides were initially unknown to analysts targeting 
pesticides.  With similar chromatographic properties, PCBs were initially unsuspected 
analytical interferences to DDT on a GC with electron capture detector which is highly 
sensitive to compounds containing multiple halogens.  An early environmental 
application of GC coupled to a mass spectrometer (GC/MS) was to identify some of the 
PCBs, which range from mono- to deca-chlorobiphenyl.5  By the mid-1970s, PCBs were 
banned for commercial use except for closed electrical transformers and these were 
phased out as replacement compounds were found.  Subsequently, CDC researchers 
gradually added other target organic pollutants including “dioxin” (2,3,7,8-
tetrachlorodibenzo-p-dioxin), which was a trace-level but highly toxic impurity in the 
herbicide 2,4,5-T and the Vietnam War defoliant, Agent Orange.  Generally, the earliest 
organic pollutants targeted were all widely used persistent organic pollutants (POPs) 
with biological half-lives of years.  Some less persistent compounds were later targeted 
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if they were incidentally detected in human specimens or were suspected toxicants.  As 
analytical equipment became more sensitive and selective (e.g. GC with high resolution 
mass spectrometer, GC/HRMS), methods and techniques were developed first to 
respond to illnesses from unsuspected toxicants and toxic occurrences (e.g. dioxin 
contamination of Love Canal, NY or Times Beach, MO) and later to measure 
concentrations in the general population.  For measuring chronic environmental 
exposure to POPs, analysts originally needed tens of grams of invasive adipose tissue 
biopsies to provide a sufficient sample mass and lipophilic matrix to measure pollutants, 
especially those dioxin-like, at concentrations far below one part per billion.6  The 
National Human Adipose Tissue Survey began in 1967 and continued into the 1980s 
under the oversight of the US Environmental Protection Agency (EPA).7  Tissues were 
taken from both autopsied cadavers and surgical patients to create a representative 
national sample.    
Alternate, less invasive biomonitoring matrices such as blood, urine, breast milk, 
umbilical cord, hair, nails, and saliva were typically first employed in forensic 
investigations and later evaluated for biomonitors as the pharmacokinetics of the 
compounds was better understood and as newer, more sensitive analytical instruments 
with enhanced trace-level techniques were developed.8   By 1990, CDC researchers had 
switched to blood samples (< 10 mL) as it is a less invasive sample matrix for measuring 
POPs including dioxin, DDE (persistent metabolite of the pesticide DDT), and PCBs.6   
When a persistent compound was detected in blood, which typically contains 
only 0.5% lipid by mass, the concentration of the POP was made comparable to adipose 
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tissue values by normalizing each value to a per gram-lipid basis, assuming equilibrium 
with bodily lipids (Figure 1).  Lipid-based concentrations of various persistent lipophilic 
organic compounds in matrices like blood or breast milk (3-5% lipid by mass) generally 
compared closely to those in adipose tissue as shown for example in pesticides and PCBs 
in 293 women from Long Island, NY.9 
 
Figure 1.  Three routes of chemical exposure and fate within the human body.  Adapted 
from Needham et al. (2005).6  Matrices colored green have been routinely analyzed in 
biomonitoring; matrices colored pink have only recently and rarely been analyzed. 
  
Subsequent work has demonstrated that even long-lived POPs concentrations 
differ in various human matrices and even among fractions of human blood 
characterized by differences in lipoprotein density (High Density Lipoprotein, Low 
Density L, Very Low Density L, and Lipoprotein-Depleted consisting primarily of 
albumin).  In blood from five fasting Swedish volunteers, the majority of POPs, including 
73% of DDE, were found in the LDLP or lipoprotein-depleted fraction.10  The authors 
conceded that the POPs distribution may have changed had they eaten instead of 
fasted.  In major human biomonitoring studies including those from the CDC, human 
Exposures:
(Hair, 
Nails)
Fate:
Nail Plate
Nail Bed
Magnified 450X
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volunteers do not necessarily fast before donating their blood for specimen 
biomonitoring.  Presumably POPs concentrations balance out with the analysis of many 
specimens adjusted to lipid-based concentrations. 
As with the variations with lipid type in blood, concentrations of organic 
compounds can differ by more than expected in human fatty tissues.11  Blood and 
multiple tissues samples from different fat compartments (subcutaneous, visceral, 
retroperitoneal, and pelvic) were collected from seven donors who had all fasted and 
were analyzed for POPs consisting of 10 PCB congeners and 22 chlorinated pesticides.11  
Only two subjects showed similar patterns and relative concentrations in all fat 
compartments.  In the majority of subjects there were major differences in 
concentrations in subcutaneous as compared with other fat compartments.  In some 
subjects, patterns of PCB concentrations (high or low) matched high or low pesticide 
concentrations but in other subjects the PCB patterns were opposite.  Hypotheses 
proposed to explain the differences included the ideas that lipid composition may have 
varied between subjects and even between different adipose tissue sites within the 
same subject, individual metabolism was different, site-specific functions in certain 
tissues favored solubility or binding of certain compounds, and different transport 
proteins favored certain compounds in different fatty tissues.11  Rönn et al. (2011)12 
reported that some PCBs (congeners 74, 99, 105, and 118) were positively correlated 
with fat mass and others (PCB 156, 157, 169, 170, 180, 189, 194, 206, and 209) were 
negatively correlated, especially in women.  Both gender and age factors were thought 
to involve differences in hormonal activity that affected distribution of compounds in 
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human matrices.  Some cancer researchers have deliberately analyzed cancerous tissue 
including breast tissue and breast fluids for suspected carcinogens, but generally 
without strong correlation if they lacked an accompanying comprehensive cytogenic cell 
study.13  Studies of pollutant transfer from pregnant and postpartum mothers to their 
children have been forced to consider various matrices (maternal blood, breast milk, 
placenta, umbilical cord tissue, and umbilical cord blood) to determine the best matrices 
for biological monitoring.  For example, umbilical cord tissue was found to be the best 
sample matrix to assess fetal contamination by persistent chemicals by Fukata et al. 
(2005).14 
In general for all compounds, possible human exposure and fate pathways exist 
(Figure 1).  Optimum human biomonitoring often requires a biological “speciation” 
approach by measuring the most appropriate compound or metabolite in the most 
appropriate or accessible matrix.6  Nonpersistent compounds with biological half-lives 
shorter than a few days within humans are usually measured by targeting metabolites in 
hydrolyzed extracts of urine whereas persistent compounds with longer biological half-
lives on the order of months or years are now measured in blood extracts because 
adipose tissue is usually too invasive.  Unfortunately, urine samples in particular provide 
only a short exposure time frame, as demonstrated by phthalate metabolite 
concentrations that are directly proportional to 48-h personal care product use.15  
Measuring several phthalates directly in blood extracts by GC/MS is rarely possible 
because they are ubiquitous and variable in lab blanks.   
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Human biomonitoring studies for inorganic exposure have successfully used the 
human nail for a number of trace nutrients and potentially toxic trace elements.  
Because of prevalent disulfide bonds in hair and nail keratin, the metals lead and 
mercury and elements like arsenic preferentially bind in the keratin and are typically 
higher in hair and nail than in blood, urine, or other tissues except bone for lead.16  
Similar to some organics noted earlier, concentrations of elements vary throughout all 
human matrices.  Some essential elements like iron have specific biochemical functions 
in certain matrices as iron is in blood hemoglobin.  Other elements are essential at low 
levels and still others are non-essential or toxic.  For elemental analysis, a standard nail 
sample is either a clipping from the big toe or thumb and is typically analyzed using 
instrumental neutron activation analysis (INAA) or inductively coupled plasma-mass 
spectrometry (ICP-MS).16   
Two elements that have been effectively biomonitored in human nail are arsenic 
and selenium.17-20  Selenium is an essential trace nutrient that, among other benefits, 
helps to prevent toxicity from compounds such as methyl-mercury.  In a rat model using 
INAA, Brockman et al. (2011)21 found that nail was an effective noninvasive biomonitor 
for determining the Hg/Se molar ratio.  Arsenic is comparable to environmental organic 
pollutants because it is a known toxin, a suspected carcinogen, and humans can be 
exposed to it from environmental sources.  Arsenic biomonitoring is challenging because 
it is cleared through the blood stream within hours and through the body within a few 
days.19  The nail matrix has become the preferred biomonitor for arsenic in humans 
because of the preferential retention in the keratin and the nail’s integration of periodic 
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exposures during the nail’s slow consistent growth.19  In 1996, Karagas et al.22 reported 
in a pilot study that toenail was an effective biomonitor of people in New Hampshire 
being exposed to trace levels of arsenic in their drinking water.  In another 
biomonitoring study in India using both hair and fingernails, Mandal et al. (2003)19 not 
only measured total arsenic but different arsenic species and metabolites aided by 
separation with a high performance liquid chromatograph coupled to ICP-MS.  
Exogenous contamination of arsenic was a concern for hair samples, so the researchers 
found the two dimethyl metabolites, dimethyl-arsenous acid and dimethyl-arsenic acid, 
in nail to be ideal biomarkers for arsenic exposure in humans.19     
From the literature on biomonitoring exposure to inorganics with human nails, 
there are additional advantages of using a human nail matrix.  Researchers have been 
able to successfully conduct human biomonitoring with nails even in remote areas of 
the world like Kenya because sampling the human nail is noninvasive making it possible 
for many more people to participate. In addition, the nail is much easier to transport 
long distances without needing special handling such as refrigeration, and nails are not 
biohazards like blood containing AIDS that is prevalent especially in Africa.23   
The toenail could also offer similar advantages as a noninvasive biomonitoring 
sampling matrix for measuring chronic environmental organic pollutant exposure.  
Collecting toenail clippings for toenail samples in any human biomonitoring program is 
noninvasive compared with biopsies of human adipose or breast tissue, collecting blood 
or breast milk samples at a medical lab or clinic, or collecting multiple urine samples 
during an entire 24-hour period for certain compounds with short half-lives or 
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metabolites.  For nail samples, an analytical laboratory and personnel do not have to 
worry about viruses and biohazards that a medical lab and personnel do with handling 
human blood.  Human hair and nails are both keratin-containing soft tissue storage 
sites, which can be sampled with minimal invasion for possible use in biomonitoring 
(Figure 1).   
Nail keratin is more complex than hair.24  A nail’s strong keratin structure helps 
shield it from external contamination and its slow growth integrates chronic internal 
exposure from the blood stream.  Alternating hydrophilic/lipophilic layers within the nail 
plate (Inset, Figure 1) may enable incorporation of both lipophilic and hydrophilic 
organic compounds.  Hair has slightly higher lipids (3%) than nails (1-2%) whereas nails 
are more hydrated (15% water).  Hair only grows lengthwise, so researchers can time 
exposures by monthly degree of, for example, drug use.25  In contrast, accurate timing 
of (drug) exposure with nails is nearly impossible because nails grow in both length and 
thickness and consist of three layers with alternating lipophilic/hydrophilic properties.26  
The primary middle nail plate layer with more water content resembles a hydrophilic gel 
membrane; the thinner top and bottom nail plate layers are slightly lipophilic as they 
contain most of the lipids in nails.26, 27   
Nail studies with three anti-fungal drugs with biological half-lives of 21 to 36 h 
assessed the extent and rates of incorporation into nails during daily dose regimen and 
pulse dosing of every few days or weeks.25, 28  Fluconazole (Diflucan), a hydrophilic drug 
(log K 0.5), was studied along with two lipophilic drugs (itraconazole and terbinafine or 
Lamisil, log K 6).  Fluconazole at relatively high plasma concentrations penetrated the 
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nails very rapidly.  Within 8 h after the first oral dose, the concentration in the distal 
(end) of the nail plate was already 50% of the peak nail concentration.  Nail 
concentrations ranged from one to three times higher than the corresponding plasma 
concentration during treatment and the compounds were detectable in the nail 
clippings for five months after treatment.25  The two lipophilic drugs penetrated more 
slowly during the first few weeks because most of the drug was protein bound by 
albumin and their concentrations kept rising throughout the dose period with similar 
concentrations observed in nails as in plasma. They also persisted with at least one 
metabolite in nails being found months after ending treatment.25  Thus, nails appear to 
be a suitable matrix for storing both lipophilic and hydrophilic compounds and show the 
possibility of integrating exposures for organic compounds. 
Recently, researchers in China and Japan used liquid chromatography-tandem 
mass spectrometry (LC/MS/MS) to target perfluoroalkyl compounds in two small 
biomonitoring studies with nail concentrations compared with serum values, and in one 
study also urine and hair concentrations.29, 30  Although such compounds are being 
phased out in the US because of effects on kidney, liver, and other organs, they are still 
widely produced and used in China in a wide variety of products including non-stick 
cooking items, and stain-resistant carpet.  Their biological half-lives in humans are on 
the order of years, however, they are not retained in lipid but in protein.30  Of the two 
most common perfluoroalkyl organics, perfluorooctane sulfonate or PFOS in nail was 
correlated with serum values in both studies, but in one study averaged nearly 10 times 
less in nail than in serum.29  In both studies, perfluorooctanoic acid or PFOA was lower 
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in nail than in serum.29, 30  At least two washes of nail samples before extraction were 
necessary to remove most of the exogenous nail (and hair) contamination and extreme 
care had to be taken to minimize lab background from various perfluorinated plastic 
products.29, 30 
For comparison, hair biomonitoring for organic compounds has primarily 
targeted drugs as reviewed by Srogi.31  Several recent studies by Covaci et al. have 
targeted environmental pollutants DDT, DDE, other pesticides, and some PCBs in  
hair.32-34  Because hair is much more porous than nails, it is more susceptible to 
contamination from sweat and external dust/smoke contamination.  Pre-rinsing or 
washing sampled hair two or more times is essential to minimize external 
contamination, but it also removes some bioincorporated compounds.31, 34 
Altshul et al. (2004)34 compared concentrations of PCBs and pesticides (including 
DDT) in hair with those in blood from 10 volunteers in Boston.  Unfortunately, a long 
interval gap of 10-25 months occurred between the sampling dates for serum and hair.  
Even with this lapse, they were able to report a strong correlation (r=0.8) for 
concentrations of the highly persistent p,p’-DDE in hair versus blood.34  Hair/serum 
ratios of pesticide and PCB concentrations ranged from about 1 for p,p’-DDE to 9 for 
o,p’-DDT in males and 48 for o,p’-DDT in females.  Preliminary results based on only five 
men and women suggest that the ratios for estrogenic o,p’-DDT may indicate that o,p’-
DDT is preferentially retained in women’s hair.  This is in contrast to the national CDC 
study using serum in which no o,p’-DDT was detected even in the 95th percentile.2 
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The DDT family series of compounds should be included among compounds 
evaluated in toenail samples for human biomonitoring.  One of the first pesticides used 
extensively around the world from the 1940s until the late 1960s, DDT was banned or 
phased out by many countries in the 1970s.  About 23 tropical countries, including 
Mexico, have continued to use it especially for malaria control.35, 36  Having 
environmental half-lives in years, the lipophilic DDT isomers (20% o,p’-; 80% p,p’-) and 
persistent metabolites, DDE and DDD, are so ubiquitous that “no living organism may be 
considered DDT-free” (Figure 2).35  Including these persistent compounds in any 
biomonitoring investigation would provide a type of positive control.  By 1978, o,p’-DDT 
was confirmed to be weakly estrogenic.37  More recently, researchers found that o,p’-
DDT binds also to other steroid receptors and p,p’-DDE is anti-androgenic.38-40  
 
Figure 2.  Structures and properties of DDT, DDE, and DDD isomers. 
Reproduction processes in mammals involve several hormones binding to 
specific proteins and steroid receptors in certain organs and are complicated with 
elaborate feedback mechanisms to maintain homeostasis.  Because hormones are 
potent at parts per billion (ppb) or less, such processes are vulnerable to 
DDT-series Compounds
ClCl
Cl
Cl
Cl
Cl Cl
ClCl
ClCl
Cl Cl
p,p’-DDT (85%) p,p’-DDE p,p’-DDD
ClCl
Cl
Cl
Cl
Cl
Cl ClCl
ClCl
Cl
Cl
o,p’-DDT (15%) o,p’-DDE
o,p’-DDD
Lipophilic:  Log K (octanol/water):  6 to 7
Biological Half-Life:  In Years
Good “positive control” as environmental analytes
p,p’-DDE – Most persistent
Most are weakly estrogenic; p,p’-DDE is anti-androgenic
13 
 
agonistic/antagonistic effects of other chemicals especially if they compete for several 
trace proteins or receptors.41, 42  Collectively, such chemicals are called endocrine 
disruptors.  Certain widely used organic chemicals that people are chronically exposed 
to collectively have low, acute toxicity but are potential disrupters of estrogen, 
androgen, thyroid, and other hormone systems by multiple mechanisms at very low 
(ng/g) concentrations.  For DDT-related analytes, the p,p’-DDE metabolite was the most 
persistent compound detected by GC/HRMS in virtually all CDC human serum extracts, 
ranging from a detection limit of 0.05 ng/g blood to 12 ng/g (95 percentile) or in blood 
lipid-basis to 1,860 ng/g-lipid.2, 43  For Mexican-Americans, concentrations were, on 
average, about double these values. 
 Polybrominated diphenyl ethers (PBDEs) are another group of lipophilic organic 
compounds that are suspected of endocrine-disruption in at least two different ways 
(Figure 3).  First, PBDEs, and especially hydroxyl-PBDE metabolites, are anti-estrogenic.44  
Second, the thyroid system may be susceptible, not directly from the PBDEs but from 
the hydroxyl metabolites that bind strongly to transthyretin, a transport protein of the 
thyroid hormone system.45  During the past 25 years, PBDEs have been used in high 
volumes commercially as “additive” flame retardants in three commercial mixtures 
(Penta, Octa, and Deca-BDE) based on the average number of bromine substitution.  To 
be effective, PBDEs have typically constituted from 10 to 25% (by weight) of the 
commercial product.46  By late 2013, the few chemical companies making PBDE flame 
retardants will begin phasing out the Deca-BDE mixture (97% deca-BDE) because of 
related PBDE toxicity concerns.47  Through sunlight photolysis or metabolism even by 
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fish, deca-BDE becomes debrominated to lesser brominated but more toxic PBDEs.48  It 
has been used worldwide in high impact plastic casing for computers and electronics, in 
wires and cables, and minor use for textiles and upholstery.  The Penta-BDE mixture 
(tetra-, penta-, and low percentages of hexa-BDEs) has been used in North America in 
polyurethane foam for mattresses and upholstery, phenolic and epoxy resins, but it is 
also being phased out because of a ban in California by 2008 and a ban in Europe for 
several years.49  The Octa-BDE mixture (primarily hepta- and octa-BDEs plus hexa- and 
nona-BDEs) was used much less, primarily in rigid ABS or acrylonitrile butadiene styrene 
plastic and computer monitor cases, and, with similar bans in Europe and in California 
by 2008, was also being phased out.  
 European researchers first identified PBDEs in the environment in the 1980s and 
became very concerned in the 1990s when PBDE concentrations in human breast milk 
rose almost exponentially.49  Though lipophilic, PBDEs have much shorter biological half-
lives of weeks to months compared to biological half-lives of years for DDT or PCBs.  
Along with food contamination, indoor dust is suspected to be the most important 
chronic exposure pathway for PBDEs.50 
For PBDEs in blood, results from the CDC were reported in 2009 from 
biomonitoring blood samples collected during 2003-2004.2  Based on approximately 
2000 human blood samples, CDC reported geometric mean concentrations (normalized 
to ng/g-lipid) for BDE 28 (1.19), BDE 47 (20.5), BDE 100 (3.93), and BDE 153 (5.69).2  
They also occasionally measured PBDEs 66, 99, 154, and 183.  The tri-BDE 17 was also 
targeted but was not detected.  They did not list deca-BDE 209. 
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Figure 3.  Structures and properties of prominent polybrominated-diphenyl ethers  
(PBDEs) compared with the thyroid hormone, thyroxine or T4.  Like PCBs, mono- 
through deca-PBDE congeners have been numbered from 1 to 209 for convenience. 
Hites (2004)51 reviewed reported PBDE concentrations in people and 
environmental samples throughout the world by 2004.  Conspicuously missing from 
human data was BDE 209, the most commonly used PBDE.  It was probably not included 
because it is quickly metabolized, is difficult to chromatograph before breaking down, 
and is typically found in lab blanks.  Before 2004, PBDEs were reported in only a few 
human samples from the US in units of ng/g-blood.  The most prominent PBDE, also 
subject to lab background, was the 2,2’,4,4’-tetrabromo-congener (BDE 47) at an 
average 0.5 ng/g-blood in women from Indiana and ranging from 0.1 to 5 ng/g-blood in 
50 Laotian immigrants who lived in San Francisco.52  Although PBDEs were not reported 
in human biomonitoring with hair, PBDEs were reported in hair and several organs from 
hedgehogs (similar to ground hogs) from road kills in Belgium.53  Mean PBDE 
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concentrations were highest in the animals’ livers (40 ng/g wet wgt), then adipose fat 
(10 ng/g), and then hair (2 ng/g).  Seven PBDE congeners were measured by 
GC/negative ion CI MS.  In the Belgian animal hair, PBDE 99 (Figure 3) and not PBDE 47 
was the highest concentration congener even though PBDE 47 was highest in the other 
organs.  For some animals, penta-BDE 99 is typically more susceptible to metabolism.53 
Metabolites of dialkyl phthalates comprise a third group of organic compounds 
of biomonitoring interest. They present a significant analytical challenge as the parent 
compounds, i.e. diethyl- dibutyl-, di-(ethylhexyl)- and butylbenzyl-phthalate (Figure 4) 
are typically too prevalent in blank QC samples to be measured.  Phthalates are widely-
used commercially as plasticizers in various plastic products including flexible PVC 
plastics, garden hoses, children’s toys, food packaging, blood-storage bags, and as 
diluent-additives in detergents, fragrances, shampoo, nail polish, and hair spray.15  
Animal exposures during the fetal period have shown lowered testosterone levels and 
testicular atrophy.15  Decline in human sperm quality and DNA damage in sperm have 
also been associated with phthalate concentrations in men.15, 54  Phthalates are 
moderately lipophilic but are generally metabolized to mono-ester organic acids and 
excreted within 1-2 days.55  Mono-ester metabolites of several phthalates, including 
dibutyl- and di-ethyl-hexyl-, are anti-androgenic. 
Although phthalates and phthalate metabolites are of biomonitoring interest, 
they have been rarely detected in blood or breast milk.  Nearly all researchers, including 
those from the CDC measure seven mono-ester phthalic acid metabolites in urine 
extracts by LC/MS/MS to avoid lab contamination concerns and to directly measure the 
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biologically-active compounds.6  However, at first, contamination at CDC occurred in 
their analyses until they found a suitable alternate enzyme.  Their original glucuronidase 
enzyme not only hydrolyzed the Phase II glucuronide metabolites but also with lipase 
activity converted any dialkyl phthalates present to the mono-ester metabolites.56  
Phthalate metabolites were measured in many of CDC’s 2800 urine samples.  
Concentrations of mono-ethyl phthalate were highest, ranging up to 5000 µg/L.2 
 
Figure 4.  Structures and properties of a di-alkyl Phthalate and a mono-alkyl-ester 
phthalate metabolite. 
In a human reference population in 2000, CDC studied the relative amounts of 
phthalate metabolites in both urine and serum and the percentage of the free phthalic 
acid form as glucuronide.57  The most hydrophilic (mono-ethyl-phthalic acid) in serum 
was only 3% of the urine concentration, but more lipophilic compounds (mono-butyl- 
and mono-(ethyl-hexyl)-phthalic acid) in serum were 47% and 100%, respectively.  The 
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portion in free phthalic acid form was the same in both urine and blood, i.e. mono-
ethyl-phthalic acid, was 71% in free form; others were ≤ 16% in free form. 
Subsequently, Swedish and US CDC researchers targeted phthalate diesters and 
metabolites in 42 Swedish women who had given birth several weeks prior.  No diesters 
or metabolites were detected in breast milk, blood, or serum.58  However, most 
phthalate metabolites were detected in the women’s urine samples comparable to 
those from the general population in US and in Germany. 
Finally, the most transient group of compounds of biomonitoring interest 
includes triclosan, 5-chloro-2-(2,4-dichlorophenoxy) phenol, a common antibacterial 
agent in many hand soaps and dish detergents and bisphenol A (BPA), an industrial 
chemical that is moderately lipophilic (log K 4) with a biological half-life of only 6 h 
(Figure 5).  BPA is a monomer used in high volume (thousands of tons annually) 
chemical production of various polymeric resins, commercial polycarbonate plastics, and 
other co-polymers.  Humans can be exposed to BPA leaching from resins that line food-
containing cans, teeth sealants in dentistry, reusable polycarbonate carboys used in 
commercial bottled water, polycarbonate commercial serving containers at restaurants, 
beverage glasses, and disposable plastic eating utensils.  In 1980, Peterman et al.59 
reported finding BPA in the environment in the effluent of a paper mill that deinked and 
recycled wastepaper.  In 1993, Krishnan et al.60 discovered that BPA leached from plastic 
polycarbonate flasks into autoclaved distilled water at 3 µg/L, which caused positive 
estrogenic findings in several different bioassays.  Recently in reviewing their own 
research and the overall BPA literature, vom Saal et al.61 stressed that endocrine-
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disrupting effects occurred at very low doses.  In mice, sexual differences in neurology 
and behavior differences between males and females were affected at low doses.62, 63   
Bisphenol A is another compound that will require a “speciation” approach.6  
With a short biological half-life, BPA would typically be measured in a urine sample.  
Only the free form of BPA is toxicologically active so measuring that concentration is 
very important.6 
 
Figure 5.  Structure and properties of Bisphenol A and Triclosan. 
For BPA, a review of about 20 references found that people throughout the 
world have BPA ranging from 0.1 to 10 ng/mL in both blood and tissue.63  In 400 urine 
samples, CDC found BPA ranged from 0.1 to 5 ng/mL (or µg/g creatinine).64 
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lipid-adjusted concentrations of representative compounds from CDC for serum 
samples, ng amounts anticipated in a 0.25 g toenail sample after adjusting for 1.2% lipid 
is shown in Table 1.  It is a daunting analytical challenge to measure compounds below 
1 ng in a toenail sample and is likely the reason it has not been done before.   
Table 1.  Analytical Challenge to Measure Contaminants below 1 ng in Toenail Samples 
 
To test this hypothesis with the implied analytical challenge, an optimized 
method was developed to carefully analyze for several organic compounds that are 
likely to be present because of their persistence or current wide use and are important 
for their potential to disrupt multiple endocrine systems at low concentrations, 
especially during fetal development.  DDE and several POPs are included because of 
their longtime history in biomonitoring and presence in nearly everyone in the world.  
Also targeted are emerging pollutants, PBDE flame retardants, which are moderately 
persistent.  And finally, biologically active transient compounds with very short 
(Transient)
(Persistent)
CDC Total ng
Geo. Mean Total ng in expected in
Compound Name  (ng/g-lipid) 2 g serum 0.25 g Toenails
Hexachlorobenzene 15.5 0.2 0.047
p,p'-DDE 268 3.38 0.82
p,p'-DDT ---
trans-nonachlor 16.9 0.212 0.052
PCB 52 2.59 0.032 0.008
PCB 99 4.52 0.056 0.014
PCB 138/158 17.7 0.222 0.054
PBDE 47 19.5 ~ 0.2 0.060
PBDE 153 5.41 ~ 0.06 0.017
Bisphenol A In urine --> 2.41 µg/L (?)
Triclosan In urine --> 13.6 µg/L (?)
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biological half-lives including BPA, tetrabromobisphenol A (a flame retardant), triclosan 
and phthalate metabolites are also targeted. The polar phenols and acidic phthalate 
metabolites will need to be derivatized (e.g. methylation) for trace-level detection by 
GC/HRMS.  Although the phenols in their “free” phenolic form are biologically active, 
they are usually conjugated as glucuronides in humans, which would require a separate 
glucuronidase enzymatic step to determine the total concentration in human toenails.  
To avoid missing an important compound of biomonitoring interest in the toenail 
sample extracts, GC/full-scan MS analysis is used to detect and identify by the 
compound’s mass spectrum.  When possible, compounds detected will be tentatively 
identified by matching mass spectra with NIST Mass Spectral Library resident in the 
GC/MS system. 
In summary, our hypothesis is that the toenail offers a minimally-invasive 
biomonitoring sampling matrix for measuring chronic environmental organic pollutant 
exposure.  A nail’s strong keratin structure helps shield it from external contamination 
and its slow growth integrates chronic internal exposure from the blood stream.  
Alternating hydrophilic/lipophilic layers within the nail plate enables incorporation of 
both lipophilic and hydrophilic organic compounds.  Although the small mass of toenail 
clippings requires an optimized method of sample preparation with minimal lab 
contamination, no sample carryover, and sensitive analytical instrument(s), its use is 
justified if the toenail matrix can be used for measuring chronic exposure to elusive 
compounds. 
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CHAPTER 2:  METHODS 
Sample Collection 
To evaluate the concept and consistency of analyzing toenail clippings for 
biomonitoring while optimizing the method, toenail clipping samples were collected 
from the same male (individual A) for five years.  Clipping samples (typically 100 to 300 
mg) were collected approximately every two to three months and stored at room 
temperature away from sunlight and bright fluorescent lights in clean glass culture 
tubes with Teflon-lined caps (Fisher Scientific Co).  Each toenail was clipped while the 
foot was placed on a large sheet of aluminum foil (solvent pre-rinsed with hexane) to 
collect the nails.  Each sample of clippings was transferred to a culture tube with clean 
tweezers to avoid any lint or tiny bits of adjoining skin tissue.  Because of the limited 
mass of individual toenail clippings samples and possible differences in clippings from 
different toes, replicate analyses of subsamples of an individual toenail sample were not 
done.  Alternatively, multiple (i.e. six for non-polar, two for polar) toenail samples from 
individual A collected during 1.5 years were used for replicate analyses with the 
assumption that exposures would be similar during that time period.  To further 
evaluate the nail as a biomonitor among other individuals, several additional toenail 
samples were donated from a 53 year old female (individual B), and from two additional 
males ages 59 (individual C) and 51 (individual D).  Finally for a contrasting non-human 
sample, a nail clipping sample was taken as part of normal grooming from a family pet 
(neutered male cat, age 15), who had lived 14 years in the same home.  None of the 
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toenails sampled were ever coated with nail polish or acetone-containing nail polish 
remover. 
Sample Cleaning 
Before extraction, each nail clipping sample was precleaned by sonicating 1 min 
with sodium laurate (supplied in a glass jar, 99% pure, Sigma, St. Louis, MO) dissolved in 
Fisher Environmental-grade water to a dilute (0.1 mg/mL) low-sudsing solution.  Each 
nail sample was then sonicated with three 2-mL Fisher water rinses.  The soap solution 
and three nail rinses were transferred to a separate glass culture tube for extraction and 
analysis with each associated toenail clipping sample to assess any superficial 
contaminants from exogenous sources. 
Sample Sets and Surrogates Spiked 
In all, four toenail sample sets were extracted and analyzed using a method that 
targeted either non-polar or more polar compounds, which allowed for a wider range of 
analytes within each polarity group (Table 2 and Figure 6).  Three initial sample sets 
(Sets 1-3, Table 2) used toenails only from individual A to test and optimize the method 
before a larger sample set (Set 4) with nails from four individuals and the cat was run.  
Because of the small mass of a nail clipping sample (100-350 mg), it was extremely 
important to develop and optimize a method that minimized lab contamination and 
background.  Some method steps were changed slightly from set to set to optimize the 
extent of sample nail digestion, to reduce lab background, and to measure previously 
unsuspected compounds.  In the initial sample set (Set 1, Table 2), extracts of the 
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samples (blanks 1B-1 and 2B-1, one toenail sample 3T-1, and a soap and water pre-wash 
3W-1) were processed first for polar phenolic compounds and then later after 
methylation were combined with non-polar organic pollutants.  Next, the method was 
modified to minimize unnecessary steps and reduce lab background.  Sample Sets 2 and 
3 were analyzed separately for non-polar and polar compounds, respectively (Table 2). 
Each set consisted of two procedure blanks, two toenail clipping samples, and two 
soap/water pre-washes.  Sample Set 4 (Table 2), run for non-polar compounds, included 
three procedure blanks (one blank without a digesting enzyme, Proteinase K), a 
soap/water blank, three nail samples from individual A, two nail clipping samples from 
individual C, and a single nail clipping sample from individuals B and D and the cat.  For 
 
Figure 6.  Overall Method Flow Chart for Toenail Samples 
Fractionate/Clean-up
4-g Basic Alumina Flash Chromatography
HO OH
ClCl
Cl Cl
O
BrBr Br
Br Br
Detect w/(GC/MS), GC/HRMS Selected ion Monitoring for Selected Analytes, Detection Limit < 0.1 ng/g
Weigh, Wash toenails (sonicate w/sodium laurate, 3 high purity water rinses) – Save,
Spike blanks, nails, & soap washes w/13C-surrogates, Shred nails (w/glass mortar/pestle), 
Sonicate w/20 mg/2 mL dithiothreitol soln), Extract (3 X w/3 mL DCM), Concentrate to 0.25 mL
Remove lipids from small organic contaminants by flash GPC (single-use)
Apply 0.25 mL extract to Flash 2 g S-X3    Separate total lipid (0-4.5 mL DCM), Evaporate, Weigh Lipid
Collect small organics (4.5-8 mL), Conc. to 0.5 mL and Target Polar or Non-Polar
[NON-POLAR [POPs, DDE, PCBs, Chlordanes, PBDEs, Musks,] [POLAR [BPA, phthalate metabolites, Triclosan ...]
Deprotonate w/0.75 mL 5% K2CO3 (pH 12)
Homogenize (add up to 10 mL acetone)
Methylate anions with 0.25 mL iodomethane
Remove most of acetone with high purity nitrogen
Extract (w/Hexane 3x) Concentrate to 0.5 mL
F1, 30 mL 1% DCM
in cyclopentane
PCBs, HCB, DDEs
F2, 15 mL 0.5%
acetone in DCM
POPs, PBDEs, musks
p,p’-DDE Pentabromodiphenyl ether Bisphenol A
CLEAN-UP residual lipid w/SPE
0.5 g basic alumina (6 mL DCM).
Concentrate to 0.5 mL
CLEAN-UP SPE 2-g sodium sulfate and 0.5-g basic 
alumina (6 mL 1% acetone in DCM). Conc. to 0.15 mL
O
OHCl Cl
Cl
Triclosan
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  Table 2.  Toenail Clippings and QC Samples with Method Steps and Analytes Targeted 
  
Date Nail % GC/MS    GC/HRMS F1-Least Polar F2 Basic Alumina      Non-Polar Compounds Polar Phenols-Methylated
Sample Type Donor M/F Age collected mass mg Lipid 30 m 13 m 30 m HCB,DDE,PCBs HCH, PCA, DDT, Chlordanes, PBDEs, Musks F1-SPE F2,F3-SPE
1B-1 Blank Set 1 FS F1,2 HCB, DDE PBDEs Triclosan BPA, TBBPA (Ph. Met)
2B-1 Blank F1,2 HCB, DDE PBDEs Triclosan BPA, TBBPA (Ph. Met)
3T-1 Toenail A M 57 Nov-05 186.6 1.21% FS F1,2 HCB, DDE PBDEs Triclosan BPA, TBBPA (Ph. Met)
3W-1 Wash F1,2 HCB, DDE PBDEs Triclosan BPA, TBBPA (Ph. Met)
4B-2 Blank Set 2 F1,2 HCB, DDE HCH, PCA, DDT Chlordanes PBDEs
5B-2 Blank F1,2 HCB, DDE HCH, PCA, DDT Chlordanes PBDEs
6T-2 Toenail A M 57 Jan-06 192.3 1.31% F1,2 HCB, DDE HCH, PCA, DDT Chlordanes PBDEs
6W-2 Wash F1,2 HCB, DDE HCH, PCA, DDT Chlordanes PBDEs
7T-2 Toenail A M 57 Mar-06 190.4 0.87% F1,2 HCB, DDE HCH, PCA, DDT Chlordanes PBDEs
7W-2 Wash F1,2 HCB, DDE HCH, PCA, DDT Chlordanes PBDEs
8B-3 Blank Set 3 FS F1,2 Triclosan BPA, TBBPA (Ph. Met)
9B-3 Blank FS F1,2 Triclosan BPA, TBBPA (Ph. Met)
10T-3 Toenail A M 58 May-06 271.5 Partial FS F1,2,3 Triclosan BPA, TBBPA (Ph. Met)
10W-3 Wash F1,2 Triclosan BPA, TBBPA (Ph. Met)
11T-3 Toenail A M 58 Jul-06 294.3 Partial FS F1,2,3 Triclosan BPA, TBBPA (Ph. Met)
11W-3 Wash F1,2 Triclosan BPA, TBBPA (Ph. Met)
12B-4 Blank Set 4 F2 F1,2 DDE, PCBs HCH, PCA, DDT Chlordanes PBDEs Dieldrin Musks
13B-4 Blank F2 F1,2 DDE, PCBs HCH, PCA, DDT Chlordanes PBDEs Dieldrin Musks
14B-4 Blank F2 F1,2 DDE, PCBs HCH, PCA, DDT Chlordanes PBDEs Dieldrin Musks
15T-4 Toenail A M 58 Oct-06 339.5 1.16% F2 F1,2 DDE, PCBs HCH, PCA, DDT Chlordanes PBDEs Dieldrin Musks
15W-4 Wash F2 F1,2 DDE, PCBs HCH, PCA, DDT Chlordanes PBDEs Dieldrin Musks
16T-4 Toenail A M 58 Feb-07 295 1.29% F2 F1,2 DDE, PCBs HCH, PCA, DDT Chlordanes PBDEs Dieldrin Musks
16W-4 Wash F2 F1,2 DDE, PCBs HCH, PCA, DDT Chlordanes PBDEs Dieldrin Musks
17T-4 Toenail A M 59 May-07 159 1.63% F2 F1,2 DDE, PCBs HCH, PCA, DDT Chlordanes PBDEs Dieldrin Musks
17W-4 Wash F2 F1,2 DDE, PCBs HCH, PCA, DDT Chlordanes PBDEs Dieldrin Musks
18T-4 Toenail B F 53 2010 65.5 1.23% F2 F1,2 DDE, PCBs HCH, PCA, DDT Chlordanes PBDEs Dieldrin Musks
18W-4 Wash F2 F1,2 DDE, PCBs HCH, PCA, DDT Chlordanes PBDEs Dieldrin Musks
19T-4 ToenailM-cat M 15 Apr-10 120 1.12% F2 F1,2 DDE, PCBs HCH, PCA, DDT Chlordanes PBDEs Dieldrin Musks
19W-4 Wash F2 F1,2 DDE, PCBs HCH, PCA, DDT Chlordanes PBDEs Dieldrin Musks
20T-4 Toenail C M 59 Jan-09 195.9 1.03% F2 F1,2 DDE, PCBs HCH, PCA, DDT Chlordanes PBDEs Dieldrin Musks
20W-4 Wash F2 F1,2 DDE, PCBs HCH, PCA, DDT Chlordanes PBDEs Dieldrin Musks
21T-4 Toenail C M 59 Apr-09 321.6 1.22% F2 F1,2 DDE, PCBs HCH, PCA, DDT Chlordanes PBDEs Dieldrin Musks
21W-4 Wash F2 F1,2 DDE, PCBs HCH, PCA, DDT Chlordanes PBDEs Dieldrin Musks
22T-4 Toenail D M 51 Nov-07 188.7 1.23% F2 F1,2 DDE, PCBs HCH, PCA, DDT Chlordanes PBDEs Dieldrin Musks
22W-4 Wash F2 F1,2 DDE, PCBs HCH, PCA, DDT Chlordanes PBDEs Dieldrin Musks
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best accuracy and to correct for analyte recovery losses throughout the method, the 
“isotope dilution technique” was used.  For non-polar compounds, several 13C-stable-
labelled surrogates were spiked into each sample at the beginning of the method 
including: 13C-mono- to deca-PBDEs and 35 13C-PCB congeners from Wellington Labs 
(Guelph, ON Canada) plus 13C-p,p’-DDE from Cambridge Isotope Labs (Andover, MA ).  
For polar compounds, 13C-surrogates for each sample included 13C-triclosan, 13C-
bisphenol A, 13C- tetrabromobisphenol A, and several 13C-mono-phthalate metabolites 
from the same companies.  Surrogate spiking solution volume was kept to a minimum 
(0.1 mL), especially to avoid denaturing the enzyme, Proteinase K (from Tritirachium 
album, BioUltra grade, Sigma, St. Louis) when used in Set 4. 
Dissolution and Extraction of Toenail  
A first important challenge was to break up, digest, and solubilize toenail 
clippings for effective solvent extraction of trace levels of organic contaminants without 
introducing any significant lab contamination or destructive reagents.  Strong acids were 
first attempted for digestion, but the toenail material was impervious to hydrochloric or 
sulfuric acid for at least several weeks at room temperature.  Strong bases were not 
tried for nail digestion because certain pollutants like DDT would break down (to DDE 
and DDD), as shown by Covaci and Schepens (2001)32 from a dilute NaOH basic 
extraction.  A possible extractor using liquid nitrogen was considered but rejected 
because of likely BPA contamination from its polycarbonate sample holder.  A small 
powered commercial mill may have been suitable but was unavailable to break up nail 
clippings to very small fragments.  For extracting hair, Covaci and Schepens (2001)32 
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tried 16 extraction methods (dilute base, dilute acids, enzyme, and various Soxhlet) to 
extract hair for environmental pollutants.  They chose an initial incubation of 3 M HCl at 
40 ºC for 12 h and then liquid-liquid extraction with hexane:dichloromethane (4:1), but 
acid-labile pesticides (dieldrin and heptachlor epoxide) were not targeted.32  
Researchers using nail to monitor for cocaine, a diester (like phthalates) which is 
susceptible to hydrolysis from a high pH extraction, used a pH 5 potassium phosphate 
buffer for three days to extract their small nail slivers for cocaine.31, 65 
The ultimate goal was to denature the protein matrix sufficiently to allow 
extraction by organic solvents while not chemically degrading the analytes and not 
hydrolyzing triglycerol lipids.  Biochemical reagents such as dithiothrietol (Figure 7), and 
enzyme, proteinase K, are known to break down protein.66  Therefore, for all sample 
sets 1-4 (Table 2), nail clippings were pre-washed and hand-ground in a 5-mL glass 
conical mortar vial with matching glass pestle (Kimble Chase, Vineland, NJ) with at least 
5 mg dithiothreitol (DTT, Sigma, St. Louis), a reducing agent commonly used to break 
disulfide bonds of cystine in proteins.  DTT dissolved in dichloromethane (DCM, Optima 
grade, Fisher) was added to the wet nails in the vial to promote extraction of small 
organic molecules, but DTT is known to work only on the solvent-accessible areas.67  
Cystine, common in nail keratin protein, typically occurs from two cysteine amino acids 
“cross-linking” within the protein.  Although a slow process, toenail was more effectively 
broken down by alternating hand-grinding (to increase surface area) with sonicating the 
vial with DTT reagent and added water.  After sufficient time (hours up to several days) 
of digesting, a white fluffy suspension from each toenail sample was observed to form.  
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Figure 7.  Structure of dithiothreitol used to break down keratin 
 
This suspension was transferred to a clean (15 mL) glass culture tube for DCM 
extraction (Figure 8).  Typically, some bits of toenail clippings remained in the mortar 
vial, though noticeably thinner and softer, and required further hand-grinding to 
dissolve as much nail as possible before transferring to the culture tube.  By comparing 
total lipid and analyte concentrations from multiple nail clippings samples from 
individual A that were dissolved or digested to varying extents, it was possible to assess 
the importance of a nearly complete dissolution or digestion of an entire nail clippings 
sample.   
In an effort to improve the extent of nail dissolution in sample set 4, a digesting 
Proteinase K enzyme (Sigma, St. Louis, MO) at 1 mg/mL Fisher water in a culture tube at 
37 ºC was added to the toenail samples with slow rocking agitation.  After several days 
of slow progress, it was necessary to then add 5-10 mg DTT in granular form to each 
sample tube followed by multiple sonication every day or two.  After seven days of 
digesting, the white fluffy suspension from each toenail sample was transferred to a  
Dithiothreitol (Cleland’s reagent) 
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Figure 8.  Sample Set 1 Culture tubes (Left to Right) of two procedure blanks (with DTT), 
one soap wash, and toenail sample, designated 1B-1, 2B-1, 3W-1, and 3T-1 (Table 2). 
clean culture tube for DCM extraction.  To the remaining nail material in each sample 
tube, freshly dissolved Proteinase K and DTT were added for another ten days of 
digestion and periodic sonication before again transferring the white nail suspension to 
the original sample culture tube.  Remaining toenail clippings were noticeably thinner 
and softer to hand-grind in a mortar vial before transferring to the culture tube, except 
for the relatively hard nails clipped from the cat that required an hour of hand-grinding 
to get most of the nail into a suspension and into the tube for extraction. 
For all sample sets, each ground nail sample was extracted three to four times 
with 3-mL DCM to extract small organic compounds from the (aqueous) nail suspension 
still containing bits of undissolved nail.  Each extract was carefully removed from the 
bottom layer with a glass transfer pipet to another culture tube and combined in a  
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15-mL glass culture tube.  For Set 4 that had more extensive emulsions in sample 
extracts, a fourth 3-mL DCM extraction was routinely used.  Whenever emulsions 
complicated extract partitioning, most of the top water layer was decanted to a 
separate culture tube and extracted separately with DCM three to four times.  In Set 3 
which only targeted phenolic and acidic compounds, two DCM extracts were made, 
initially at neutral pH 7 and later at pH 3 after acidification with several drops of dilute 
HCl.  With a pKa of 9-10, bisphenol A, tetrabromobisphenol A, and triclosan were 
expected to be in the neutral extract, but the mono-phthalate metabolites were 
expected to be in the acidic extract.  For Set 3, only “free” or unconjugated phenols 
were targeted.  No glucuronidase/sulfatase enzyme was added to the aqueous dissolved 
nail solution before acidification to release any glucuronide metabolites present for a 
possible third DCM extract.  In general, each DCM sample extract was gently 
concentrated with high purity nitrogen to 0.25 mL to prepare for a miniaturized 2-g flash 
gel permeation chromatography (GPC) step to remove lipids. 
Lipid removal using Miniature Flash Gel Permeation Chromatography 
(GPC)  
Based on size-exclusion chromatography, GPC with BioBeads S-X3 (BioRad, 
Hercules, CA) is an effective technique to remove lipids from environmental samples 
extracted for various organic compounds to be analyzed using gas chromatography 
(GC).68  However, any automated GPC system is prone to carryover from one sample to 
the next, prone to trapped gas bubbles requiring pumping the solvent upwards through 
the column, and is designed for large samples up to 100 g using a large amount (350 mL) 
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of solvent.  The availability of long narrow (45 cm x 5 mm i.d.) glass flash columns, 
custom made by Kimble Chase, Vineland, NJ made it possible to devise a miniaturized  
2-g flash GPC with similar length but five times narrower i.d. that uses high purity 
nitrogen (0.5 bar) for downward DCM flow (Figure 9).  A single sample use for each 
column avoided carryover from any previous sample.  A 40-mL reservoir with 20-400 GPI 
glass screw thread on top of the column connects to the nitrogen and the bottom end of 
the column is tapered to a glass male Luer lock for a small glass fiber plug (0.45 μm).  
Miniaturized by a factor of 35, the smaller GPC used only a small eluant (< 10 mL DCM), 
which minimized solvent and lab background. 
 
Figure 9. Top reservoir and adapter-cap for nitrogen-pressurized flash GPC. A 0.25-mL 
beta-carotene test solution was applied to the column before adding DCM eluant. 
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All sample sets (1-4) used the same GPC column packing procedure.  To wet-pack 
S-X3 (2.00 g, 3% cross-linked gels, 40-80 µm) in an empty column, S-X3 and DCM were 
added alternatingly in partial portions until within 30 min the S-X3 swelled and settled 
as a contiguous gel without any significant air bubbles.  A small plug of cleaned glass 
wool was then added on top (to keep gel from floating into the reservoir) and DCM 
flowed under pressure until the bottom of the glass wool. 
To carefully collect the drops of eluting DCM solvent, a stainless steel vial rack 
with new specially-chosen GC glass vials was placed under the column end when the 
reservoir was opened for a manual injection of a DCM extract (0.25 mL).  The column 
was re-pressurized for a 0.25-mL rinse before 10 mL DCM was added.  GC glass vials 
were chosen for their consistent volumes, lot-tested by manufacturers for minimal 
contaminants, and suitably packaged to minimize exposure to lab dust.  With 
convenient volumes known to the nearest 0.1 mL, vials were chosen for accurate 
collection (1.6-mL “Maximum Recovery” vial and 0.3-mL amber conical vial, Waters, 
Milford, MA or Shamrock Glass, Seaford, DE) and a conical 1.0-mL vial (Sun-SRI, 
Rockwood, TN).    The sequence of vials used began with two 1.6 mL vials, a 1.0 mL vial, 
two 0.3 mL vials, and two more 1.6 mL vials (Figures 10-11).  The two small (0.3 mL) 
conical vials were strategically placed at the end of the elution of bulkier lipid and at the 
beginning of the elution of smaller molecule (mass <1000 Da.) organic 
contaminants/pollutants.  For Sets  1, 2, and 4, the bulkier lipid eluted in 0-4.5 mL DCM 
just ahead of smaller molecule organic pollutants from 4.5-8.0 mL DCM. 
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Figure 10.  Flash GPC elution was collected in appropriate-sized vials   (left to right, two 
1.6 mL, one 1.0 mL, two 0.3 mL amber, and two 1.6 mL) for beta-carotene check.  
A key feature of this miniaturized GPC column was that the separated lipid was 
collected accurately in the first four tared glass GC vials (Figures 10-11).  After 
evaporation, the lipid mass, left mostly in vials 2-4, was then measured directly with a 
five-decimal place balance negating the need to use any of the valuable small extract for 
a separate lipid determination (Figure 12). 
 
Figure 11.  Orange-colored beta-carotene, eluted before 4.5 mL, as did lipid. 
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Figure 12.  Lipid can be seen to coat the walls of evaporated GPC collection vials (2-4) of 
elution from 1.6-4.5 mL for extracts of both toenail samples in Set 2 (vials “A” or “B”). 
For Sets 1, 2, and 4, one GPC eluate (4.5-8.0 mL) was collected for all targeted 
organic compounds.  However, for Set 3 targeted for phenolic and acidic compounds, 
two portions of the GPC eluate were collected ([A] 4.2 – 4.8mL and [B] 4.8-8.0 mL) to 
ensure at least partial recovery of early eluting, bulky phthalate metabolites in [A] 
despite also collecting the remainder of the eluting lipid.  From each sample in all sets, 
collected GPC eluate solutions were combined in a glass culture tube and concentrated 
to < 0.5 mL with a gentle stream of high purity nitrogen.  For quality control and initial 
miniature GPC method development, GPC elutions were checked (a) gravimetrically 
with cod liver oil or corn oil for lipid recovery; (b) colormetrically with beta-carotene 
(Figure 11), a bulky C40 unsaturated pigment with intense orange color that elutes just 
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before the early di-(ethylhexyl) phthalate (DEHP); and (c) radiometrically with 14C-DEHP 
or 14C-cholesterol.  GPC elutions were consistent, provided that the 2.0 g mass of S-X3 
media was accurately apportioned and the S-X3 gel swelled effectively with minimal 
trapped air bubbles. 
Methylation of (Polar) Phenols and Acids with Iodomethane 
Sets 1 and 3 included a methylation with back-extraction step for converting 
polar phenolic and acidic compounds to much less polar methyl ethers or methyl esters, 
which appeared as sharp detectable peaks by GC/MS.  After concentrating the eluates 
to < 0.5 mL, 0.75-mL 5% K2CO3 (Sigma and Fisher water) was added to deprotonate the 
compounds (at pH 12), 10-mL acetone to homogenize the solutions, and 0.25-mL 
iodomethane to methylate the anions (reaction times of several hours or overnight) at 
room temperature.  A high purity nitrogen stream removed most of the acetone before 
extraction (three times) with 3-mL hexane, concentration to 0.5 mL, and cleanup using a 
3-mL glass solid phase extraction (SPE) cartridge with 0.5-g basic alumina topped with  
2-g Na2SO4, a common drying agent (Figure 13). 
Cleanup with 0.5-g Basic Alumina SPE 
Following GPC, a 3-mL glass SPE cartridge with glass fiber frits pre-packed with 
0.5-g basic alumina (Macherey-Nagel, Bethlehem, PA) was used as a clean-up step for all 
methods.  Alumina is a common sorbent for normal phase liquid chromatography, and 
basic alumina is especially suited to remove (by chemi-sorbing) fatty acids that would 
have at least partially been collected via GPC.  For Set 3, the basic alumina SPE was   
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Figure 13.  Cleanup with 0.5-g Basic Alumina (and 2-g Na2SO4) SPE Cartridge 
topped with the drying agent, 1 g Na2SO4, as the final cleanup/fractionation step for the 
methylated derivatives of phenolic/acidic compounds.  Several fractions, using eluants 
each progressively more polar, were collected from the SPE in Set 3 using 6-mL eluants 
of DCM, 2% acetone in DCM, and finally 10% acetone in DCM, to ensure elution of both 
methyl ethers and methyl esters.  In the other sample sets for non-polar compounds, a 
basic alumina SPE was used to remove residual fatty acids while eluting targeted 
compounds with 6-mL DCM.  Fractions were collected in culture tubes and concentrated 
to 0.5 mL with a gentle stream of high purity nitrogen. 
    SPE Cartridge    
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Fractionation of Non-Polar Compounds with 4-g Basic Alumina Flash 
Chromatography Column 
Lacking a clean room, a 4-g basic alumina flash chromatography column was 
used to provide a clean environment (0.5 bar high purity nitrogen) to replace open-air 
gravity normal phase chromatography columns which are prone to contamination from 
lab air or dust.  With higher performance flash-sized basic alumina available, (40-63 μm, 
Sorbent Technologies, Atlanta, GA), eluant solvent volume could be reduced.  The flash 
column was used for Sets 1, 2, and 4 to split non-polar compounds into two eluate 
fractions.  Previously, I reported consistent separations with this flash column 
(irrespective of room humidity) with significantly lower contamination of PBDEs and 
PCBs in blank samples.69  Storing basic alumina in a stoppered glass flask at 130 ºC 
minimized dust but required slightly stronger eluant strength than in Figure 14.  Clean, 
empty glass columns were pre-heated to 130 ºC before dry-packing.  The first (least 
polar) fraction (1) now used 30 mL 1% DCM in cyclopentane to isolate DDEs,  
hexachlorobenzene (HCB), and common ortho-substituted PCBs.  The eluant, 
cyclopentane, with slight aromaticity and slightly increased elutropic strength compared 
with hexane, was key to separating common ortho-substituted PCBs from dioxin-like 
non-ortho-PCBs.69  Subsequently, Fraction 2 with 15 mL 0.5% acetone in DCM was used 
to elute many other compounds including PBDEs, chlordanes, and other organochlorine 
pesticides.  An additional more polar fraction was considered, but natural (more polar) 
sterols and cholesteryl esters could also have eluted to hamper GC/MS detection of 
possible pollutants.  For quality assurance, elution checks were made by measuring  
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Figure 14.  Non-polar organic pollutants were chromatographed by a 4-g basic alumina flash column  with 60 mL 0.5% DCM in 
cyclopentane eluant followed by 4 mL of 2%, 10%, 25%, and 100% DCM.  Fraction 1 had DDE (light blue), (most PCBs, not shown), 
and a few pesticides; Fraction 2 had PBDEs, chlordanes, dieldrin, and a few non-ortho-PCBs (final:  15 mL 0.5% acetone in DCM).69 
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14C-p,p’DDE (typically in Fraction 1, Figure 14) with a Beckman LS 6500 scintillation 
counter. 
GC/Full-scan Mass Spectrometry to Identify Unsuspected Compounds 
Trace-level detection and quantitation of targeted compounds were done 
effectively by using a highly selective GC/High Resolution Mass Spectrometer 
(GC/HRMS).  This research was greatly helped by also using a less sensitive and less 
selective benchtop GC/quadrupole MS (GC/MS) in full-scan MS analysis for a broader 
investigation to detect and identify unsuspected compounds and to confirm targeted 
compounds at higher concentrations.  A GC/full scan MS analysis was done for Set 1 
after GC/HRMS was run with a short capillary column to target relatively few analytes 
and for Set 3 to investigate polar compounds following methylation in several fractions 
before targeted GC/HRMS analysis (Table 2, p.25).  Final 0.3 mL eluates (from basic 
alumina) in nonane were analyzed by injecting 3 µL into a cool-on-column inlet on a 
Thermo 8000 Top GC/TRACE MS Plus system (Austin, TX) with a 30 m x 0.15 mm i.d. 
BPX5 column (SGE, Austin, TX).  A deactivated retention gap (0.25 m x 0.25 mm and 2.5 
m x 0.25 mm i.d., MEGA Scientific, Legnano, Italy) was connected with glass press-tight 
connectors (Restek, Bellefonte, PA) to the column to accommodate the syringe needle 
for on-column injection.  The column was temperature programmed from 110 ºC-330 ºC 
at 3 ºC/min and helium pressure programmed from 300-500 kPa at 3 kPa/min.  For 
maximum sensitivity, the TRACE MS Plus was tuned by the analyst before mass 
calibration by the computer data system (with perfluoro-t-butylamine) with built-in 
specifications.  With the photomultiplier set at 350 V, GC/full scan (m/z 50-750) MS 
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spectra were acquired at the fastest speed possible (0.7 s/scan) and data processed 
using Thermo XCalibur (V1.4) software.  Identifying compounds by mass spectra was 
aided by the data system reference MS libraries, totaling nearly 500,000 spectra, NIST 
2011 Mass Spectral Library (NIST, Washington, D.C.) and Wiley Registry Seventh Edition 
MS Library (Wiley, Indianapolis, IN). 
GC/High Resolution Mass Spectrometry (GC/HRMS) Selected ion 
monitoring 
The Waters Autospec GC/HRMS system was setup at a mass resolution of at 
least 10,000 (Resolving Power, 10% valley) in Selected Ion Monitoring (SIM) mode, a 
highly selective technique for targeted compounds.  For example, at m/z 500, the 
instrument in this mode could selectively detect two different compounds with masses 
differing by only 0.05 Da if their concentrations were within a factor of 10 of each other.  
The magnet was held within each group of selected ions during a specified time range at 
a “lock mass” of known accurate mass.  Within a limit of 1.5 times the lowest mass in 
the group, the accelerating voltage was rapidly switched by the data system (downward 
within a factor of 1.5) from one ion to another within an ion group for a dwell period (12 
to 40 ms) for each ion.  Also, an extra delay or settling time (10 ms) for each ion was 
required to stabilize from the voltage for the previous ion.  With GC peak widths of only 
a few seconds, it was important to minimize the total time to cycle within a group to 
about 500 ms or less to provide sufficient data points to measure the Gaussian-shaped 
analyte GC peaks.  Each ion mass was specified accurately to four decimal places and 
multiple ion groups were analyzed tailored to analytes known or suspected in each basic 
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alumina eluate fraction (Tables 3-6).  Given the HRMS mass range limitation within an 
ion group and various GC retention times of analytes, ions selected often had to be 
alternate, less abundant, fragment ions of compounds with excessively large mass 
compared to other compounds eluting within the same GC time frame.  GC/HRMS SIM 
data were acquired and data processed using Waters’ Masslynx software, and 
comprehensive quantitative analysis was performed using Waters’ Targetlynx software.  
After retention times of analyte standards were established for current GC conditions, 
SIM groups of selected accurate mass ions in electron impact ionization mode were 
acquired with the Autospec HRMS at 36 eV electron energy, filament trap current of  
500 µA, photomultiplier at 350 V, and source temperature of 250 ºC.   
GC/HRMS SIM methods shown in Tables 3-6 became more comprehensive than 
in Set 1, when the number of analytes (ions) targeted were fewer.  In basic alumina 
Fraction 1, mainly DDE (metabolite of DDT), 13C-DDE surrogate, pentachlorobenzene, 
and hexachlorobenzene were targeted in Set 1 (Table 2).  PCBs (tri- to decachloro-) were 
included in case nail concentrations greatly exceeded method blank levels.  Fraction 2 of 
Set 1 was analyzed for di- to deca-PBDEs, two metabolites, pentachloroanisole (of 
pentachlorophenol) and oxychlordane (of chlordane), plus methylated ether derivatives 
of BPA, triclosan, tetrabromobisphenol A, tri-to hexa-PCB hydroxyl metabolites, and 
methylated esters of phthalate metabolites.  Possible metabolites were targeted 
because of concern that lab background levels of parent compounds may mask actual 
levels in the nails.  Later sample sets 2 and 4 included additional compounds in Fraction 
2 that were originally unsuspected (e.g. chlordanes and synthetic musk fragrances).  
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Table 3.  GC/HRMS Selected Ion Monitoring of Fraction 1 (PCBs, Pesticides) 
 
SIM Group 1 Dwell Ion SIM Group 2 Dwell Ion
(2.8-7.0 min) (14 ions) (ms) Ratio (7.0-15.2 min) (24 ions) (ms) Ratio
Di-PCBs 222.0003 15 1.00 Tri-PCBs 255.9614 15 1.00
Di-PCBs 223.9974 15 0.66 Tri-PCBs 257.9584 15 0.99
13C-Di-PCBs 234.0406 15 1.00 Tetra-PCNs 263.9067 15 0.76
13C-Di-PCBs 236.0376 15 0.66 Tetra-PCNs 265.9038 15 1.00
Lock Mass 242.9856 16 --- 13C-Tri-PCBs 268.0016 15 1.00
Lock Mass Check 242.9856 12 --- 13C-Tri-PCBs 269.9986 15 0.99
Penta-Cl-benzene 247.8521 15 0.61 Tetra-PCBs 289.9224 15 0.76
Penta-Cl-benzene 249.8491 15 1.00 Tetra-PCBs 291.9194 15 1.00
Tri-PCBs 255.9614 15 1.00 Lock Mass 292.9824 16 ---
Tri-PCBs 257.9584 15 0.99 Lock Mass Check 292.9824 12 ---
13C-Tri-PCBs 268.0016 15 1.00 Penta-PCNs 299.8648 15 1.00
13C-Tri-PCBs 269.9986 15 0.99 Penta-PCNs 301.8618 15 0.66
Hexa-Cl-benzene 283.8102 15 1.00 13C-Tetra-PCBs 301.9626 15 0.76
Hexa-Cl-benzene 285.8072 15 0.82 13C-Tetra-PCBs 303.9597 15 1.00
o,p'- & p,p'-DDEs 315.9380 15 0.76
o,p'- & p,p'-DDEs 317.9351 15 1.00
Penta-PCBs 323.8834 15 0.61
Penta-PCBs 325.8804 15 1.00
13C-p,p'-DDE 327.9783 15 0.76
13C-p,p'-DDE 329.9753 15 1.00
13C-Penta-PCBs 335.9236 15 0.61
13C-Penta-PCBs 337.9207 15 1.00
Hexa-PCBs 359.8414 15 1.00
SIM Group 3 Dwell Ion Hexa-PCBs 361.8385 15 0.82
(15.2-23.5 min) (22 ions) (ms) Ratio
Penta-PCBs 323.8834 15 0.61 SIM Group 4 Dwell Ion
Penta-PCBs 325.8804 15 1.00 (23.5-35.0 min) (20 ions) (ms) Ratio
Hexa-PCNs 333.8258 15 1.00 Hepta-PCBs 393.8025 15 1.00
Hexa-PCNs 335.8229 15 0.82 Hepta-PCBs 395.7995 15 0.98
13C-Penta-PCBs 335.9236 15 0.61 13C-Hepta-PCBs 405.8428 15 1.00
13C-Penta-PCBs 337.9207 15 1.00 13C-Hepta-PCBs 407.8398 15 0.98
o,p'-DDT 351.9147 15 0.64 Octa-PCBs 427.7635 15 0.87
o,p'-DDT 353.9118 15 1.00 Octa-PCBs 429.7606 15 1.00
Hexa-PCBs 359.8414 15 1.00 13C-Octa-PCBs 439.8038 15 0.87
Hexa-PCBs 361.8385 15 0.82 13C-Octa-PCBs 441.8008 15 1.00
13C-Hexa-PCBs 371.8817 15 1.00 Lock Mass 454.9729 12 ---
13C-Hexa-PCBs 373.8788 15 0.82 Lock Mass Check 454.9729 16 ---
Hepta-PCBs 393.8025 15 1.00 Nona-PCBs 461.7245 15 0.76
Hepta-PCBs 395.7995 15 0.98 Nona-PCBs 463.7216 15 1.00
Lock Mass 404.9761 16 --- Hexa-Br-Biphenyls 467.7006 15 1.00
Lock Mass Check 404.9761 12 --- Hexa-Br-Biphenyls 469.6986 15 0.66
13C-Hepta-PCBs 405.8428 15 1.00 13C-Nona-PCBs 473.7648 15 0.76
13C-Hepta-PCBs 407.8398 15 0.98 13C-Nona-PCBs 475.7619 15 1.00
Octa-PCBs 427.7635 15 0.87 Deca-PCB 497.6826 15 1.00
Octa-PCBs 429.7606 15 1.00 Deca-PCB 499.6797 15 0.87
13C-Octa-PCBs 439.8038 15 0.87 13C-Deca-PCB 509.7229 15 1.00
13C-Octa-PCBs 441.8008 15 1.00 13C-Deca-PCB 511.7199 15 0.87
KEY:  Quality Assurance Tolerance for ratios of ion abundances is within 15%
PCBs = Polychlorinated Biphenyls; PCNs = Polychlorinated Naphthalenes;
DDE = Dichlorodiphenyldichloroethylene;  DDT = Dichlorodiphenyltrichloroethane
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Table 4.  PCB Congeners and Pesticides in Fraction 1 by GC Retention Time 
 
 
SIM
Analyte Min. Group Surrogate Std Internal Std Analyte Min. Group Surrogate Std Internal Std
Pentachlorobenzene 3.78 1 13C-p,p'-DDE None Hexa-PCB 149 15.21 3 13C-PCB 153
Di-PCBs 4/10 4.53 1 13C-PCB 4 13C-PCB 9 Hexa-PCB 153/168 16.49 3 13C-PCB 153
Di-PCB 6 5.25 1 13C-PCB 8 13C-PCB 9 Hexa-PCB 141 17.15 3 13C-PCB 153
Di-PCB 8 5.41 1 13C-PCB 8 Hexa-PCB 137 17.41 3 13C-PCB 138 13C-PCB 162
Hexachlorobenzene 5.48 1 13C-p,p'-DDE None Hexa-PCB 138/158 17.91 3 13C-PCB 138
Tri-PCB 19 5.82 1 13C-PCB 19 13C-PCB 37 Hexa-PCB 129 18.18 3 13C-PCB 138
Tri-PCB 18 6.41 1 13C-PCB 19 Hexa-PCB 128 19.23 3 13C-PCB 167 13C-PCB 162
Tri-PCB 16 6.94 2 13C-PCB 28 13C-PCB 37 Hexa-PCB 167 19.41 3 13C-PCB 167
Tri-PCBs 31/28 7.88 2 13C-PCB 28 Hexa-PCB 156 20.56 3 13C-PCB 156 13C-PCB 162
Tri-PCB 33 8.16 2 13C-PCB 28 Hexa-PCB 157 20.80 3 13C-PCB 157 13C-PCB 162
Tri-PCB 22 8.47 2 13C-PCB 28
Tetra-PCB 54 7.33 2 13C-PCB 54 13C-PCB 79 Hepta-PCB 188 15.91 3 13C-PCB 188 13C-PCB 162
Tetra-PCB 52 9.04 2 13C-PCB 52 13C-PCB 79 Hepta-PCB 178 18.09 3 13C-PCB 188
Tetra-PCB 49 9.17 2 13C-PCB 52 Hepta-PCB 187 18.54 3 13C-PCB 188
Tetra-PCB 44 9.77 2 13C-PCB 52 Hepta-PCB 183 18.82 3 13C-PCB 188
Tetra-PCB 41 10.21 2 13C-PCB 52 Hepta-PCB 174 19.78 3 13C-PCB 180 13C-PCB 194
Tetra-PCB 40 10.53 2 13C-PCB 70 13C-PCB 79 Hepta-PCB 177 20.04 3 13C-PCB 180
Tetra-PCB 74 11.28 2 13C-PCB 70 Hepta-PCB 171 20.28 3 13C-PCB 180
Tetra-PCB 70 11.48 2 13C-PCB 70 Hepta-PCB 180/193 21.34 3 13C-PCB 180
Tetra-PCB 66 11.58 2 13C-PCB 70 Hepta-PCB 191 21.55 3 13C-PCB 180
Tetra-PCB 60 12.31 2 13C-PCB 70 Hepta-PCB 170 22.80 3 13C-PCB 170 13C-PCB 194
o,p'-DDE 12.31 2 13C-p,p'-DDE None Hepta-PCB 189 24.47 4 13C-PCB 189 13C-PCB 194
Octa-PCB 202 20.04 3 13C-PCB 202 13C-PCB 194
Penta-PCB 104 9.47 2 13C-PCB 104 13C-PCB 111 Octa-PCB 201 20.48 3 13C-PCB 202
Penta-PCB 95 11.48 2 13C-PCB 95 13C-PCB 111 Octa-PCB 200 21.76 3 13C-PCB 202
Penta-PCB 84 12.38 2 13C-PCB 101 13C-PCB 111 Octa-PCB 199 23.10 3 13C-PCB 202
Penta-PCB 90 12.46 2 13C-PCB 101 Octa-PCB 203 23.44 4 13C-PCB 202
Penta-PCB 101 12.53 2 13C-PCB 101 Octa-PCB 194 26.18 4 13C-PCB 205 13C-PCB 194
Penta-PCB 99 12.72 2 13C-PCB 101 Octa-PCB 205 26.35 4 13C-PCB 205
Penta-PCB 119 12.96 2 13C-PCB 101 Nona-PCB 208 24.76 4 13C-PCB 208 13C-PCB 206
Penta-PCB 97 13.42 2 13C-PCB 101 Nona-PCB 207 25.22 4 13C-PCB 208
Penta-PCB 87 13.75 2 13C-PCB 101 Nona-PCB 206 27.93 4 13C-PCB 208
p,p'-DDE 13.86 2 13C-p,p'-DDE None Deca-PCB 209 29.30 4 13C-PCB 209 13C-PCB 206
Penta-PCB 85 13.89 2 13C-PCB 101
Penta-PCB 110 14.17 2 13C-PCB 101 Internal Standards:
Penta-PCB 123 15.31 3 13C-PCB 123 13C-PCB 111 13C-Di-PCB 9 5.03 1
Penta-PCB 118 15.52 3 13C-PCB 118 13C-PCB 111 13C-Tri-PCB 37 10.10 2
o,p'-DDT 15.95 13C-p,p'-DDE None 13C-Tetra-PCB 79 13.00 2
Penta-PCB 114 15.99 3 13C-PCB 114 13C-PCB 111 13C-Penta-PCB 111 13.67 2
Penta-PCB 105 16.77 3 13C-PCB 105 13C-PCB 111 13C-Hexa-PCB 162 19.08 3
Hexa-PCB 151 14.62 2 13C-PCB 153 13C-PCB 162 13C-Octa-PCB 194 26.16 4
Hexa-PCB 135 14.81 2 13C-PCB 153 13C-Nona-PCB 206 27.92 4
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Table 5.  GC/HRMS Selected Ion Monitoring of PBDEs, Pesticides, and 13C-Surrogates in 
Basic Alumina - Fraction 2 
 
 
 
  
GC Retention 16 ions Dwell Ion GC Retention 14 ions Dwell Ion
SIM Group 1 2.15-4.95 min m/z (ms) Ratios SIM GROUP 2 4.95-7.6 min m/z (ms) Ratios
Traseolide 4.47 215.1436 12 1.00 Lock mass check ion --- 292.9824 10 ---
Hexachlorocyclohexanes α-3.40, γ-3.93, 216.9145 12 0.76 Lock mass ion --- 292.9824 20 ---
Hexachlorocyclohexanes β-4.03, δ-4.74 218.9115 12 1.00 Dacthal 6.17 298.8836 20 0.78
Lock mass ion --- 242.9856 15 --- Dacthal 6.17 300.8807 20 1.00
Lock mass check ion --- 242.9856 10 --- Di-PBDEs 5.04 - 6.78 325.8942 20 0.51
Galaxolide; Tonalide 4.52; 4.59 243.1749 12 1.00 Di-PBDEs 5.04 - 6.78 327.8921 20 1.00
Mono-PBDEs 3.16, 3.26, 3.39 249.9816 12 --- Chlordene (s) Unknown 337.8571 20 1.00
Galaxo-,Tona-,Traseo-lide4.47, 4.52, 4.59 258.1984 12 Varies 13C-Di-PBDE 15 6.76 337.9344 20 0.51
13C-Mono-PBDE 3 3.39 260.0239 12 --- Chlordene (s) Unknown 339.8542 20 0.80
Trifluralin; Benfluralin 2.99; 3.04 264.0232 12 Varies 13C-Di-PBDE 15 6.76 339.9324 20 1.00
Pentachloroanisole 3.45 277.8627 12 0.65 Heptachlor Epoxide 7.09 352.8442 20 1.00
Pentachloroanisole 3.45 279.8597 12 1.00 Heptachlor Epoxide 7.09 354.8413 20 0.80
Trifluralin (M+.) 2.99 292.0545 12 1.00 Oxychlordane 7.01 386.8052 20 1.00
Tribromoanisole (s) 2.85 300.7686 12 1.00 Oxychlordane 7.01 388.8023 20 1.00
Tribromoanisole (s) 2.85 302.7666 12 0.97
Benfluralin (M+.) 3.04 306.0702 12 1.00
GC Retention 23 ions Dwell Ion GC Retention 22 ions Dwell Ion
SIM GROUP 3 7.6-11.8 min m/z (ms) Ratios SIM GROUP 4 11.8-17.35 min m/z (ms) Ratios
Tetra-PCBs (#81, 77) 9.29; 9.67 289.9224 12 0.77 Tetra-PCDD (dioxin) < 11.8-12.5 319.8965 12 0.77
Tetra-PCBs (#81, 77) 9.29; 9.67 291.9194 12 1.00 Tetra-PCDD (dioxin) < 11.8-12.5 321.8936 12 1.00
Methyl Triclosan 8.46 301.9668 12 0.77 Penta-PCB (#126) 12.66 323.8834 12 0.62
Methyl Triclosan 8.46 303.9640 12 1.00 Penta-PCB (#126) 12.66 325.8804 12 1.00
p,p'-DDE (most in F1) 9.19 315.9380 12 0.77 13C-PCB 126 12.64 335.9236 12 0.62
p,p'-DDE (most in F1) 9.19 317.9351 12 1.00 13C-PCB 126 12.64 337.9207 12 1.00
DDDs (o,p'- and p,p') 9.45; 10.84 319.9507 12 1.00 Penta-PCDF (furans) 12.5-  339.8597 12 1.00
DDDs (o,p'- and p,p') 9.45; 10.84 321.9478 12 0.45 Penta-PCDF (furans) 12.5-  341.8567 12 0.66
13C-p,p'-DDE 9.18 327.9783 12 0.77 p,p'-DDT 12.11 351.9147 12 1.00
13C-p,p'-DDE 9.18 329.9753 12 1.00 p,p'-DDT 12.11 353.9118 12 0.64
Endosulfan I and II 8.18; 10.49 336.8760 12 1.00 Hexa-PCB (#169) 15.66 359.8415 12 1.00
Endosulfan I and II 8.18; 10.49 338.8731 12 0.64 Hexa-PCB (#169) 15.66 361.8385 12 0.80
Dieldrin & Endrin 9.09; 9.81 342.9018 12 0.61 13C-Hexa-PCB 169 15.65 371.8817 12 1.00
Dieldrin & Endrin 9.09; 9.81 344.8989 12 1.00 13C-Hexa-PCB 169 15.65 373.8788 12 0.80
Chlordanes (cis-, trans-) 7.87; 8,19 372.8260 12 1.00 Endosulfan Sulfate 11.94 386.8400 12 1.00
Chlordanes (cis-, trans-) 7.87; 8,19 374.8231 12 0.95 Endosulfan Sulfate 11.94 388.8371 12 0.64
Lock mass ion --- 404.9760 15 --- Lock mass ion --- 404.9760 10 ---
Lock mass check ion --- 404.9760 10 --- Lock mass check ion --- 404.9760 15 ---
Tri-PBDEs 8.21 - 11.60 405.8027 12 1.00 Tetra-PBDEs 12.52 - 17.00 483.7132 12 0.68
Nonachlors (cis-, trans-) 8.21; 10.37 406.7870 12 0.87 Tetra-PBDEs 12.52 - 17.00 485.7111 12 1.00
Tri-PBDEs 8.21 - 11.60 407.8006 12 0.98 13C-Tetra-PBDEs Various 495.7534 12 0.69
Nonachlors (cis-, trans-) 8.21; 10.37 408.7840 12 1.00 13C-Tetra-PBDEs Various 497.7514 12 1.00
13C-Tri-PBDE 28 10.61 417.8429 12 ---
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GC Retention 20 ions Dwell Ion GC Retention 20 ions Dwell Ion
SIM GROUP 5 17.35-23.2 min m/z (ms) Ratios SIM GROUP 6 23.2-31.05 min m/z (ms) Ratios
Hexa-PBDEs (M-2Br) 21.26 -> 481.6975 15 0.68 Lock mass check ion --- 554.9665 10 ---
Hexa-PBDEs (M-2Br) 21.26 -> 483.6955 15 1.00 Lock mass ion --- 554.9665 16 ---
Methoxy-Tetra-PBDEs Unknown 513.7238 15 0.68 HexaBr-cyclododecane Undetermined 560.7284 15 0.77
Methoxy-Tetra-PBDEs Unknown 515.7218 15 1.00 Hepta-PBDEs (M-2Br) 26.32 - 31.28 561.6060 15 1.00
Methoxy-Cl-TetraBr-PBDEs Unknown 549.6826 15 1.00 HexaBr-cyclododecane Undetermined 562.7264 15 1.00
Methoxy-Cl-TetraBr-PBDEs Unknown 551.6805 15 0.81 Hepta-PBDEs (M-2Br) 26.32 - 31.28 563.6040 15 0.97
Lock mass ion --- 554.9665 16 --- Methoxy-Penta-PBDEs Unknown 593.6323 15 1.00
Lock mass check ion --- 554.9665 10 --- Methoxy-Penta-PBDEs Unknown 595.6303 15 0.98
Penta-PBDEs (M+.) 16.92 - 22.04 563.6216 15 1.00 Hexa-PBDEs (M+.) 23.2 - 27.52 641.5321 15 0.77
Penta-PBDEs (M+.) 16.92 - 22.04 565.6196 15 0.97 Hexa-PBDEs (M+.) 23.2 - 27.52 643.5301 15 1.00
TetraBr-BPA-dime-ether Undetermined 569.7864 15 1.00 13C-Hexa-PBDEs 23.70-26.41 653.5724 15 0.77
TetraBr-BPA-dime-ether Undetermined 571.7844 15 0.69 13C-Hexa-PBDEs 23.70-26.41 655.5704 15 1.00
13C-Penta-PBDEs Various 575.6619 15 1.00 Bis(TriBrPhenoxyEthane) 28.71 685.5582 15 0.80
13C-Penta-PBDEs Various 577.6598 15 0.97 Bis(TriBrPhenoxyEthane) 28.71 687.5562 15 1.00
Methoxy-Penta-PBDEs Unknown 593.6323 15 1.00 13C-Bis[TriBr-PhenoxyEt] 28.69 697.5985 15 0.80
Methoxy-Penta-PBDEs Unknown 595.6303 15 0.98 13C-Bis[TriBr-PhenoxyEt] 28.69 699.5965 15 1.00
Hexa-PBDEs (M+.) 21.26 -> 641.5322 15 0.77 Hepta-PBDEs (M+.) 26.32 - 31.28 721.4407 15 1.00
Hexa-PBDEs (M+.) 21.26 -> 643.5302 15 1.00 Hepta-PBDEs (M+.) 26.32 - 31.28 723.4386 15 0.97
13C-Hexa-PBDE 154 22.12 653.5724 15 0.77 13C-Hepta-PBDEs 27.56; 29.31 733.4809 15 1.00
13C-Hexa-PBDE 154 22.12 655.5704 15 1.00 13C-Hepta-PBDEs 27.56; 29.31 735.4788 15 0.97
GC Retention 14 ions Dwell Ion GC Retention 12 ions Dwell Ion
SIM GROUP 7 31.05-36.1 min m/z (ms) Ratios SIM GROUP 8 36.1-39.7 min m/z (ms) Ratios
Octa-PBDEs (M-2Br) 31.19 - 35.36 639.5165 25 0.77 Nona-PBDEs (M-2Br) 36.57 - 37.97 719.4250 30 1.00
Octa-PBDEs (M-2Br) 31.19 - 35.36 641.5144 25 1.00 Nona-PBDEs (M-2Br) 36.57 - 37.97 721.4229 30 0.97
Hexa-PBDEs Unnecessary 641.5321 25 0.77 13C-Nona-PBDEs 36.96; 37.96 731.4652 30 1.00
Hexa-PBDEs Unnecessary 643.5301 25 1.00 13C-Nona-PBDEs 36.96; 37.96 733.4632 30 0.97
Nona-PBDEs (M-2Br) QC Check 719.4250 25 1.00 Lock mass check ion --- 770.9598 15 ---
Nona-PBDEs (M-2Br) QC Check 721.4229 25 0.97 Lock mass ion --- 770.9598 29 ---
Hepta-PBDEs (M+.) <  - 31.28 721.4406 25 1.00 Octa-PBDEs (M+.) QC Check 799.3511 30 0.82
Hepta-PBDEs (M+.) <  - 31.28 723.4386 25 0.97 Octa-PBDEs (M+.) QC Check 801.3491 30 1.00
Lock mass ion --- 770.9598 20 --- Nona-PBDEs (M+.) 36.57 - 37.97 879.2596 30 1.00
Lock mass check ion --- 770.9598 15 --- Nona-PBDEs (M+.) 36.57 - 37.97 881.2575 30 0.97
Octa-PBDEs (M+.) 31.19 - 35.36 799.3512 25 0.82 13C-Nona-PBDEs (M+.) 36.96; 37.96 891.2998 30 1.00
Octa-PBDEs (M+.) 31.19 - 35.36 801.3491 25 1.00 13C-Nona-PBDEs (M+.) 36.96; 37.96 893.2978 30 0.97
13C-Octa-PBDEs (M+.) 31.96; 33.91 811.3912 25 0.82
13C-Octa-PBDEs (M+.) 31.96; 33.91 813.3892 25 1.00 GC Retention 15 ions Dwell Ion
SIM GROUP 9 39.7-47 min m/z (ms) Ratios
GC Retention 15 ions Dwell Ion Deca-PBDE 209 (M+.) 41.77 957.1701 30 0.87
SIM GROUP 9 39.7-47 min m/z (ms) Ratios Deca-PBDE 209 (M+.) 41.77 959.1680 30 1.00
Deca-PBDE 209 (M-2Br) 41.77 797.3355 30 0.82 Deca-DiPh-Ethane 44.09 971.2048 30 1.00
Deca-PBDE 209 (M-2Br) 41.77 799.3334 30 1.00 Deca-DiPh-Ethane 44.09 973.2029 30 0.76
13C-PBDE 209 (M-2Br) 41.75 811.3737 30 1.00 13C-PBDE 209 (M+.) 41.75 973.2063 30 0.81
13C-PBDE 209 (M-2Br) 41.75 813.3716 30 0.78 13C-PBDE 209 (M+.) 41.75 975.2042 30 0.45
Lock mass ion --- 865.9581 25 --- 13C-PBDE 209 (M+.) 41.75 977.2022 30 0.17
Lock mass check ion --- 865.9581 15 --- 13C-Deca-DiPh-Ethane 44.08 983.2533 30 0.81
Continued -----------------------------> 13C-Deca-DiPh-Ethane 44.08 985.2513 30 1.00
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Table 6.  GC/HRMS Selected Ion Monitoring for Triclosan, Bisphenol A, and Other Polar 
Compounds 
 
GC Retention 6 ions Dwell Ion
SIM GROUP 1 5.0-16.5 min m/z (mass)  (ms) Ratios
Most Phthalates (< Octyl) Variety possible 149.0239 40 1.00
13C4-Phthalates (several surrogates) Several 153.0373 40 1.00
Methyl Phthalates (methylated metabolites) Variety possible 163.0395 40 0.20-0.50
13C4-Methyl Phthalates (several surrogates) Several 167.0529 40 0.20-0.50
Lock mass check ion --- 180.9888 25 ---
Lock mass ion --- 180.9888 45 ---
GC Retention 18 ions Dwell Ion
SIM GROUP 2 16.5-30 min m/z (mass)  (ms) Ratios
Bisphenol A (as dimethylether) 17.37 241.1229 25 1.00
13C12-BPA (as dimethylether) 17.36 253.1631 25 1.00
Bisphenol A (as dimethylether) M+. 17.37 256.1463 25 0.22
13C12-PCB 101 (Int. Std)-Fragment ion 18.57 265.9859 25 1.00
13C12-BPA (as dimethylether) M+. 17.36 268.1865 25 0.22
13C12-PCB 101 (Int. Std)-Fragment ion 18.57 269.9800 25 0.20
Lock mass check ion --- 292.9824 20 ---
Lock mass ion --- 292.9824 35 ---
Triclosan (as methyl ether) 18.80 301.9668 25 1.00
Triclosan (as methyl ether) 18.80 303.9640 25 0.97
13C-Triclosan (as methyl ether) 18.79 314.0070 25 1.00
p,p'-DDE [detected with polar compds?] 20.17 315.9380 25 0.77
13C-Triclosan (as methyl ether) 18.79 316.0041 25 0.97
p,p'-DDE [detected with polar compds?] 20.17 317.9351 25 1.00
Hydroxy-Tetra-PCBs (as methyl ether) Undetermined 319.9329 25 0.77
Hydroxy-Tetra-PCBs (as methyl ether) Undetermined 321.9301 25 1.00
13C-p,p'-DDE [recovered w/polars?] 20.15 327.9783 25 0.77
13C-p,p'-DDE [recovered w/polars?] 20.15 329.9753 25 1.00
GC Retention 10 ions Dwell Ion
SIM GROUP 3 30-45 min m/z (mass)  (ms) Ratios
Hydroxy-Tetra-PBDEs (as methyl ether) Undetermined 513.7238 30 0.68
Hydroxy-Tetra-PBDEs (as methyl ether) Undetermined 515.7218 30 1.00
Tetrabromo-BPA (as dimethylether) 38.44 554.7629 30 0.69
Lock mass check ion --- 554.9665 20 ---
Lock mass ion --- 554.9665 35 ---
Tetrabromo-BPA (as dimethylether) 38.44 556.7609 30 1.00
13C-Tetrabromo-BPA (as dimethylether) 38.40 566.8032 30 0.68
13C-Tetrabromo-BPA (as dimethylether) 38.40 568.8011 30 1.00
Hydroxy-Penta-PBDEs (as methyl ether) Undetermined 593.6323 30 1.00
Hydroxy-Penta-PBDEs (as methyl ether) Undetermined 595.6303 30 0.98
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Only a short 13 m capillary column was used in Sets 1-2 with GC/HRMS (Table 2, p.25). 
For all samples, final 0.3 mL eluates (Fractions 1 and 2) from basic alumina in 
nonane were analyzed by injecting 3 µL into an Agilent 6890N GC/Autospec HRMS.  
Eluates from Set 4 were injected using a heated (240 ºC) direct (splitless) inlet for 
Fraction 1 and cool-on-column inlet for Fraction 2.  For Set 4, two narrow (0.15 mm i.d.), 
highly efficient BPX5 (SGE) capillary columns with 0.1 µm film thickness were co-
resident in the GC/HRMS; a 30-m column for Fraction 1 of PCBs (Figures 15-16) and a 
few non-polar POPs pesticides and a 13-m column for most POPs and mono- to deca-
PBDEs in Fraction 2 (Figures 17-18).  For the 30-m BPX5 capillary column, the oven 
temperature was programmed from 165 ºC to 250 ºC at 3 ºC/min and to 325 ºC at  
12 ºC/min while helium carrier gas was pressure programmed from 370 kPa to 475 kPa 
at 3 kPa/min.  For the 13-m capillary BPX5 column, the oven was temperature 
programmed from 150 ºC to 334 ºC at 4 ºC/min and helium carrier gas was pressure-
programmed from 245 kPa to 386 kPa at 3 kPa/min. 
GC/HRMS chromatograms of PCBs in Figures 15 and 16 show both the 
chromatographic separations by the longer (30 m) capillary column in the composite 
chromatogram in Figure 15 and the instrument’s mass selectivity and sensitivity with 
stacked chromatograms of individual (accurate mass) ions in Figure 16.  The three 
lowest levels of analytical calibration mixtures of native PCBs with 13C-surrogates PCBs 
were purchased (Wellington Labs) to complement existing 13C-PCBs standards for 
spiking into every sample to provide accurate, quantitative trace-level analysis.  These 
PCB mixtures contained sufficient PCB congeners to match the majority of PCBs typically  
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Figure 15.  GC/HRMS analysis with a 30 m x 0.15 mm i.d. BPX5 column of a low calibration mixture of 80 PCBs (6 pg each injected) as 
a composite of 14 selected ion chromatograms from the 4 ion groups measured (Tables 3-4) for basic alumina Fraction 1 analytes.   
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Figure 16.  Four selected ions from Group 3 of the GC/HRMS analysis of PCBs (Figure 15), from 15.25-23.25 min, are stacked to 
show the instrument's sensitivity and selectivity.  From bottom to top, penta- to octa-PCBs were measured using m/z 325.8804, 
359.8414, 393.8025, and 429.7606 (Table 3), respectively.  
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Figure 17.  GC/HRMS analysis with a 13 m x 0.15 mm i.d. BPX5 column is shown as an overlaid composite chromatogram 
from the first four ion groups measured (Table 5) for basic alumina Fraction 2.  Analytes include mono- through tetra-PBDEs 
(numbered congener peaks in green), pesticides, three synthetic musk fragrances, and four non-ortho-PCBs. 
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Figure 18.  The last portion of the same composite chromatogram from GC/HRMS analysis of basic alumina Fraction 2  
(Figure 17) from ion groups five through nine includes the rest of the PBDEs (penta- through deca-). 
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detected, to challenge chromatographic resolution, and to exceed the number of 
congeners typically targeted by the CDC in their blood biomonitoring.  The GC/HRMS 
analysis in Figures 15 and 16 show the highest of the three mixtures at 2 pg/µL (6 pg 
injected from 3 µL).  GC/HRMS analysis of the lowest concentrated mixture at 0.1 pg/µL 
(0.3 pg injected) showed that all PCB congener peaks were still detectable, 
demonstrating the potential for measuring PCBs in nails if lab background was 
sufficiently low. 
GC/HRMS chromatograms in Figures 17 and 18 show the complete analysis 
possible in one 41 minute run with a short 13-m BPX5 column for the compounds eluted 
into the basic alumina Fraction 2.  In Figure 17, mono- through tetra-PBDEs are 
numbered peaks (ion chromatograms in green) while pesticides, three fragrances, and 
four non-ortho-PCBs are labeled with names alongside the peaks.  Calibration standards 
shown in Figure 17 ranged from 25 to 80 pg injected.  GC/HRMS sensitivity was low for 
DDT, because the 1.5 mass range limitation forced choosing its low abundant molecular 
ions.  Penta- through deca-PBDEs follow in Figure 18 in the latter half of the run from 
17-42 min. 
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CHAPTER 3.  ANALYTICAL RESULTS AND DISCUSSION 
Various criteria were used to evaluate the nail methods used, including  
effectiveness in digesting/dissolving nail for solvent extraction, extent of lab 
contamination of various compounds in method blank samples, recovery of 13C-
surrogates, detection limits of analytes, replicate analysis of multiple samples from the 
same individuals collected over an extended time, and breadth of method to measure a 
variety of compounds at ppb concentrations, typical of biomonitoring requirements.  
Dissolution of Nail 
An important first step was to evaluate the effectiveness of the methods to 
break up the toenail matrix through various means (grinding, DTT reagent, and enzyme 
digestion) for effective solvent (DCM) extraction of small organic compounds.  Of the 
total of 13 toenail samples processed, all had residual nail material consisting of small 
thin slivers that was not fully dissolved.  After the two Individual A samples of Set 2 
(Table 2, p.25) were ground and processed, the residue in the conical mortar vials was 
allowed to dry passively.  In each vial, undissolved nail, measured 96.9 and 124.9 mg, 
respectively, or approximately half of each initial 190 mg sample.  By Set 4 (Table 2, 
p.25), the attempt to more thoroughly dissolve a nail sample led to adding Proteinase K 
enzyme digestion for up to two weeks.  Solutions of dissolved and digested nail in 
extracts from Set 4 were clearer, consistent with less suspended (undissolved) nail 
(Figure 19).  However, emulsions in DCM extracts of Set 4 samples were more difficult to 
resolve than in previous sample sets. 
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Lipid removal by GPC flash column 
During the time of using flash GPC for samples in Set 4, quality assurance elution 
tests were performed separately with 14C-cholesterol and 14C-palmitic acid using the 
same two GPC columns after their use for the soap wash blank sample and a soap wash 
of one of the nail samples, respectively.  For 14C-cholesterol, no activity was observed in 
the first collection vial, 1% in the second vial, 70% in the third vial, 23% in the small 
fourth vial (from 4.2-4.8 mL), and only 3% in each of the fifth and sixth vials destined for 
 
Figure 19.  Culture tubes of all human toenail extracts of Set 4 (Table 2).  The top layer in 
tubes is aqueous, bottom layer is in DCM solvent, and small intermediate density layer 
suggests denatured keratin protein.    
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GC/HRMS demonstrating a 94% separation of this bulky steroid.  For the 16-chain fatty 
acid, 14C-palmitic acid eluted in a broader range (0%, 2%, 43%, 39%, 8%, and 8%) with 
84% in vials 1-4 before the normal GPC collection range began.  However, for the polar 
compounds targeted in Set 3, both quality assurance tests confirmed that the small 
fourth vial (collected in an extra early GPC eluate) contained significant amounts of 
bulkier, polar compounds, including naturally occurring ones. 
For eight of the 10 human nail samples in Sets 1, 2, and 4, the percent lipid 
measured collectively in the first four vials of the flash GPC was consistent between 1.03 
and 1.31 weight percent (Table 2, p.25); mean 1.21%, sd 0.09.  Including the other two 
nail samples with lipid values of 0.87% and 1.63% resulted in a mean 1.22%, sd 0.20, 
n=10.  The former (0.87%) corresponds to Sample 7T-2, whose dried nail residue 
weighed about half of the original nail sample, demonstrating incomplete dissolution.  
The higher value (1.63%) corresponds to Sample 17T-4 (Figure 19), which was a smaller 
sample than others from Individual A and with the additional Proteinase K and time, 
may have dissolved more completely.  Also it is possible that with such a small nail 
sample, lipids from bits of skin included with the nail clippings increased the total nail 
lipid percentage.  Such “stratum corneum” lipids that constitute 2% of skin on a human 
foot70 may have solubilized in the soap wash (Sample 17W-4), that results (still to be 
covered) showed some exogenous contamination.  Still another possibility for the higher 
lipid value is that a residual amount of styrene-divinylbenzene co-polymer from the S-X3 
GPC column may have sloughed off from the cleanup column.  Set 3 for targeted polar 
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compounds used just the first three GPC vials for measuring lipid so the measured 0.5% 
in that set correlates with only half of the total observed in the other sample sets. 
Cleanup with SPE Basic Alumina Glass Cartridge 
 An SPE glass cartridge with 0.5 g basic alumina was used with every sample from 
all of the methods.  Except for Set 3, the SPE cartridge was only a quick intermediate 
cleanup step following GPC and before final 4-g basic alumina flash chromatography.  
However, for Set 3 with methylation and more polar analytes, an SPE cartridge was the 
final cleanup/fractionation step before GC/full scan MS and GC/HRMS.  Ordinarily, SPEs 
made in the US contribute various artifacts and thus are unsuitable for trace-level 
analyses, but the German-made Macherey-Nagel SPEs performed well to clean up any 
unreacted polar compounds without leaching any artifacts into the final sample 
extracts, as evidenced by relatively clean GC/full scan MS analyses for the Set 3 blank 
and samples run (Table 2, p.25).  Because the 0.5 g basic alumina in an SPE cartridge was 
less active than the heated 4-g basic alumina packed in a flash column and because 
some acetone used in Set 3 was likely present, most ether and ester derivatives (after 
methylation) eluted along with cholesterol with DCM from the SPE.  Subsequently, 
smaller amounts of the same compounds were eluted using a slightly more polar (2% 
acetone in DCM) eluant, but again without any contaminants.  
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Final Cleanup and Separation with Basic Alumina Flash 
Chromatography 
Basic alumina flash elutions shifted slightly from expected in Set 1, necessitating 
a slight adjustment in solvent elution strength in subsequent sample sets as was noted 
in Chapter 2.  Basic alumina became slightly more adsorptive when it was carefully 
stored in a heated, tightly-covered glass Erlenmeyer flask to minimize exposure to lab 
dust and moisture.  A few analytes expected in Fraction 1, e.g. 13C-DDE, were retained 
until Fraction 2 and several analytes expected in Fraction 2, e.g. methyl ether derivatives 
of 13C-BPA and 13C-tetrabromobisphenol A likely remained on the column for Set 1.  To 
compensate, the GC/HRMS was set up to run both fractions for a certain group of 
analytes to ensure detection and Set 3 for just polar analytes used just an SPE.  In Set 4, 
a third more polar fraction was collected, in case Fraction 2 analytes such as synthetic 
musk fragrances of ethers and ketones were retained until Fraction 3. 
Elutions from basic alumina also occasionally shifted if too much residual DCM 
was in a sample extract applied to the alumina column.  Just before a sample extract 
was applied, a complete solvent exchange from moderately polar, volatile DCM to non-
polar, less volatile isooctane was necessary to prevent analytes expected in Fraction 2 
(0.5% acetone in DCM) to shift into Fraction 1 (only 1% DCM in cyclopentane).  Solvent 
exchange was successful by routinely adding slightly more isooctane than the DCM and 
blowing down to the original volume. With a significantly higher boiling point (100 ºC) 
than DCM (40 ºC), isooctane also kept the extract from going dry as high purity nitrogen 
was blown into each sample tube to purge the DCM. 
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 In general, basic alumina flash chromatography with high purity nitrogen kept 
background compounds very low and effectively fractionated compounds as described 
in the Methods chapter.  GC/full-scan MS analyses of Fraction 1 of Set 1 nail and blank 
samples detected various non-polar long-chain hydrocarbons as expected.  In Fraction 2 
of all Set 1 blanks and sample, slightly more polar polycyclic aromatic hydrocarbons 
were detected.  Also consistently in Fraction 2 were the 13C-PBDEs surrogates.  Native 
PBDEs were higher in the Set 1 nail sample than in the blank samples and several other 
compounds that were not in the blank samples were identified in the nail sample. 
GC/full-scan MS to identify unsuspected compounds in Set 1 samples 
Analyses with GC/full-scan MS with unit mass resolution were important to 
detect and identify unsuspected compounds present in the nail samples and not in 
blanks amidst background hydrocarbon, siloxane, and phthalate compounds in all 
samples.  These less selective GC/MS analyses were also helpful to assess how well the 
method cleaned up and fractionated the sample extracts with a minimum of lab 
background and artifacts from sorbents, reagents, and technique. 
For example, a total ion chromatogram of Fraction 2 of Set 1 blank (1B-1) was 
compared with that of Fraction 2 of individual A Nail (3T-1) in Figure 20.  Almost all of 
the peaks shown were common to both blank and nail sample.  Based on 13C-PCB 
congener 101, internal standard of 5 ng total (~ 25 ppb) comprising most of the small 
peak at 34.91 min of each chromatogram, each compound peak shown ranges from < 1 
ng to about 500 ng, which corresponds to ppb concentrations.  
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Figure 20.  Total ion chromatogram of Fraction 2 of Set 1 blank (1B-1) compared with that of Toenail (3T-1). 
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Common polycyclic aromatic hydrocarbons in both blank and nail samples include 
phenanthrene (24.79 min), methyl phenanthrenes (28.31, 28.56, 29.09, and 29.29 min), 
fluoranthene (33.55 min), and pyrene (35.14 min).  Beginning at 47.69 min, almost all 
major late-eluting compounds were long chain hydrocarbons (C26 to C32) that were 
retained in Fraction 2.  After comparing both total ion chromatograms, two late-eluting 
compounds in the nail sample at 52.70 min and 54.37 min were identified that were not 
in the blank sample (Figure 20).  Mass spectra matched those in the NIST MS Library for 
squalene and cholesta-3,5-diene, respectively, which occur naturally in biological tissue 
and are not chemical pollutants or contaminants. 
Further GC/MS data processing was necessary to uncover all of the 13C-
surrogates and other compounds which were in the nail sample but not in the blank 
sample.  For more specificity, low target compounds could be recognized by displaying 
several mass chromatograms of a compound’s abundant ions.  For example, the internal 
standard, 13C-PCB 101, was more easily located (at 34.91 min) in each sample by 
selecting an abundant ion (m/z 338) of its molecular ion cluster shown in the bottom 
two traces in Figure 21.  Because the areas of each internal standard peak at 34.91 min 
were nearly identical (within 2%), the GC/MS analysis of the nail sample was directly 
comparable with that of the blank sample. 
Some low unsuspected compounds were recognized by reviewing all mass 
spectra for detectable ions with masses higher than that from the solvent and 
background (> m/z 130).  In that way and using mass chromatograms to pinpoint a peak, 
several chlordane-related compounds were recognized and then identified.  In Figure  
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Figure 21.  Pairs of chromatograms from 33.4-36.8 min of blank and nail samples were 
compared for top two total ion chromatograms (TIC) and with peak areas for mass 
chromatograms m/z 373 (chlordane), 409 (nonachlor), and 338 for 13C-penta-PCB 101 
internal standard.  Similar peak areas for the internal standard (5 ng total) at 34.91 min 
confirm data of both sample extracts can be directly compared.  
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21, mass chromatograms of m/z 373 and 409 are shown from 33.4-36.8 min for both a 
blank sample and Individual A nail (3T-1) from Set 1.  In the nail sample, two isomeric 
peaks (34.30 and 34.96 min) for (trans- and cis-) chlordane and one trans-nonachlor 
(35.09 min) were detected with peak responses in the 104 range (6 E4 in Figure 21), but 
not in the blank sample with only 102 (3 E2) background noise level.  Using the data 
system’s built-in “Refine” automatic spectral processing feature, an enhanced 
background subtracted, full-scan mass spectrum near the apex of the peak (34.29 min) 
closely matched the NIST MS Library spectrum for chlordane (Figure 22) and later our 
own spectrum and retention times from an analytical chlordane standard.  Similarly, an 
enhanced background subtracted, full-scan mass spectrum of trans-nonachlor at 35.09 
min matched the NIST MS Library reference spectrum (Figure 23) and also later our own 
spectrum and retention times from a trans-nonachlor standard.  Later in the GC/MS 
chromatograms, the 13C-surrogate of PBDE 47 was detected in both the blank and 
toenail samples at 45.98 min, shown in the top two m/z 498 mass chromatograms 
(Figure 24).  Peak areas of the surrogate in the samples were nearly identical (230,633 
and 220,530, respectively) and, compared to the peak areas at 48.75 min for the 
internal standard (13C-PBDE 79) at 2 ng total added into the final GC vial, the 13C-PBDE 
47 was consistently well recovered (76% and 82%) through the entire Set 1. 
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Figure 22.  Mass spectrum at 34.29 min in nail sample confirmed as chlordane.  A loss of 
chlorine corresponds to the base peak cluster.  
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Figure 23.  Mass spectrum at 35.09 min in nail sample confirmed as trans-nonachlor.  
2008-Oct27-05 #2081 RT: 35.09 AV: 1 RF: 6.00,3 NL: 3.10E4
T: {0,0}  + c EI det=349.00 Full ms [50.00-750.00]
100 150 200 250 300 350 400 450 500
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
R
el
at
iv
e 
Ab
un
da
nc
e
408.92
205.27
67.24
407.06
91.21
193.20 410.99
116.21
178.24
115.15 141.13
165.14
128.22
206.32 263.1083.39 405.07
221.35
264.31
235.18 273.93
413.02
275.83 300.08
342.22 355.32 415.12 449.41315.19 482.44
(mainlib) trans-Nonachlor
60 120 180 240 300 360 420 480 540 600 660
0
50
100
73
109
133
169
237
272
300
335 371
409
444
Cl
Cl
Cl
ClCl
Cl
Cl
Cl
Cl
2008-Oct27-05#2081  RT: 35.09  AV: 1 trans-NonachlorHead to Tail MF=552 RMF=573
60 90 120 150 180 210 240 270 300 330 360 390 420 450 480 510 540 570 600 630 660
0
50
100
50
100
51
51
58
61
67
73 85
91
109
116
119 133
141
169
178
193
194
205
221
235
237
263
272
300
300
315
335
342
349 371
375
409
409
444
449 482 536 551 623 644 667
 65 
 
 
Figure 24.  Pairs of chromatograms of m/z 498 (13C-PBDE 47; 79 Internal Standard) and 
486 (PBDE 47) in blank and nail samples were compared (44.3-50.2 min). Mass spectrum 
of nail sample at 45.98 min shows molecular ion clusters and fragment ions for both 
compounds.  
For the native PBDE 47 in the blank and toenail samples, corresponding m/z 486 
mass chromatograms showed an extremely small peak in the blank sample at 46.01 min 
with peak area 1182, but a much larger peak at 45.99 min in the toenail sample with 
peak area 83,092.  Based on the 13C-PBDE 47 (2 ng total or 10.7 ng/g) and assuming a 
similar response factor for PBDE 47, an approximate concentration for PBDE 47 was  
4 ng/g (or ppb).  The background-subtracted mass spectrum in the bottom of Figure 24 
at 45.98 min in the toenail sample shows both 13C-PBDE 47 and PBDE 47 with 
C:\Xcalibur\Data\2008-Oct27-05 10/28/2008 1:16:08 AM Toenails Nov 2005 187 mg B-Al-F2 ~3/50 uL nonane
RT: 44.26 - 50.22
44.5 45.0 45.5 46.0 46.5 47.0 47.5 48.0 48.5 49.0 49.5 50.0
Time (min)
0
50
100
0
50
100
0
50
100
R
el
at
iv
e 
A
bu
nd
an
ce
0
50
100
RT: 48.74
AA: 304188RT: 45.98
AA: 230633
RT: 45.98
AA: 220530 RT: 48.76
AA: 267998
RT: 49.05
AA: 1103
RT: 46.01
AA: 1182
RT: 45.99
AA: 83092
NL: 6.83E4
m/z= 
497.50-498.50  MS  
ICIS 2008-Oct27-04
NL: 5.75E4
m/z= 
497.50-498.50  MS  
ICIS 2008-Oct27-05
NL: 5.48E2
m/z= 
485.50-486.50  MS  
ICIS 2008-Oct27-04
NL: 2.16E4
m/z= 
485.50-486.50  MS  
ICIS 2008-Oct27-05
2008-Oct27-05 #2983 RT: 45.98 AV: 1 RF: 6.00,3 NL: 5.70E4
T: {0,0}  + c EI det=349.00 Full ms [50.00-750.00]
100 150 200 250 300 350 400 450 500 550 600 650 700
m/z
0
10
20
30
40
50
60
70
80
90
100
R
el
at
iv
e 
A
bu
nd
an
ce
57.10
497.95
71.21
338.15
230.01 499.88340.06
85.27
140.63 324.05162.08 485.95207.22133.15
259.21170.15
316.57265.24 502.03343.31 481.78 550.25429.59
13
C-PBDE 79 I.S. 
Nail 3T-1 
Blank 1B-1 
Blank 1B-1 
Nail 3T-1 
13
C-PBDE 79 I.S. 
13
C-PBDE 47 
13
C-PBDE 47 
PBDE 47 
PBDE 47 
13
C-PBDE 47 
PBDE 47 PBDE 47 
13
C-PBDE 47 
m/z 498 
m/z 498 
m/z 486 
m/z 486 
 66 
 
corresponding molecular ion clusters of m/z 494-502 and 482-490 and (M-2Br)+ 
fragment ions with losses of 158. 
GC/full-scan MS to identify unsuspected compounds in Set 3 samples 
GC/full-scan MS was also used to analyze for more polar compounds, including 
phenolic and acidic compounds detectable following methylation (Set 3), in several 
fractions of two Individual A toenail samples (10T-3 and 11T-3) and a representative 
blank sample, either of 8B-3 or 9B-3.  Using a typical DCM extraction, GPC collection, 
methylation, and a first (DCM) eluate from basic alumina SPE cartridge, some 
compounds of possible interest were detected in both toenail samples but not in a blank 
sample.  Although compounds of natural origin, e.g. cholesterol, were also detected in 
nail samples but not in a blank, this section will focus primarily on other compounds.   
Reporting generally in GC elution order, an early eluting compound with 
molecular mass 158 at 9.8 min was tentatively identified in both nail samples as 2,4-
dimethyl quinazoline but was not detected in a blank sample as shown by comparing 
m/z 158 chromatograms (Figure 25).  The mass spectrum closely matched the NIST 
Library that included several dimethyl quinazoline isomers with formula C10H10N2.  The 
abundant, even mass, molecular ion is consistent with a stable aromatic compound with 
an even number of nitrogens.  An abundant fragment ion (mz/ 143) shows an expected 
loss of a methyl group.  This was one of several compounds containing nitrogen and, 
from a detailed literature search, is not a compound used commercially. 
In Figure 26, an early eluting compound at 15.25 min with apparent molecular 
ion at m/z 179 was tentatively identified as 6-methoxy-2-methyl-benzothiazole by 
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Figure 25.  Mass spectrum at 9.75 min was tentatively identified as 2,4-dimethyl-
quinazoline by NIST Library match after mass (m/z 158) chromatograms from 8.5-11.4 
min of blank and nail samples of Set 3 showed a compound peak at 9.8 min in both nails 
but not blank.  
 
C:\Xcalibur\data\PHP-2009-Jan-13-03 1/13/2010 5:24:04 PM
RT: 8.46 - 11.44
8.5 9.0 9.5 10.0 10.5 11.0
Time (min)
0
50
100
0
50
100
0
50
100 8.46
9.61 10.149.13 9.64 10.409.399.03 11.148.93 10.828.73 10.7210.109.28 9.90 10.9410.21 10.61
9.80
9.71 10.149.28 10.388.95 10.808.73 11.269.56 11.0810.498.55
9.75
9.66 10.01 10.13 10.48 11.2110.629.58 10.869.03 9.198.51 8.69
NL:
1.83E3
m/z= 
157.50-158.50 
 MS 
PHP-2009-
Jan-13-01
NL:
1.54E6
m/z= 
157.50-158.50 
 MS 
PHP-2009-
Jan-13-02
NL:
1.19E7
m/z= 
157.50-158.50 
 MS 
PHP-2009-
Jan-13-03
PHP-2009-Jan-13-03 #229 RT: 9.75 AV: 1 RF: 6.00,3 NL: 8.68E6
T: {0,0}  + c EI det=349.00 Full ms [50.00-750.00]
60 80 100 120 140 160 180 200 220 240
m/z
0
10
20
30
40
50
60
70
80
90
100
R
el
at
iv
e 
A
bu
nd
an
ce
158.3
143.1
117.2
157.6
76.1
102.275.1 159.377.263.1 89.3 144.274.1 118.2
103.2
m/z 158, Blank 8B-3 
m/z 158, Nail 10T-3 
m/z 158, Nail 11T-3 
Nail 11T-3 
PHP-2009-Jan-13-03#229  RT: 9.75  AV: 1 Quinazoline, 2,4-dimethyl-Head to Tail MF=863 RMF=880
50 60 70 80 90 100 110 120 130 140 150 160 170
0
50
100
50
100
51 57 63
66 71
71
76
76
78
83
85 89
89
92
102
102
117
117
130
130
143
143
155
158
158
N
N
 68 
 
 
 
 
Figure 26.  Mass spectrum at 15.25 min was tentatively identified as 6-methoxy-2-
methyl-benzothiazole by NIST Library match after mass (m/z 179) chromatograms from 
14.6-21.3 min of blank and nail samples of Set 3 showed a peak at 15.25 min in both 
nails but not blank. 
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matching the NIST Library.  Because of the methylation step in the method, it is possible 
that the compound may have been originally 6-hydroxy-2-methyl-benzothiazole.  The 
abundant odd number molecular ion is consistent with an aromatic compound 
containing an odd number of nitrogen.  The main fragment ions are a methyl loss (m/z 
164) and a likely additional CO loss (m/z 136).  
Benzophenone was identified by the mass spectrum at a retention time of 17.44 
min, which is consistent with unpublished USGS data run recently.  Mass m/z 182 
chromatograms in blank and nail samples were compared in the top of Figure 27.  In the 
blank sample, a very small peak (area 26,517) was detected, but in the nail samples, 
much larger peaks with respective areas 1.7 million and 2.1 million were detected.  In 
the bottom of Figure 27, a mass spectrum from sample 11T-3 at 17.44 min closely 
matches a reference mass spectrum of benzophenone from the NIST Library. 
Just a few seconds later (at 23.64 min) in each nail sample of Set 3 (Figure 28) 
was a synthetic musk fragrance compound with molecular mass 258 that matched the 
mass spectra of at least two C18H26O isomers (common names, Galaxolide and Versalide, 
bottom and lower bottom matches).  By mass spectrometry, these isomeric compounds 
cannot be distinguished, although a Galaxolide standard did match GC times using 
GC/HRMS.  Subsequently, in Set 4, several synthetic musk fragrance compounds 
including galaxolide were targeted in the expanded basic alumina Fraction 2 (Table 2, 
p.25). 
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Figure 27.  Mass spectrum at 17.44 min from Nail 11T-3 was confirmed as 
benzophenone by a standard after mass (m/z 182) chromatograms from 14.6-21.3 min 
of blank and nail samples of Set 3 showed a compound peak at 17.4 min, primarily in 
nail samples.  
Next-eluting analytes in the Set 3 chromatograms were BPA-dimethyl ether 
(BPA-DME) and surrogate, 13C-BPA-DME at 31.4 min (Figure 29).  In both nail samples, 
GC/full scan MS detected both BPA-DME and the 13C-surrogate (5 ng total) that was 
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Figure 28.  Mass (m/z 243) chromatograms from 22.9-26.5 min of Set 3 samples show a 
compound peak at 23.64 min in the nail samples only, whose mass spectra (red) match 
that of two C18H26O isomers (galaxolide and below, versalide) from NIST Library (blue).  
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Figure 29.  Mass chromatograms (m/z 241 and 253 for native- and 13C-BPA-dimethyl 
ether) from 30.8-32.1 min of Set 3 samples show both were detected at 31.4 min in 
both nail samples, but neither was detected in a blank sample, due to a bad injection 
and poor recovery of the 13C-BPA surrogate.  Sample mass spectrum (31.42 min) of both 
compounds co-eluting matched NIST spectrum of BPA-dimethyl ether.  
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spiked at the beginning of extract.  However, neither BPA-DME nor surrogate was 
detected by GC/full scan MS in a Set 3 blank sample, either due to a poor, partial 
injection by the GC autosampler and/or because of a poor recovery of the surrogate 
through the method.  Checking the 13C-PCB 101 (5 ng total) internal standard peak areas 
for the blank and nail samples using m/z 338 at 32.54 min showed the blank sample 
internal standard peak area (11,108) was about four times lower than the nails (45,723 
and 51,665), indicating that only a partial injection of the blank had been made.  
Unfortunately, Blank 9B-3 which was not run by GC/full scan MS had more BPA than in 
Blank 8B-3.  Complete quantitative data for BPA in all Set 3 samples will be reported and 
discussed in the GC/HRMS section upcoming in this chapter. 
Methyl ether derivatives of another polar analyte, triclosan, with 13C-surrogate 
(10 ng total) eluted at 33.1 min (Figure 30).  The surrogate was well recovered in 
samples, even in the blank sample after allowing for the poor injection.  In both nail 
samples, peak areas for the native triclosan-methyl ether were double that of the 
surrogate for an estimated 20 ng total in each nail sample and thus a concentration of 
about 70 ng/g.  Although triclosan-methyl ether was not detected in the blank (only 
partially injected) by GC/full scan MS, more sensitive GC/HRMS analyses were also done 
and will be discussed. 
 The non-polar 13C-p,p’-DDE surrogate (5 ng total), eluting at 34.35 min, was 
among those spiked in Set 3 samples to assess whether it would be recovered through 
the method.  The DDE surrogate was detected in all Set 3 samples in alumina SPE-
Fraction 1 by GC/full scan MS, and percent recoveries were determined by GC/HRMS. 
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Figure 30.  Mass chromatograms (m/z 302 and 314 for native- and 13C-triclosan-dimethyl 
ether) from 32.3-34.1 min of Set 3 samples show both were detected at 33.1 min in 
both nail samples, but only surrogate was detected in a blank sample.  Mass spectrum 
(33.07 min) of both compounds co-eluting matches NIST spectrum of methoxy-triclosan.  
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 The surrogate, 13C-tetrabromo-BPA (5 ng total) was searched for in all of Set 3 
samples and fractions run by GC/full scan MS, but was not detected using the abundant 
ion chromatograms (m/z 555, 557, and 559), necessitating further GC/HRMS analyses. 
 Other unsuspected compounds were found in Fraction 1 of Set 3 samples.  In 
both nail samples, a compound peak at 31.95 min with abundant m/z 233 was 
tentatively identified as 2-anilino-4-methyl quinoline by NIST Library match (Figure 31).  
At 46.87 min, a compound peak with molecular mass 360 was detected in both nails and 
less in a blank sample, even after adjusting for poor injection.  It matched the NIST 
Library as octocrylene, a UV filter compound used in sun blocking lotions (Figure 32).  Its 
mass spectrum showed the octyl-alkyl group loss as the base peak cluster at m/z 248-
248, with a rare oxygen loss to m/z 232 and CO loss further to m/z 204.  Although the 
molecular ion is m/z 361, which is consistent for an odd number nitrogen compound, it 
readily loses a hydrogen to m/z 360, a loss more typically seen in aldehyde compounds. 
At least one compound was detected in only one (10T-3) of the two nail samples 
and not in a blank sample at 18.52 min (Figure 33).  It was tentatively identified by 
matching the NIST Library of 4(4-methoxyphenyl)-3-butene-2-one (Figure 33), which is a 
flavoring agent and more commonly called anisalacetone.  In the original nail extract 
before methylation, it is possible that the methoxy-group was a hydroxyl-group.   
Several mass spectra of detected compounds did not match NIST Library but 
were interpreted.  The mass spectrum in Figure 34 from nail sample 11T-3 appears to be 
related to the C10H10N2 compound in Figure 25 because of similar ions.  With an 
apparent molecular mass of 200, loss of a methyl group (m/z 185) and a base peak of  
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Figure 31.  Mass spectrum at 31.93 min from Nail 11T-3 was tentatively identified as 2-
anilino-4-methylquinoline by NIST Library match after mass (m/z 233) chromatograms 
from 31.0-33.6 min of Set 3 samples compared show a compound peak at 31.9 min in 
the nail samples only.  
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Figure 32.  Mass spectrum at 46.87 min from Nail 11T-3 was tentatively identified as 
octocrylene by NIST Library match after mass (m/z 360) chromatograms from 46.1-48.1 
min of Set 3 samples showed a peak at 46.9 min in all samples, especially in the nails.  
m/z 158, the additional 42 mass units correspond to either having an added C3H6 or 
C2H2O.  Based on the hydrocarbon fragment losses, we theorize an elemental formula of 
C13H16N2.  Mass m/z 158 chromatograms in Set 3 samples show the compound was not 
detected in the blank but in both nails.  Another unidentified compound that was 
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Figure 33.  Mass spectrum at 18.52 min was tentatively identified as 4-(4-
methoxyphenyl)-3-butene-2-one by NIST Library match after mass (m/z 161) 
chromatograms from 16.6-23.3 min of Set 3 samples showed a peak at 18.52 min in just 
nail sample 10T-3.  
detected at 30.2 min in Fraction 1-Set 3 nail samples was not detected in the blank 
sample.  Based on m/z 261 chromatograms (Figure 35) for the samples, the unknown 
compound with an apparent molecular mass of 261 was about 100 times higher in nail 
sample 10T-3 than in nail 11T-3.  Its mass spectrum from nail 10T-3 indicates a 
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Figure 34.  Mass spectrum at 16.20 min of nail 11T-3 sample could be of a C13H16N2 
related to Figure 25 with an apparent molecular mass 200 after mass (m/z 158) 
chromatograms for Set 3 samples showed a 16.2 min peak for both nail samples but no 
detected peak in the blank sample.  
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Figure 35.  Mass spectrum at 30.23 min of nail 11T-3 with apparent molecular mass of 
261 for an odd number of nitrogen and (M+2)+ possibly a sulfur.  Mass (m/z 261) 
chromatograms for Set 3 samples showed a 30.2 min peak for both nail samples but 
none in the blank.  The peak was about 100 times higher in nail 10T-3 than in 11T-3.  
compound with an odd number of nitrogen, the m/z 77 fragment ion strongly hints of a 
phenyl-substitution, and the loss of M-43 at m/z 218 from M-(CO-CH3)+ (Figure 35). 
 Slightly later at 34.3 min, an unknown compound was detected in both nail 
m/z 261 
m/z 261 
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Figure 36.  Mass spectrum at 34.30 min of nail 10T-3 showed an apparent molecular 
mass of 244 and base peak m/z 215 from an ethyl loss.  Mass (m/z 215 and 244) 
chromatograms for Set 3 samples showed no peak in the blank sample but a 34.3 min 
peak in both nail samples and higher in nail 10T-3.  
samples but not the blank sample with an apparent molecular mass of 244, and base 
peak of m/z 215 likely from the loss of an ethyl group.  Abundant high mass ions suggest 
at least some aromatic groups in the molecule (Figure 36).  This unknown compound of 
mass 244 may possibly be a fragrance compound related to the molecular mass 258 
fragrance compound of galaxolide (Figure 28).  
GC/full scan MS data for Set 3 Neutral Extract -- Fraction 2 (2% acetone in DCM 
from basic alumina SPE) showed some of the same compounds from Fraction 1 were 
still detected but no new compounds were detected.  If more polar compounds were 
C:\Xcalibur\data\PHP-2009-Jan-13-02 1/13/2010 3:58:52 PM
RT: 33.67 - 34.93
33.7 33.8 33.9 34.0 34.1 34.2 34.3 34.4 34.5 34.6 34.7 34.8 34.9
Time (min)
R
el
at
iv
e 
A
bu
nd
an
ce
RT: 34.30
AA: 2921116 RT: 34.63
AA: 15956
RT: 34.30
AA: 1311582
RT: 34.30
AA: 469781 RT: 34.57
AA: 11654
RT: 34.30
AA: 180494
NL: 8.40E2
m/z= 214.50-215.50  MS  
ICIS PHP-2009-Jan-13-01
NL: 4.36E2
m/z= 243.50-244.50  MS  
ICIS PHP-2009-Jan-13-01
NL: 4.17E5
m/z= 214.50-215.50  MS  
ICIS PHP-2009-Jan-13-02
NL: 2.01E5
m/z= 243.50-244.50  MS  
ICIS PHP-2009-Jan-13-02
NL: 8.38E4
m/z= 214.50-215.50  MS  
ICIS PHP-2009-Jan-13-03
NL: 3.47E4
m/z= 243.50-244.50  MS  
ICIS PHP-2009-Jan-13-03
PHP-2009-Jan-13-02 #2264 RT: 34.30 AV: 1 RF: 6.00,3 NL: 1.06E5
T: {0,0}  + c EI det=349.00 Full ms [50.00-750.00]
60 80 100 120 140 160 180 200 220 240 260 280 300 320
m/z
0
10
20
30
40
50
60
70
80
90
100
R
el
at
iv
e 
A
bu
nd
an
ce
215.3
244.3
76.5
84.259.1
216.3
214.6
172.3 243.685.5 200.3 229.395.375.2 108.2 135.298.3 245.3157.2128.3 185.3 230.3207.2 275.1 326.4286.5261.3
m/z 215,  Blank 8B-3 
m/z 244,  Blank 8B-3 
m/z 215,  Nail 10T-3 
m/z 244,  Nail 10T-3 
m/z 215,  Nail 11T-3 
m/z 244,  Nail 11T-3 
Nail 10T-3 
 82 
 
present but still adsorbed onto the SPE, a stronger eluant, e.g. with a higher percentage 
of acetone in DCM, would have been necessary to elute those types of compounds. 
In Set 3 samples, an early GPC eluate with two alumina SPE fractions was collected to 
target possible phthalate metabolites.  However, no target phthalate metabolites were 
detected.  Only high concentrations of fatty acids (as methyl esters), cholesterol, and 
minor sterols (sitosterol and lanosterol) were detected as would be expected in the 
early GPC eluate fraction.  No anthropogenic compounds were detected in either 
fraction of the early GPC eluate, which confirmed that the small flash GPC elution 
performed as expected to isolate small organic molecules after bulkier sterols, fatty 
acids, and phthalates.  Set 3 samples were also extracted a second time at pH< 3 with 
DCM for stronger acidic compounds before the methylation step and the following were 
analyzed using GC/full scan MS:  Blank 9B-3 and Nail 10T-3 with normal GPC-Fraction 1 
SPE, Nail 11T-3 with normal GPC-Fraction 2 SPE, and Nail 10T-3 with early GPC-Fraction 
1.  Only a relatively few compounds were detected (Figure 37) and primarily included 
various substituted benzoic acid compounds (detected as methyl ester) (Figures 38-42). 
Para-methoxy-benzoate (Figure 39), probably as para-hydroxy-benzoic acid in 
the pH<3 extract before methylation, also can occur naturally or as a hydroxyl-
metabolite of “methyl paraben” (para-hydroxy-benzoate), which is widely used 
commercially in personal care products of shampoo, lotions, and cosmetics.  Methyl 
anthranilate or methyl 2-(dimethylamino)-benzoate (Figure 40) is both naturally 
occurring in various fruits and used commercially as a flavoring agent and in perfumes.71  
Several other compounds detected and tentatively identified in the Set 3 pH< 3 samples 
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Figure 37.  Summed ion chromatograms (m/z 130-750) from 8.0-17.3 min of Set 3 blank  
and nail samples extracted at pH<3 with varying GPC eluates and SPE fractions.   
 
Figure 38.  Tentative identification of methyl anthranilate or methyl 2-amino-benzoate.  
Mass spectrum at 8.56 min of Nail 10T-3 (top in red) matches NIST Library. 
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Figure 39.  Tentative identification of 4-methoxy-benzoate by NIST Library match of 
mass spectrum at 9.37 min of Nail 10T-3 (top in red).  
 
Figure 40.  Tentative identification of methyl 2-(dimethylamino)-benzoate by NIST 
Library match (bottom, blue) of mass spectrum at 9.95 min of Nail 10T-3 (top, red).  
 
Figure 41.  Tentative identification of methyl 2-(methylamino)-benzoate by NIST Library 
match of mass spectrum at 10.19 min of Nail 10T-3 (top, red).  
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Figure 42.  Tentative identification of 2-(acetylamino)-benzoate by NIST Library match of 
mass spectrum at 16.45 min of Nail 10T-3 with Early GPC, SPE-1 (top, red).  
were all amino-substituted benzoic acid (methyl esters) (Figures 40-42). 
GC/HRMS Analysis to detect and quantitate target polar compounds 
More sensitive and selective GC/HRMS analyses complemented GC/full scan MS 
analyses of Set 3 samples for more polar, transient compounds and will be discussed 
followed by GC/HRMS analyses for the less polar, persistent compounds in samples 
from Sets 1, 2, and 4.  For example, GC/HRMS selected ion chromatograms for BPA and 
the surrogate 13C-BPA in Set 3 samples (Figure 43) complemented those by GC/MS 
(Figure 29) by detecting all analytes, even the surrogate that was only partially 
recovered in blank samples.  Peaks of BPA-dimethyl ether and the surrogate at 17.3 min 
tailed in most sample analyses, because a slightly earlier flash GPC eluate was taken and 
the 0.5-g basic alumina SPE cartridge after methylation may not have been optimal for 
GC with 5% of the final extract (3 µL of 60 µL) injected for trace-level analyses.  Results 
for targeted polar analytes and surrogates in Set 3 samples plus non-polar p,p’-DDE and 
surrogate are tabulated in Table 7, albeit with the caveat that any DDT present may 
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have been converted to DDE from the basic buffer (pH 12) conditions before 
methylation.    Analyses of the first two compounds listed, triclosan and p,p’-DDE, were 
successful in Set 3.  Their surrogates were consistently recovered (≥ 64%).  Background 
levels of triclosan and DDE in both blank samples were either very low or not detected 
at the GC/HRMS detection limit of 0.1 ng/g, therefore only 0.25 ng/g was blank-
subtracted from the toenail sample concentrations (average of blanks plus 3 times 
standard deviation) (Table 7).  Thus, blank-corrected “free” triclosan (without any 
enzyme deconjugation step) in toenail samples was 53.6 and 62.9 ng/g (mean 58.3, sd 
6.6, n=2) and p,p’-DDE 1.00 and 2.02 ng/g.  In soap washes of the Set 3 toenail samples, 
p,p’-DDE was not detected and triclosan was low (1.1 and 2.8 ng/g) compared to 
concentrations in the toenail samples. 
Although BPA analyses in Set 3 had lower surrogate recoveries in the blanks, 
isotope dilution quantitation still provided accurate concentrations by self-correcting 
BPA concentrations for the lower recoveries.  Unfortunately, relatively high blank 
concentrations (average 9.09 ng/g) plus three times standard deviation) totaled  
12.23 ng/g for the blank BPA subtraction from each toenail sample.  After blank 
subtraction, BPA was 15.0 ng/g in one toenail sample, but meaningless in the other 
sample (0 ng/g).  Set 3 soap washes had BPA concentrations similar to the original 
toenail sample concentrations, so again, one of the two blank-subtracted soap wash 
samples would have had a meaningless blank-corrected BPA concentration.  Finding BPA 
in method blanks may require a pooling of several toenail samples to overcome it in 
future research. 
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Figure 43.  From Set 3 samples, GC/HRMS selected ion chromatograms of m/z 241.1229 
for dimethyl ether-BPA and m/z 253.1631 for 13C-BPA surrogate at 5 ng total show 
integrated peaks labeled with retention time and peak area.  Not shown were 13C-BPA in 
soap washes 10W-3 and 11W-3 (peak areas 235,900 and 196,917, respectively).  
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Analyses of tetrabromobisphenol A were also problematic with consistently very 
low surrogate recoveries especially in blanks and soap washes that prevented 
determining accurate blank-subtracted concentrations in the toenail samples, which 
originally were measured at 4.9 and 8.9 ng/g (Table 7).  Low recoveries may have been 
caused by a later than expected elution through the flash S-X3 GPC column, because 
some phenolic compounds can be retained longer than other neutral compounds.73 
 Not included in Table 7 for Set 3 samples were mono-methyl-phthalic acids, 
metabolites of various phthalates, and several 13C-surrogates spiked for the method’s 
quality assurance.  None of these phthalate metabolites or surrogates were detected in 
any of Set 3 sample extracts, including early GPC eluates and pH < 3 sample extracts, by 
GC/full scan MS or by GC/HRMS.  Lack of methylation efficiency, shown to be a concern 
even with standards, was likely a major factor.  
Table 7.  Concentrations (ng/g) with Surrogate Recoveries of DDE and Several Polar 
Compounds in Set 3 Toenail Samples 
 
 
METHOD BLANKS TOENAIL SAMPLES    SOAP RINSES
8B-3 9B-3 Subtract from 10T-3 11T-3 10W-3 11W-3
Toenail Samples A 10T-3 A 11T-3
AVG (3 * SD) - [Avg + 3 * SD)] May-06 NET Jul-06 NET
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g
Successful:
Triclosan (as methyl ether) 0.1 ND< 0.1 0.1 0.15 -0.25 53.8 53.6 63.1 62.9 1.1 2.8
p,p'-DDE (non-polar metab. of DDT) ND< 0.1 ND< 0.1 0.1 0.15 -0.25 1.25 1.00 2.27 2.02 ND< 0.1 ND< 0.1
Problematic:
Bisphenol A (as dimethyl ether) 9.83 8.35 9.09 3.14 -12.23 27.2 15.0 10.5 --- 30.2 8.37
Tetrabromo-BPA (dimethyl ether) --- --- --- --- -(Indeterminate) 4.9 < 4.9 8.9 < 8.9 --- ---
8B-3 9B-3 10T-3 11T-3 10W-3 11W-3
13C-SURROGATE RECOVERY % % % % % %
Triclosan (as methyl ether) 70% 66% 80% 64% 66% 68%
p,p'-DDE 72% 75% 80% 65% 78% 78%
Bisphenol A (dimethyl ether) 16% 26% 82% 77% 71% 78%
Tetrabromo-BPA (dimethyl ether) < 1% < 1% 3% 6% 1% 1%
  Denotes Data that do not meet common Quality Assurance Criteria
ND <        Denotes Not Detected at Specified Detection Limit
---            Denotes Indeterminate because blank exceeded sample or poor recovery shown by surrogate
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GC/HRMS analysis of non-polar organic pollutants in Sets 1, 2, and 4 
GC/HRMS analyses will now focus on non-polar persistent organic pollutants 
beginning with Set 1 samples followed by those in Sets 2 and 4.  The sensitive and 
selective GC/HRMS was an ideal detector after good sample cleanup for concentrations 
as low as 0.003 ng/g, provided that targeted analytes in blank samples were consistently 
very low or not detected.  The first targeted analyte, p,p’-DDE, the persistent metabolite 
of p,p’-DDT, was detected at a net value of 0.323 ng/g after subtracting the average of 
the blanks plus three times the standard deviation between the blanks (Table 8).  
Despite extreme caution during sample preparation, detecting p,p’-DDE in the blanks at  
< 0.1 ng/g was not surprising at an environmental lab where samples can often reach 
10,000 ng/g p,p’-DDE.  In Set 1, p,p’-DDE and the 13C-DDE surrogate were partially 
recovered in both fractions from basic alumina flash chromatography, but the isotope 
dilution quantitative technique based on the surrogate still resulted in an accurate 
quantitation.  Subsequently in later methods, the eluant was adjusted to 1% DCM 
Table 8.  Concentrations (ng/g) of p,p'-DDE and Several PBDEs in Set 1 Samples 
 
METHOD BLANKS TOENAIL SAMPLE SOAP WASH
1B-1 2B-1 Subtract from 3T-1 3T-1 3T-1 3W-1
Toenail Sample A Lipid=1.21%
AVG (3 * SD) - [Avg + 3 * SD)] Nov-05 NET NET NET
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g-lipid ng/g
p,p'-DDE 0.020 0.009 0.014 0.023 -0.038 0.361 0.323 27 0.008
tri-PBDE 17 0.113 0.051 0.082 0.132 -0.214 0.422 0.208 17 ---
tri-PBDE 28 0.124 0.096 0.110 0.060 -0.171 0.505 0.335 28 ---
tetra-PBDE 47 1.59 1.14 1.36 0.95 -2.31 10.5 8.19 677 ---
penta-PBDE 100 0.27 0.10 0.18 0.37 -0.55 1.57 1.02 84 ---
penta-PBDE 99 0.63 0.58 0.60 0.10 -0.70 7.02 6.32 522 0.18
hexa-PBDE 153 0.05 0.14 0.10 0.18 -0.28 1.59 1.31 108 ---
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in cyclopentane (instead of 0.5%) to match the slightly stronger alumina adsorbency 
caused by storing the alumina in a tightly closed glass flask in an oven rather than in one 
vulnerable to moisture in the air.  Several compounds including hexachlorobenzene and 
pentachloroanisole were not listed in Table 8 for the Set 1 toenail sample because the 
compounds were present in blank samples at or higher than in the toenail sample. 
 Six PBDEs, ranging from tri- to hexabromo-diphenyl ethers, were detected in all 
Set 1 samples in the expected second fraction from alumina, but at concentrations 
higher in the first toenail sample (3T-1) for valid blank-subtracted concentrations (Table 
8).  Blank-subtracted concentrations in the soap wash sample were almost all less than 
the blank samples.  Relative proportions of PBDE congener concentrations typified 
environmental samples except that the higher PBDE 153 was more prominent in human 
samples; this result is discussed in the next chapter about relevance to biomonitoring.
 For Set 2 samples, GC/HRMS analyses targeted chlordanes, following their 
detection and identification by GC/full scan MS in the Set 1 sample along with an 
expanded list of persistent, non-polar organochlorine pesticides (Table 9) to 
complement the moderately persistent, PBDE flame retardant compounds (Table 10).  
By targeting only non-polar compounds with fewer steps than Set 1, blanks had lower 
background for some compounds like hexachlorobenzene, pentachloroanisole, methyl 
ether metabolite of triclosan, and beta-hexachlorocyclohexane.  Thus, toenail samples 
had valid blank-subtracted concentrations of more analytes (shaded in blue in Table 9).  
An exception was that p,p’-DDE was slightly higher in Set 2 blanks, which caused 
concern for accurately measuring p,p’-DDE in toenail samples after blank subtraction. 
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Table 9.  Concentrations (ng/g) of Organochlorine Pesticides in Set 2 Samples 
 
Table 10.  Background-Subtracted Concentrations (ng/g) of PBDEs in Set 2 Blank, 
Toenails, and Soap Washes 
 
METHOD BLANKS TOENAIL SAMPLES SOAP WASHES
4B-2 5B-2 Subtract from 6T-2 6T-2 7T-2 7T-2 6W-2 7W-2
Toenail Samples A A NET NET
AVG (3 * SD) - [Avg + 3 * SD)] Jan. 2006 NET Mar. 2006 NET Jan. 2006 Mar. 2006
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g
Hexachlorobenzene 0.013 0.017 0.015 0.003 -0.023 0.330 0.31 0.21 0.19 0.024 ---
Pentachloroanisole 0.010 0.010 0.010 est. 0.005 est. -0.015 1.34 1.33 0.89 0.88 --- ---
Methyl (ether) Triclosan ND < 0.10 ND < 0.10 < 0.10 est. 0.05 est. -0.15 0.42 0.31 0.37 0.26 --- ---
β-Hx-Chloro-Cyclohexane ND < 0.05 ND < 0.05 < 0.05 est. 0.005 est. -0.055 0.08 0.03 0.11 0.06 --- ---
Dieldrin ND < 0.15 ND < 0.15 < 0.15 est. 0.005 est. -0.155 ND < 0.15 --- ND < 0.15 --- --- ---
Chlordanes:
Heptachlor ND < 0.04 ND < 0.04 < 0.04 est. 0.005 est. -0.045 0.38 0.34 1.28 1.24 --- ---
Heptachlor Epoxide ND < 0.02 ND < 0.02 < 0.02 est. 0.005 est. -0.025 0.21 0.19 0.16 0.13 --- ---
Oxychlordane ND < 0.04 ND < 0.04 < 0.04 est. 0.005 est. -0.045 0.04 --- ND < 0.04 --- --- ---
trans-Chlordane 0.05 < 0.04 0.05 0.008      -0.069 8.52 8.45 5.92 5.85 0.46 0.19
cis-Chlordane 0.08 < 0.04 0.06 0.029      -0.147 5.33 5.18 3.70 3.55 0.34 0.17
trans-Nonachlor 0.06 0.06 0.06 0.004      -0.071 4.60 4.53 3.31 3.23 0.09 ---
cis-Nonachlor ND < 0.04 < 0.04 < 0.04 est. 0.005 est. -0.045 0.25 0.20 0.36 0.31 --- ---
DDT Series:
p,p'-DDE 0.05 0.33 0.19 0.20        -0.78 1.40 0.62 1.27 0.49 --- ---
p,p'-DDD ND < 0.8 ND < 0.8 < 0.8 ND est. -0.85 ND < 0.8 --- ND < 0.8 --- --- ---
p,p'-DDT ND < 0.8 ND < 0.8 < 0.8 ND est. -0.85 ND < 0.8 --- ND < 0.8 --- --- ---
ND <   Not Detected at Specified Detection Limit
est.     Estimated for Quality Assurance
METHOD BLANKS TOENAIL SAMPLES SOAP WASHES
4B-2 5B-2 6T-2 6T-2 7T-2 7T-2 6W-2 7W-2
Subtract from
Toenails and A A NET NET
Soap Washes Jan-06 NET Mar-06 NET Jan-06 Mar-06
ANALYTE ng/g ng/g AVG 3 *SD - [Avg+3*SD)] ng/g ng/g ng/g ng/g ng/g ng/g
tri-BDE 17 ND < 0.05 ND < 0.05 < 0.05 ND est. 0.055 0.15 0.10 0.21 0.16 --- ---
tri-BDE 28 < 0.05 ND < 0.05 < 0.05 ND est. 0.055 0.36 0.31 0.49 0.43 --- ---
tetra-BDE 49 ND < 0.06 ND < 0.06 < 0.06 ND est. 0.065 0.57 0.51 0.82 0.75 --- ---
tetra-BDE 47 2.05 3.11 2.58 2.25 4.83 12.8 8.0 13.5 8.7 --- ---
tetra-BDE 66 ND < 0.06 ND < 0.06 < 0.06 ND est. 0.065 0.28 0.21 ND < 0.06 --- --- ---
penta-BDE 100 0.10 0.27 0.19 0.36 0.55 1.50 0.95 1.49 0.94 --- ---
penta-BDE 99 0.27 0.76 0.51 1.05 1.56 9.19 7.63 9.68 8.12 --- ---
penta-BDE 85 ND < 0.10 ND < 0.10 < 0.10 ND est. 0.15 0.32 0.17 0.41 0.26 --- ---
hexa-BDE 154 0.10 ND < 0.10 0.10 --- est. 0.15 0.19 0.04 0.18 0.03 --- ---
hexa-BDE 153 ND < 0.10 ND < 0.10 < 0.10 ND est. 0.15 2.32 2.17 2.04 1.89 --- ---
nona-BDE 208 0.86 0.91 0.88 0.11 0.99 ND < 0.20 --- 0.76 --- --- ---
nona-BDE 207 < 0.20 0.21 0.21 0.03 0.24 ND < 0.20 --- 0.40 0.16 --- ---
nona-BDE 206 ND < 0.20 < 0.20 < 0.20 --- est. 0.25 ND < 0.20 --- 0.30 0.05 --- ---
ND <   Not Detected at Specified Detection Limit
est.     Estimated for Quality Assurance
PBDE Concentrations are self-corrected for recovery by isotope dilution quantitation technique using 13C-surrogates
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Despite fewer steps in Set 2 than Set 1, PBDEs in blanks and toenail samples were very 
similar, except now 13 PBDE congeners were detectable (Table 10).  Most PBDEs were 
consistently measured in both toenail samples except for two nona-BDEs in sample 7T-
2, which may indicate recent exposure to the common flame retardant, deca-BDE 209 
followed by metabolic debromination.  Deca-BDE 209 was not detected above the 
blanks average plus three standard deviations (0.3 ng/g).  Resulting blank-subtracted 
PBDE concentrations in the two toenail samples in Table 10 were shaded blue for easier 
inspection. 
 Results of Set 4 sample analyses are presented in the next 12 tables (Tables 11-
22) grouped by analyte and sample types.  Because toenail sample masses in Set 4 
ranged from 65.5 mg to about 300 mg, five different columns (shaded yellow) in Table 
11 were used to compute blank-subtracted concentrations of organochlorine pesticides 
to match the varying masses of toenail samples in Table 12.  At low ppb concentrations, 
achieving consistently low blanks was most important for the smaller toenail sample 
sizes.  Set 4 was the first time that the enzyme Proteinase K was used in toenail sample 
digestion.  Therefore to evaluate whether the enzyme solution contained any targeted 
compounds, one of Set 4 blanks, 12B-4, did not contain Proteinase K while two blanks, 
13B-4 and 14B-4, contained Proteinase K.  At least for organochlorine pesticides, 
Proteinase K solutions did not contain any higher background of these targeted 
pesticides, so all three blanks were included and averaged in Table 11.  Generally, 
compound background levels in Set 4 blanks (Table 11) were comparable to Set 2 blanks 
(Table 9), however hexachlorobenzene was both higher and more variable in Set 4  
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Table 11.  Concentrations (ng/g) of Organochlorine Pesticides in Set 4 Blank Samples 
 
Table 12.  Blank-Subtracted Concentrations (ng/g-nail) of POPs Pesticides in Set 4 
Toenail Samples 
 
METHOD BLANKS        For 18T-4 SUB. For 19T-4 SUB. For 17T-4 SUB. For 20T-4, 22T-4 SUB. For 15T-4, 16T-4, SUB.
12B-4 13B-4 14B-4 Blank/0.0655 g from Blank/0.12 g from Blank/0.159 g from Blank/0.190 g from 20T and 21T-4 from 15T
No Concentration 18T-4 Concentration 19T-4 Concentration 17T-4 Concentration or 22T-4 Concentration 16T, 21T
Proteinase K ng/g ng/g  [Avg ng/g ng/g  [Avg ng/g ng/g  [Avg ng/g ng/g  [Avg ng/g ng/g  [Avg
ANALYTE NAME Total ng Total ng Total ng AVG. 3 SD + 3 SD] AVG. 3 SD + 3 SD] AVG. 3 SD + 3 SD] AVG. 3 SD + 3 SD] AVG. 3 SD + 3 SD]
Hexachlorobenzene 0.047 0.114 0.034 0.99 1.97 2.96 0.54 1.08 1.62 0.41 0.81 1.22 0.34 0.68 1.02 0.22 0.43 0.65
Pentachloroanisole 0.053 0.050 0.048 0.77 0.11 0.88 0.42 0.06 0.48 0.31 0.05 0.36 0.26 0.04 0.30 0.17 0.03 0.19
Me- (ether) Triclosan ND < 0.05 ND < 0.05 ND < 0.05 0.76 0.05 0.81 0.42 0.03 0.44 0.31 0.02 0.33 0.26 0.02 0.28 0.17 0.01 0.18
gamma-HCH ND < 0.02 ND < 0.02 ND < 0.02 0.31 0.23 0.53 0.17 0.13 0.29 0.13 0.09 0.22 0.11 0.08 0.18 0.07 0.05 0.12
beta-HCH ND < 0.02 ND < 0.02 ND < 0.02 0.31 0.23 0.53 0.17 0.13 0.29 0.13 0.09 0.22 0.11 0.08 0.18 0.07 0.05 0.12
Dieldrin  ND < 0.07  ND < 0.07  ND < 0.07 1.03 0.19 1.22 0.56 0.10 0.67 0.42 0.08 0.50 0.36 0.06 0.42 0.23 0.04 0.27
Chlordanes:
Oxychlordane ND < 0.01 ND < 0.01 ND < 0.01 0.15 0.09 0.24 0.08 0.05 0.13 0.06 0.04 0.10 0.05 0.03 0.08 0.03 0.02 0.05
Heptachlor Epoxide ND < 0.01 ND < 0.01 ND < 0.02 0.20 0.26 0.47 0.11 0.14 0.26 0.08 0.11 0.19 0.07 0.09 0.16 0.04 0.06 0.10
trans-Chlordane 0.067 0.068 0.070 1.04 0.07 1.11 0.57 0.04 0.61 0.43 0.03 0.46 0.36 0.02 0.38 0.23 0.01 0.24
cis-Chlordane 0.059 0.059 0.062 0.92 0.07 0.99 0.50 0.04 0.54 0.38 0.03 0.40 0.32 0.02 0.34 0.20 0.02 0.22
trans-Nonachlor 0.068 0.068 0.071 1.05 0.09 1.14 0.58 0.05 0.62 0.43 0.04 0.47 0.36 0.03 0.39 0.23 0.02 0.25
cis-Nonachlor ND < 0.02 ND < 0.02 ND < 0.02 0.31 0.05 0.35 0.17 0.03 0.19 0.13 0.02 0.14 0.11 0.02 0.12 0.07 0.01 0.08
DDT Series:
o,p'-DDE ND < 0.01 ND < 0.01 ND < 0.01 0.15 0.23 0.38 0.08 0.13 0.21 0.06 0.09 0.16 0.05 0.08 0.13 0.03 0.05 0.08
p,p'-DDE 0.029 0.052 0.027 0.55 0.64 1.19 0.30 0.35 0.65 0.23 0.26 0.49 0.19 0.22 0.41 0.12 0.14 0.26
o,p'-DDD ND < 0.05 ND < 0.05 ND < 0.05 0.76 0.14 0.90 0.42 0.08 0.49 0.31 0.06 0.37 0.26 0.05 0.31 0.17 0.03 0.20
p,p'-DDD ND < 0.05 ND < 0.05 ND < 0.05 0.76 0.14 0.90 0.42 0.08 0.49 0.31 0.06 0.37 0.26 0.05 0.31 0.17 0.03 0.20
o,p'-DDT ND < 0.05 ND < 0.05 ND < 0.05 0.76 0.23 0.99 0.42 0.13 0.54 0.31 0.09 0.41 0.26 0.08 0.34 0.17 0.05 0.22
p,p'-DDT ND < 0.05 ND < 0.05 ND < 0.05 0.76 0.14 0.90 0.42 0.08 0.49 0.31 0.06 0.37 0.26 0.05 0.31 0.17 0.03 0.20
ND <   Not Detected at Specified Detection Limit
NOTE:   In a Soap Wash sample BLANK (not shown), no analytes were detected above the (average blank + 3 SD) concentrations. 
TOENAIL SAMPLES
15T-4 16T-4 17T-4 18T-4 19T-4 20T-4 21T-4 22T-4
Date Sampled: Oct 2006 Feb 2007 May 2007 Jan 2010 Apr 2010 Jan 2009 Apr 2009 Nov 2007
Sample Submitter A A A B M-cat C C D
Mass (g): 0.340 0.295 0.159 0.0655 0.120 0.196 0.322 0.189
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g
Hexachlorobenzene --- --- --- --- --- --- --- ---
Pentachloroanisole 0.16 0.38 0.34 0.47 0.95 0.16 0.24 ---
Methyl (ether) Triclosan 1.78 0.20 0.07 --- --- --- --- ---
gamma-HCH (Lindane) 0.05 --- 0.13 --- 0.14 --- --- 0.16
beta-HCH 0.11 0.16 0.24 --- --- 0.18 0.12 0.20
Dieldrin --- --- --- 0.69 --- --- 0.24 ---
Chlordanes:
Oxychlordane --- 0.09 --- 0.38 0.26 0.13 0.09 0.13
Heptachlor Epoxide 0.07 0.09 0.08 --- 0.31 0.07 0.09 ---
trans-Chlordane 3.68 4.45 6.53 7.11 13.6 4.25 4.41 0.59
cis-Chlordane 2.40 2.81 4.18 4.56 8.22 1.86 1.96 0.33
trans-Nonachlor 1.92 2.27 3.47 4.11 9.48 1.32 1.57 0.32
cis-Nonachlor 0.16 0.19 0.40 0.69 0.80 0.30 0.24 0.22
DDT Series:
o,p'-DDE --- --- --- --- --- 0.13 0.11 ---
p,p'-DDE 0.79 1.14 1.07 0.57 0.67 2.81 2.89 1.31
o,p'-DDD --- --- --- --- --- --- --- ---
p,p'-DDD --- --- --- --- --- --- --- ---
o,p'-DDT --- --- --- --- --- 0.64 0.39 ---
p,p'-DDT --- --- --- --- --- 0.89 1.04 1.33
--- Not Detected or not detected above method blank
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blanks, resulting in no blank-subtracted concentrations in any Set 4 toenail sample 
(Table 12).  In contrast, p,p’-DDE was consistently lower in Set 4 blanks, which enabled 
blank-subtracted concentrations in all toenail samples, even the one (18T-4) that was 
only 65.5 mg.  As in all methods, p,p’-DDE was quantitated in all samples based on the 
13C-p,p’-DDE surrogate recovery, which will be included in the upcoming table with 13C-
PBDE surrogates.  With several of Set 4 toenail samples from other individuals, both 
isomers of DDT and the second isomer (o,p’-) of DDE were now detected and reported 
(Table 12).  In all Set 4 toenail samples (Table 12), trans-Chlordane had the highest 
concentration, followed closely by other chlordane components of cis-Chlordane, and 
trans-Nonachlor. 
 After blank-subtraction, concentrations in Set 4 soap washes of the toenail 
samples for organochlorine pesticides primarily contained only the major chlordane 
components (Table 13).  Such compounds are likely from air and dust from homes 
treated with chlordane for termites before its ban in 1988.  It is plausible that some 
amount would adsorb to the outside nail surface and then be released in an ultrasonic 
soap bath. 
 Earlier in this chapter, a synthetic musk fragrance compound, Galaxolide, (or 
isomer, Versalide) was identified in a Set 3 toenail sample (11T-3) by GC/full scan MS.  
Being neutral with little polarity, galaxolide and two other related synthetic musk 
compounds were compatible with and were thus added to Set 4 analyses of the second 
fraction from basic alumina.  Table 14 lists blank-subtracted concentrations of 
traseolide, galaxolide, and tonalide in Set 4 toenail samples, soap washes, and blank  
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Table 13.  Blank-Subtracted Concentrations (ng/g-wet wgt) of Organochlorine Pesticides 
in Soap Washes 
 
average plus three standard deviations amount subtracted for each toenail and soap 
wash sample.  Galaxolide was highest of the fragrance compounds in all samples and 
exceeded 1000 ng/g (one ppm) even in many of the blank-subtracted toenail samples, 
except for samples 19T-4 (cat) and 22T-4. 
Results of Set 4 sample analyses of basic alumina-Fraction 2 continue with PBDEs 
and a newer brominated flame retardant, 1,2-bis(2,4,6-tribromophenoxy)ethane, 
abbreviated as Bis-TriBr-PE in Tables 15-18.  Set 4 blanks in Table 15 show significantly 
higher amounts of PBDEs 49, 47, 100, and 99 in the blank samples 13B-4 and 14B-4 that 
SOAP WASHES of TOENAILS
15W-4 16T-4 17T-4 18T-4 19T-4 20T-4 21T-4 22T-4
Sample Submitter A A A B M-cat C C D
Mass (g): 0.34 0.295 0.159 0.0655 0.120 0.196 0.322 0.189
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g
Hexachlorobenzene --- --- --- --- --- --- --- ---
Pentachloroanisole --- --- --- --- 0.45 --- --- ---
Methyl (ether) Triclosan 0.06 --- --- --- --- --- --- ---
gamma-HCH (Lindane) --- --- --- --- --- --- --- ---
beta-HCH --- --- --- --- --- --- --- ---
Dieldrin --- --- --- --- --- --- --- ---
Chlordanes:
Oxychlordane --- --- --- --- --- --- --- ---
Heptachlor Epoxide --- --- --- --- --- --- --- ---
trans-Chlordane 0.19 0.16 0.75 1.04 2.50 0.23 0.06 ---
cis-Chlordane 0.13 0.10 0.44 0.68 1.47 0.08 0.04 ---
trans-Nonachlor 0.11 0.06 0.43 0.65 1.48 0.04 0.03 ---
cis-Nonachlor 0.11 --- 0.23 0.53 0.40 0.17 0.12 ---
DDT Series:
o,p'-DDE --- --- --- --- --- --- --- ---
p,p'-DDE --- --- --- --- --- --- --- ---
o,p'-DDD --- --- --- --- --- --- --- ---
p,p'-DDD --- --- --- --- --- --- --- ---
o,p'-DDT --- --- --- --- --- --- --- ---
p,p'-DDT --- --- --- --- --- --- --- ---
--- Not Detected or not detected above method blank
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Table 14.  Blank-Subtracted Concentrations (ng/g) of Synthetic Musk Fragrances in Set 4 
Toenail Samples 
 
 
had Proteinase K enzyme than in the blank sample 12B-4 without Proteinase K.  Those 
PBDEs are major constituents in the “Penta” formulation used commercially.  Deca-BDE 
209, all three nona-BDEs and several octa-BDEs were only slightly higher in the two 
blank samples with Proteinase K.  Therefore, for blank-subtraction of PBDEs in Set 4 
samples, the enzyme significantly raised the method background of common PBDEs, so 
method blank 12B-4 was excluded in the averaging process.  Blank-subtracted 
concentrations of PBDEs in Set 4 toenail samples therefore lack most values in Table 16 
for PBDEs 17, 49, 47, and 100.  The larger blank subtraction for PBDE 99 likely affected 
its accurate measurement in the nails.  Of the remaining PBDEs with values in Table 16 
TOENAIL SAMPLES
15T-4 16T-4 17T-4 18T-4 19T-4 20T-4 21T-4 22T-4
Date Sampled: Oct 2006 Feb 2007 May 2007 Jan 2010 Apr 2010 Jan 2009 Apr 2009 Nov 2007
Sample Submitter A A A B M-cat C C D
Mass (g): 0.340 0.295 0.159 0.0655 0.120 0.196 0.322 0.189
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g
Traseolide 0.25 2.24 0.72 --- --- 0.40 0.45 ---
Galaxolide 700 1,030     2,300     3,440     100 1,860     1,880     41.6
Tonalide 25.0 48.3 30.4 136 11.8 57.1 126 4.43
SOAP WASHES
15W-4 16W-4 17W-4 18W-4 19W-4 20W-4 21W-4 22W-4
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g
Traseolide --- --- --- --- --- --- --- ---
Galaxolide 44.3 46.0 383 572 --- 565 141 ---
Tonalide 0.61 0.45 10.5 27.3 --- 7.9 1.08 ---
METHOD 4 BLANKS [Avg + 3*Std Dev] Subtracted from SAMPLES ABOVE
15T-4 16T-4 17T-4 18T-4 19T-4 20T-4 21T-4 22T-4
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g
Traseolide 0.20 0.20 0.38 0.92 0.50 0.32 0.20 0.32
Galaxolide 17.4 17.4 32.7 79.9 43.6 27.5 17.4 27.5
Tonalide 1.02 1.02 1.91 4.66 2.54 1.61 1.02 1.61
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Table 15.  Concentrations (ng/g) of PBDEs in Set 4 Blanks 
 
for Set 4, the hexa-BDE 153 is likely the best indicator for relative amount of PBDEs in 
the various toenail samples.  In toenail samples from individual A in Set 4, blank-
subtracted PBDE 153 concentrations were 1.16, 2.50, and 1.87 ng/g (mean 1.84, sd 0.67, 
n=3), which closely compare to 1.31 ng/g for Set 1 and 2.17 and 1.89 ng/g for Set 2 
(mean 1.79, sd 0.44, n=3).  In contrast, toenail samples from individual C in Set 4 
contained sevenfold less PBDE 153 (mean 0.25, sd 0.12, n=2).  In soap washes of Set 4 
toenail samples, there were very few blank-subtracted PBDE concentrations in Table 17, 
similar to none in Table 10 for Set 2 washes.  Therefore, there was no significant 
exogenous PBDE contamination detected in the soap washes.  
No Prot. K METHOD BLANKS For 18T-4 SUB. For 19T-4 SUB. For 17T-4 SUB. For 20T-4, 22T-4 SUB. For 15T-4, 16T-4, SUB.
12B-4 13B-4 14B-4 Blank/0.0655 g from Blank/0.12 g from Blank/0.159 g from Blank/0.190 g from 20T and 21T-4 from 15T
NOT WITH PROTEINASE K Concentration 18T-4 Concentration 19T-4 Concentration 17T-4 Concentration or 22T-4 Blank/0.30 g 16T, 21T
AVERAGED ng/g ng/g  [Avg ng/g ng/g  [Avg ng/g ng/g  [Avg ng/g ng/g  [Avg ng/g ng/g  [Avg
ANALYTE NAME Total ng Total ng Total ng AVG. 3 SD + 3 SD] AVG. 3 SD + 3 SD] AVG. 3 SD + 3 SD] AVG. 3 SD + 3 SD] AVG. 3 SD + 3 SD]
tri-BDE 17 ND < 0.005 0.05 ND < 0.005 0.42 1.46 1.88 0.23 0.80 1.02 0.17 0.60 0.77 0.14 0.50 0.65 0.09 0.32 0.41
tri-BDE 28 ND < 0.005 ND < 0.005 0.01 0.08 0.05 0.12 0.04 0.03 0.07 0.03 0.02 0.05 0.03 0.02 0.04 0.02 0.01 0.03
tetra-BDE 49 ND < 0.005 0.06 0.02 0.57 1.20 1.76 0.31 0.65 0.96 0.23 0.49 0.73 0.20 0.41 0.61 0.12 0.26 0.38
tetra-BDE 47 0.06 1.80 0.71 19.2 35.3 54.5 10.5 19.3 29.7 7.89 14.5 22.4 6.61 12.2 18.8 4.18 7.71 11.9
tetra-BDE 66 ND < 0.005 0.05 ND < 0.005 0.42 1.45 1.87 0.23 0.79 1.02 0.17 0.60 0.77 0.14 0.50 0.64 0.09 0.32 0.41
penta-BDE 100 0.01 0.46 0.22 5.17 7.93 13.1 2.82 4.33 7.15 2.13 3.27 5.40 1.78 2.74 4.52 1.13 1.73 2.86
penta-BDE 99 0.03 0.85 0.64 11.3 6.80 18.1 6.19 3.71 9.90 4.67 2.80 7.47 3.91 2.34 6.26 2.48 1.48 3.96
penta-BDE 85 ND < 0.01 0.01 0.01 0.22 0.01 0.23 0.12 0.004 0.12 0.09 0.003 0.09 0.08 0.002 0.08 0.05 0.00 0.05
hexa-BDE 154 0.01 0.02 0.01 0.22 0.18 0.40 0.12 0.10 0.22 0.09 0.07 0.17 0.08 0.06 0.14 0.05 0.04 0.09
hexa-BDE 153 ND < 0.01 0.03 ND < 0.01 0.28 0.53 0.81 0.15 0.29 0.44 0.11 0.22 0.33 0.10 0.18 0.28 0.06 0.12 0.18
hexa-BDE 139 ND < 0.01 ND < 0.01 ND < 0.01 0.15 0.05 0.20 0.08 0.03 0.11 0.06 0.02 0.08 0.05 0.02 0.07 0.03 0.01 0.04
hexa-BDE 140 ND < 0.01 0.03 ND < 0.01 0.27 0.51 0.79 0.15 0.28 0.43 0.11 0.21 0.33 0.09 0.18 0.27 0.06 0.11 0.17
hexa-BDE 138 ND < 0.01 ND < 0.01 ND < 0.01 0.15 0.05 0.20 0.08 0.03 0.11 0.06 0.02 0.08 0.05 0.02 0.07 0.03 0.01 0.04
hepta-BDE 183 ND < 0.01 0.02 0.02 0.27 0.14 0.41 0.15 0.07 0.22 0.11 0.06 0.17 0.09 0.05 0.14 0.06 0.03 0.09
octa-BDE 201 0.02 0.04 0.03 0.53 0.46 0.99 0.29 0.25 0.54 0.22 0.19 0.41 0.18 0.16 0.34 0.12 0.10 0.22
octa-BDE 204 ND < 0.015 ND < 0.015 0.05 0.47 1.04 1.51 0.26 0.57 0.83 0.20 0.43 0.62 0.16 0.36 0.52 0.10 0.23 0.33
octa-BDE 197 ND < 0.015 0.02 0.02 0.24 0.06 0.30 0.13 0.03 0.16 0.10 0.02 0.12 0.08 0.02 0.10 0.05 0.01 0.07
octa-BDE 203 ND < 0.015 0.04 0.01 0.42 0.84 1.26 0.23 0.46 0.69 0.17 0.35 0.52 0.14 0.29 0.43 0.09 0.18 0.27
octa-BDE 196 ND < 0.015 0.08 0.07 1.17 0.31 1.48 0.64 0.17 0.81 0.48 0.13 0.61 0.40 0.11 0.51 0.26 0.07 0.32
octa-BDE 205 ND < 0.015 0.06 0.04 0.79 0.73 1.53 0.43 0.40 0.83 0.33 0.30 0.63 0.27 0.25 0.53 0.17 0.16 0.33
nona-BDE 208 0.06 0.17 0.09 1.98 2.87 4.85 1.08 1.56 2.65 0.82 1.18 2.00 0.68 0.99 1.67 0.43 0.63 1.06
nona-BDE 207 0.02 0.10 0.06 1.23 1.51 2.74 0.67 0.83 1.50 0.51 0.62 1.13 0.42 0.52 0.95 0.27 0.33 0.60
nona-BDE 206 0.02 0.15 0.08 1.71 2.12 3.83 0.94 1.16 2.09 0.71 0.87 1.58 0.59 0.73 1.32 0.37 0.46 0.84
deca-BDE 209 0.08 0.23 0.13 2.70 3.24 5.94 1.48 1.77 3.24 1.11 1.33 2.45 0.93 1.12 2.05 0.59 0.71 1.30
Bis-TriBr-PE ND < 0.02 ND < 0.02 ND < 0.02 0.31 0.05 0.35 0.17 0.03 0.19 0.13 0.02 0.15 0.11 0.02 0.12 0.07 0.01 0.08
  ND <   Not Detected at Specified Detection Limit
  NOTE:   Only Method Blanks 13B-4 and 14B-4 were averaged and used for blank-subtracting concentrations in Method 4 samples
  Blank for the Soap Wash was not shown because after blank subtraction, all concentrations for soap wash blank were < [avg + 3 SD]
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 Table 16.  Blank-subtracted Concentrations (ng/g) of PBDEs in Set 4 Toenail Samples 
 
Surrogate 13C-PBDE and 13C-DDE recoveries in Set 4 blanks and toenail samples 
were tallied in Table 18.  For 13C-PBDEs, 167 out of 176 measurements were recovered 
above 40%, while 10 out of 11 13C-DDE recoveries exceeded 40%.  In the Blank 13B-4, a 
few volatile surrogates had low recoveries, likely when a small solvent extract nearly 
went dry.  A few computations exceeded 100%, when a few corresponding internal 
TOENAIL SAMPLES
15T-4 16T-4 17T-4 18T-4 19T-4 20T-4 21T-4 22T-4
Date Sampled: Oct 2006 Feb 2007 May 2007 Jan 2010 Apr 2010 Jan 2009 Apr 2009 Nov 2007
Sample Submitter A A A B M-cat C C D
Mass (g): 0.340 0.295 0.159 0.0655 0.120 0.196 0.322 0.189
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g
tri-BDE 17 --- --- --- --- --- --- --- ---
tri-BDE 28 0.13 0.22 0.33 0.15 0.19 0.36 0.34 0.34
tetra-BDE 49 --- --- --- --- --- --- --- ---
tetra-BDE 47 --- 9.92 --- --- --- --- 5.0 ---
tetra-BDE 66 --- --- --- --- --- --- --- ---
penta-BDE 100 --- --- --- --- --- --- --- ---
penta-BDE 99 2.77 7.31 2.63 14.0 21.4 0.43 3.74 ---
penta-BDE 85 0.21 0.29 0.32 0.71 0.79 0.18 0.28 0.16
hexa-BDE 154 0.21 0.39 0.18 1.10 1.95 0.15 0.20 0.17
hexa-BDE 153 1.16 2.50 1.87 2.15 3.48 0.16 0.33 0.45
hexa-BDE 139 0.06 0.09 0.07 0.17 0.46 0.03 0.05 0.10
hexa-BDE 138 --- --- --- 0.35 0.45 0.14 0.07 ---
hepta-BDE 183 0.04 0.07 --- --- 0.19 --- 0.03 0.10
octa-BDE 197 --- --- --- --- 0.05 --- --- 0.11
nona-BDE 208 --- --- --- --- --- --- --- ---
nona-BDE 207 --- --- --- --- --- --- --- ---
nona-BDE 206 --- --- --- --- --- --- --- ---
deca-BDE 209 0.53 2.28 3.51 --- 3.17 3.28 2.98 4.82
Bis-TriBr-PE 0.91 1.16 0.11 --- --- --- --- ---
---   Not Detected at Specified Detection Limit or < [Blank Avg + 3SD]
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Table 17.  Blank-Subtracted Concentrations (ng/g) of PBDEs in Set 4 Soap Washes of 
Toenails 
 
standards added in the final vial may have been partially lost from evaporation and 
were therefore detected with slightly less response than expected from calibration 
standards. 
 Because of renewed interest in biomonitoring PCB congeners and, with the 
newly acquired (Wellington Labs, Ontario, Canada) comprehensive set of low level PCB 
calibration and 13C-PCB surrogate standards, PCBs were targeted in Set 4 samples.  PCBs 
15W-4 16W-4 17W-4 18W-4 19W-4 20W-4 21W-4 22W-4
Date Sampled: Oct 2006 Feb 2007 May 2007 Jan 2010 Apr 2010 Jan 2009 Apr 2009 Nov 2007
Sample Donated by: A A A B M-cat C C D
Mass Rinsed (g): 0.340 0.295 0.159 0.0655 0.120 0.196 0.322 0.189
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g
tri-BDE 17 --- --- --- --- --- --- --- ---
tri-BDE 28 --- --- --- --- --- 0.07 --- 0.07
tetra-BDE 49 --- --- --- --- --- --- --- ---
tetra-BDE 47 --- --- --- --- --- --- 2.50 ---
tetra-BDE 66 --- --- --- --- --- --- --- ---
penta-BDE 100 --- --- --- --- --- --- 0.19 ---
penta-BDE 99 --- --- --- --- --- --- 2.82 ---
penta-BDE 85 --- --- --- --- --- --- --- ---
hexa-BDE 154 --- --- --- 0.10 0.22 --- --- ---
hexa-BDE 153 0.02 --- --- 0.16 0.17 --- --- ---
hexa-BDE 139 --- --- --- --- --- --- --- ---
hexa-BDE 138 --- --- --- --- --- --- --- ---
hepta-BDE 183 --- --- --- --- --- --- --- ---
octa-BDE 197 --- --- --- --- --- --- --- ---
nona-BDE 208 --- --- --- --- --- --- --- ---
nona-BDE 207 --- --- --- --- --- --- --- ---
nona-BDE 206 --- --- --- --- --- --- --- ---
deca-BDE 209 --- --- --- --- --- --- --- ---
Bis-TriBr-PE --- --- --- --- --- --- --- ---
---    Not Detected above Method Blank
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Table 18.  Percent Recoveries of 13C-PBDEs and DDE in Set 4 Toenail Samples and Blanks 
 
were accurately measured, both individually as 53 congeners and as homolog totals.  
For 20 of the 53 congeners, accuracy was improved using matching 13C-PCB surrogates.  
An important key to the successful PCB analyses in Set 4 samples was achieving 
consistently low blanks at or below 1 ng total (Table 19) in a 50-year old building prone 
to PCB contamination from previous electrical equipment and light fixtures.  
Consistently low PCB blanks in the Set 4 sample set were some 20 times lower than 
nominal blank levels by other analysts using extraction and cleanup procedures that 
were less isolated to lab air and dust and who used much higher volumes of reagents 
and chromatographic eluants.  All PCBs were measured in basic alumina-Fraction 1 
BLANKS TOENAIL SAMPLES
12B-4 13B-4 14B-4 15T-4 16T-4 17T-4 18T-4 19T-4 20T-4 21T-4 22T-4
Sample Submitter A A A B M-cat C C D
SURROGATE % % % % % % % % % % %
13C-di-BDE 15 49 9 55 83 57 61 53 46 75 77 86
13C-tri-BDE 28 54 17 66 91 64 69 62 50 84 92 94
13C-tetra-BDE 47 70 43 65 98 59 64 63 55 80 87 94
13C-tetra-BDE 77 68 58 64 93 57 65 66 55 79 90 94
13C-penta-BDE 100 68 35 76 108 60 78 72 62 73 97 103
13C-penta-BDE 99 71 58 82 116 66 82 74 62 89 102 108
13C-penta-BDE 126 69 68 80 116 64 84 74 63 93 108 111
13C-hexa-BDE 154 62 42 72 89 50 66 63 51 66 78 98
13C-hexa-BDE 153 69 64 78 101 57 75 72 55 78 91 103
13C-hexa-BDE 169 61 67 68 113 60 70 69 54 85 102 98
13C-hepta-BDE 183 65 71 80 81 60 69 64 58 88 99 114
13C-octa-BDE 197 85 91 92 121 92 61 100 77 101 71 143
13C-octa-BDE 205 83 80 94 117 74 47 87 65 90 60 147
13C-nona-BDE 207 61 68 76 96 63 49 65 52 93 72 109
13C-deca-BDE 209 55 48 47 82 21 11 28 28 38 33 53
13C-bis-triBrPE 68 72 97 120 87 82 85 64 106 108 122
13C-p,p'-DDE 88 11 92 75 84 90 60 73 49 88 91
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Table 19.  Amount of PCBs (ng) in Set 4 Blanks 
 
METHOD BLANKS Amt Blank-
12B-4 13B-4 14B-4 Subtracted
No Proteinase K WITH PROTEINASE K Avg [Avg + 3SD]
PCB Congener (Number) Total ng Total ng Total ng Total ng Total ng
Di-PCB 15 * 0.007 0.010 0.008 0.008 0.014
Tri-PCB 18 0.120 0.043 0.046 0.070 0.200
Tri-PCB 31/28 * 0.041 0.024 0.026 0.030 0.058
Tri-PCB 33 0.043 0.023 0.026 0.031 0.064
Tetra-PCB 52 * 0.047 0.037 0.023 0.036 0.071
Tetra-PCB 49 0.017 0.014 0.007 0.013 0.030
Tetra-PCB 44 0.027 0.024 0.012 0.021 0.044
Tetra-PCB 41 0.014 0.016 0.010 0.013 0.023
Tetra-PCB 74 0.011 0.012 0.010 0.011 0.014
Tetra-PCB 70 * 0.032 0.031 0.025 0.029 0.042
Tetra-PCB 66 0.013 0.014 0.013 0.013 0.015
Tetra-PCB 60 0.009 0.008 0.007 0.008 0.010
Tetra-PCB 81 * ND < 0.003 ND < 0.003 ND < 0.003 0.003 0.005
Tetra-PCB 77 * 0.005 0.005 0.006 0.005 0.007
Penta-PCB 95 * 0.066 0.062 0.051 0.060 0.083
Penta-PCB 84 0.016 0.022 0.015 0.018 0.029
Penta-PCB 101 * 0.063 0.066 0.052 0.060 0.082
Penta-PCB 99 0.023 0.021 0.015 0.020 0.032
Penta-PCB 97 0.021 0.017 0.017 0.019 0.026
Penta-PCB 87 0.037 0.032 0.031 0.033 0.043
Penta-PCB 85 0.012 0.014 0.010 0.012 0.018
Penta-PCB 110 0.056 0.067 0.063 0.062 0.079
Penta-PCB 123 * 0.003 0.003 0.004 0.003 0.005
Penta-PCB 118 * 0.052 0.044 0.042 0.046 0.061
Penta-PCB 105 * 0.042 0.026 0.038 0.035 0.060
Hexa-PCB 135 0.011 0.010 0.011 0.011 0.013
Hexa-PCB 153 */168 0.028 0.029 0.023 0.027 0.036
Hexa-PCB 141 0.016 0.013 0.014 0.014 0.019
Hexa-PCB 137 0.007 0.005 0.007 0.007 0.010
Hexa-PCB 138 */158 0.030 0.031 0.029 0.030 0.032
Hexa-PCB 129 ND < 0.003 ND < 0.003 0.006 0.004 0.008
Hexa-PCB 128 0.007 0.012 0.009 0.009 0.017
Hexa-PCB 167 * ND < 0.003 0.004 0.004 0.004 0.006
Hexa-PCB 156 * 0.008 0.009 0.009 0.008 0.010
Hexa-PCB 157 * ND < 0.003 ND < 0.003 ND < 0.003 0.003 0.004
Hepta-PCB 178 0.007 0.007 0.006 0.007 0.008
Hepta-PCB 187 0.003 0.004 0.004 0.004 0.006
Hepta-PCB 183 0.003 0.003 0.003 0.003 0.004
Hepta-PCB 174 0.008 0.009 0.007 0.008 0.011
Hepta-PCB 177 0.003 0.004 0.003 0.003 0.004
Hepta-PCB 171 ND < 0.003 0.003 0.003 0.003 0.006
Hepta-PCB 180 */193 0.004 0.005 0.004 0.004 0.006
Hepta-PCB 170 * 0.003 0.004 0.005 0.004 0.006
Octa-PCB 202 * 0.003 0.003 0.003 0.003 0.006
Octa-PCB 199 0.006 0.007 0.006 0.006 0.008
Octa-PCB 194 0.004 0.004 0.004 0.004 0.007
Nona-PCB 208 * 0.003 0.003 0.003 0.003 0.006
Nona-PCB 206 0.004 ND < 0.003 0.003 0.003 0.005
Deca-PCB 209 * 0.005 0.004 0.006 0.005 0.007
*   Denotes Quantitation with same 13C-PCB congener
Homolog quantitation:
SUM of Di-PCBs 0.032 --- --- 0.011 0.067
SUM of Tri-PCBs 0.250 0.161 0.117 0.176 0.379
SUM of Tetra-PCBs 0.143 0.131 0.042 0.105 0.271
SUM of Penta-PCBs 0.413 0.440 0.376 0.410 0.506
SUM of Hexa-PCBs 0.169 0.108 0.149 0.142 0.235
SUM of Hepta-PCBs 0.003 0.005 0.009 0.006 0.016
SUM of Octa-PCBs 0.010 0.007 --- 0.006 0.021
SUM Di-Octa-PCBs 1.020 0.852 0.693 0.860 1.500
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except PCBs 15, 81, and 77 that eluted in Fraction 2.  Dioxin-like PCBs 126 and 169 were 
targeted but not detected.  For simplicity, the far right column in Table 19 used to blank 
subtract from toenail samples and soap washes listed the amount (ng) based on blank 
average plus three standard deviations.  For each toenail and soap wash sample, that 
amount divided by the mass of each sample gave the appropriate concentration to 
subtract for each congener and each sample. 
 Blank-subtracted concentrations of PCBs in Set 4 toenail samples and soap 
washes were listed in Tables 20 and 21, respectively.  Reviewing the toenail samples 
data for individual A toenails in Table 20, sample 17T-4 at 37.6 ng/g total was 
significantly higher than 7.0 ng/g and 4.5 ng/g, respectively, for samples 15T-4 and 16T-
4.  In soap wash data of Table 21, PCBs were highest for the wash sample (17W-4) of 
that 17T-4 toenail sample, which seems to indicate that much of the elevated PCB 
concentration for sample 17T-4 was from exogenous contamination. 
 For quality assurance, percent recoveries of the 13C-PCB surrogates in Set 4 
toenail samples are listed in Table 22.  Nearly all (150 out of 160 measurements) in the 
expected basic alumina fraction exceeded 40% recovery except for 13C-PCBs 28 and 105, 
which were near the cutoff for fraction one to fraction two and they split between the 
two fractions.  For 13C-PCB 28 and 105, both basic alumina fractions were checked and 
quantitation was made based on the fraction which contained the majority of the 
surrogate.  The percentages slightly above 100% for 13C-PCBs 15, 81, and 77 in fraction 
two occurred because the internal standards in those samples that are used to calculate 
the 13C-PCB surrogates had a slightly lower response than in the calibration standards. 
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Table 20.  Blank-Subtracted Concentrations (ng/g) of PCBs in Set 4 Toenail Samples 
 
TOENAIL SAMPLES
15T-4 16T-4 17T-4 18T-4 19T-4 20T-4 21T-4 22T-4
Date Sampled: Oct 2006 Feb 2007May 2007 Jan 2010 Apr 2010 Jan 2009 Apr 2009 Nov 2007
Sample Submitter A A A B M-cat C C D
Mass (g): 0.340 0.295 0.159 0.0655 0.120 0.196 0.322 0.189
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g
Di-PCB 15 * 0.06 0.05 0.20 --- 0.03 --- 0.03 0.35
Tri-PCB 18 0.14 --- --- --- 1.05 --- 0.09 ---
Tri-PCB 31/28 * 0.32 0.20 0.45 0.16 0.87 0.24 0.59 0.69
Tri-PCB 33 0.34 0.09 0.23 0.11 0.67 0.11 0.64 0.57
Tetra-PCB 52 * 0.08 0.18 1.41 --- 0.73 0.28 0.33 1.47
Tetra-PCB 49 0.08 0.11 0.58 --- 0.29 0.13 0.21 0.54
Tetra-PCB 44 0.11 0.13 0.79 --- 0.47 0.16 0.28 1.13
Tetra-PCB 41 0.08 0.13 0.65 --- 0.29 0.09 0.13 0.92
Tetra-PCB 74 0.13 0.16 0.64 0.17 0.42 0.24 0.26 1.08
Tetra-PCB 70 * 0.29 0.24 2.15 0.58 1.36 0.60 0.70 4.56
Tetra-PCB 66 0.17 0.18 0.87 0.27 0.62 0.37 0.45 1.82
Tetra-PCB 60 0.06 0.08 0.32 0.06 0.20 0.07 0.09 0.65
Tetra-PCB 81 * 0.003 0.005 0.01 0.02 --- 0.01 0.01 0.01
Tetra-PCB 77 * 0.01 0.003 0.03 --- 0.01 0.02 0.03 0.19
Penta-PCB 95 * 0.14 0.19 3.58 0.65 2.08 0.65 0.83 5.92
Penta-PCB 84 0.02 0.06 1.05 --- 0.48 0.12 0.13 1.87
Penta-PCB 101 * 0.39 0.34 4.65 1.19 2.86 1.04 1.36 10.3
Penta-PCB 99 0.15 0.14 1.71 0.30 0.94 0.36 0.47 3.64
Penta-PCB 97 0.17 0.11 1.44 0.39 0.98 0.35 0.50 3.92
Penta-PCB 87 0.29 0.16 2.30 0.68 1.63 0.55 0.89 7.03
Penta-PCB 85 0.09 0.03 0.64 0.11 0.42 0.10 0.25 2.01
Penta-PCB 110 0.39 0.21 3.00 0.80 2.09 0.57 1.25 14.5
Penta-PCB 123 * 0.03 --- 0.12 0.07 0.16 0.02 0.06 0.43
Penta-PCB 118 * 0.74 0.23 2.34 1.25 2.33 0.93 1.39 9.98
Penta-PCB 105 * 0.43 --- 0.44 0.58 2.11 0.43 1.78 3.76
Hexa-PCB 135 0.07 0.04 0.52 0.30 0.38 0.18 0.28 1.65
Hexa-PCB 153 */168 0.32 0.20 0.93 0.52 0.93 0.50 0.74 3.92
Hexa-PCB 141 0.11 0.03 0.24 0.18 0.41 0.19 0.25 1.42
Hexa-PCB 137 0.03 --- 0.10 0.04 0.16 0.06 0.10 0.55
Hexa-PCB 138 */158 0.31 0.13 0.52 0.71 0.98 0.45 0.65 3.28
Hexa-PCB 129 0.04 0.01 0.07 0.08 0.19 0.05 0.09 0.58
Hexa-PCB 128 0.02 --- 0.03 --- 0.11 0.05 0.04 0.12
Hexa-PCB 167 * 0.09 --- 0.02 --- 0.06 0.02 0.03 0.18
Hexa-PCB 156 * 0.03 0.05 0.06 0.18 0.19 0.09 0.11 0.46
Hexa-PCB 157 * 0.03 0.01 0.03 0.09 0.06 0.02 0.03 0.11
Hepta-PCB 178 0.03 0.02 0.04 --- --- 0.04 0.05 0.10
Hepta-PCB 187 0.13 0.09 0.16 0.21 0.29 0.24 0.30 0.65
Hepta-PCB 183 0.06 0.03 0.06 0.10 0.14 0.11 0.13 0.31
Hepta-PCB 174 0.06 0.02 0.06 0.10 0.18 0.15 0.17 0.49
Hepta-PCB 177 0.04 0.02 0.03 0.06 0.08 0.08 0.10 0.23
Hepta-PCB 171 0.02 0.01 0.01 --- 0.04 0.05 0.04 0.14
Hepta-PCB 180 */193 0.12 0.10 0.10 0.07 0.10 0.16 0.20 0.26
Hepta-PCB 170 * 0.12 0.11 0.09 0.14 0.16 0.19 0.19 0.33
Octa-PCB 202 * 0.02 0.02 0.03 --- 0.06 0.04 0.05 0.18
Octa-PCB 199 0.11 0.09 0.08 0.11 0.21 0.12 0.13 0.36
Octa-PCB 194 0.06 0.06 0.05 --- --- 0.08 0.09 0.07
Nona-PCB 208 * 0.02 0.01 0.01 --- 0.08 0.03 0.03 0.12
Nona-PCB 206 0.07 0.05 0.03 0.10 0.09 0.05 0.05 0.09
SUM: 52 PCB congeners 6.6 4.1 32.9 10.4 28.0 10.4 16.6 92.9
*   Denotes Quantitation with same 13C-PCB congener
HOMOLOG Quantitation:
SUM of Trichloro-PCBs 0.61 0.27 0.49 0.24 3.17 --- 1.80 1.21
SUM of Tetrachloro-PCBs 0.82 1.15 7.29 0.58 4.53 3.61 2.97 13.7
SUM of Pentachloro-PCBs 2.33 2.14 26.7 8.95 21.3 6.82 10.8 76.9
SUM of Hexachloro-PCBs 0.44 0.50 4.03 3.22 5.64 2.71 3.98 22.9
SUM of Heptachloro-PCBs 0.58 0.14 0.38 0.89 1.11 0.74 1.00 3.20
SUM of Octachloro-PCBs 0.89 0.10 --- --- 2.56 0.13 0.04 0.40
Homolog SUM Tri-Octa-PCBs 5.7 4.3 38.9 13.9 38.3 14.0 20.6 118.3
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 Table 21.  Blank-Subtracted Concentrations of PCBs in Set 4 Toenail Soap Washes 
 
15W-4 16W-4 17W-4 18W-4 19W-4 20W-4 21W-4 22W-4
Date Sampled: Oct 2006 Feb 2007May 2007 Jan 2010 Apr 2010 Jan 2009 Apr 2009 Nov 2007
Sample Donated by: A A A B M-cat C C D
Mass Rinsed (g): 0.340 0.295 0.159 0.0655 0.120 0.196 0.322 0.189
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g
Tri-PCB 18 --- --- --- --- --- --- --- ---
Tri-PCB 31/28 * --- --- --- --- --- --- --- ---
Tri-PCB 33 --- --- --- --- --- --- --- ---
Tetra-PCB 52 * --- --- --- --- --- --- --- ---
Tetra-PCB 49 --- --- --- --- --- --- --- ---
Tetra-PCB 44 --- --- --- --- --- --- --- ---
Tetra-PCB 41 --- --- --- --- --- --- --- ---
Tetra-PCB 74 --- --- 0.06 --- --- --- --- 0.03
Tetra-PCB 70 * --- --- 0.25 --- --- --- --- 0.09
Tetra-PCB 66 --- --- 0.10 --- --- --- --- 0.04
Tetra-PCB 60 --- --- 0.04 --- --- --- --- ---
Penta-PCB 95 * --- --- 0.58 --- --- --- --- 0.12
Penta-PCB 84 --- --- 0.09 --- --- --- --- ---
Penta-PCB 101 * --- --- 0.70 --- --- --- --- 0.28
Penta-PCB 99 --- --- 0.25 --- --- --- --- 0.09
Penta-PCB 97 --- --- 0.26 --- --- --- --- 0.15
Penta-PCB 87 --- 0.01 0.47 --- --- --- --- 0.21
Penta-PCB 85 --- --- 0.13 --- --- --- --- 0.03
Penta-PCB 110 --- --- 0.64 --- --- --- --- 0.23
Penta-PCB 123 * --- 0.01 0.02 --- --- --- --- 0.03
Penta-PCB 118 * --- 0.03 0.54 --- --- --- --- 0.30
Penta-PCB 105 * --- 0.01 0.14 0.43 --- --- --- 0.04
Hexa-PCB 135 --- 0.01 0.12 0.04 --- --- --- 0.05
Hexa-PCB 153 */168 --- 0.02 0.21 --- --- --- --- 0.10
Hexa-PCB 141 --- --- 0.07 --- --- --- --- 0.05
Hexa-PCB 137 --- --- 0.01 --- --- --- --- 0.02
Hexa-PCB 138 */158 --- 0.06 0.18 0.29 --- --- --- 0.16
Hexa-PCB 129 --- 0.01 0.03 --- --- --- --- 0.02
Hexa-PCB 128 --- --- --- --- --- --- --- ---
Hexa-PCB 167 * --- --- --- --- --- --- --- ---
Hexa-PCB 156 * --- 0.02 0.02 0.08 --- 0.01 --- 0.04
Hexa-PCB 157 * --- 0.01 0.01 0.07 0.01 --- --- 0.02
Hepta-PCB 178 --- --- --- --- --- --- --- ---
Hepta-PCB 187 --- 0.02 0.04 0.03 --- --- --- 0.03
Hepta-PCB 183 --- 0.01 0.03 0.01 --- --- --- 0.02
Hepta-PCB 174 --- 0.01 --- --- --- --- --- ---
Hepta-PCB 177 --- --- 0.01 0.01 --- --- --- 0.01
Hepta-PCB 171 --- --- --- --- --- --- --- ---
Hepta-PCB 180 */193 --- 0.01 --- 0.01 --- --- --- 0.01
Hepta-PCB 170 * --- 0.02 0.01 0.11 --- --- --- 0.02
Octa-PCB 202 * --- --- --- --- --- --- --- ---
Octa-PCB 199 --- 0.01 --- --- --- --- --- 0.01
Octa-PCB 194 --- --- --- --- --- --- --- ---
Nona-PCB 208 * --- --- --- --- --- --- --- ---
Nona-PCB 206 --- --- --- --- --- --- --- ---
SUM: 49 PCB congeners --- 0.27 5.01 1.09 0.01 0.01 --- 2.20
*   Denotes Quantitation with same 13C-PCB congener
HOMOLOG Quantitation:
SUM of Trichloro-PCBs --- --- --- --- --- --- --- ---
SUM of Tetrachloro-PCBs --- --- --- --- --- --- --- ---
SUM of Pentachloro-PCBs --- --- 2.96 --- --- --- --- 1.85
SUM of Hexachloro-PCBs --- 0.12 1.12 --- --- --- --- 0.51
SUM of Heptachloro-PCBs --- 0.07 0.18 0.16 --- --- --- 0.14
SUM of Octachloro-PCBs --- --- --- --- --- --- --- ---
Homolog SUM Tri-Octa-PCBs --- 0.18 4.26 0.16 --- --- --- 2.49
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Table 22.  Percent Recoveries of 13C-PCB Surrogates in Set 4 Toenail Samples 
 
Replicate Analysis through Time of Multiple Toenail Samples of 
Individuals A and C 
 To reiterate, replicate analysis of the same toenail sample collected on a specific 
date was not done because sample mass was too small near the detection limits to 
routinely collect and analyze samples based on an individual’s left or right foot and 
subsampling errors from a larger pool of nails were likely because toenails are not 
homogenous.  Therefore, measurements of precision in the true sense are not available 
TOENAIL SAMPLES
15T-4 16T-4 17T-4 18T-4 19T-4 20T-4 21T-4 22T-4
Date Sampled: Oct 2006 Feb 2007May 2007 Jan 2010 Apr 2010 Jan 2009 Apr 2009 Nov 2007
Sample Submitter A A A B M-cat C C D
Mass (g): 0.340 0.295 0.159 0.0655 0.120 0.196 0.322 0.189
13C-PCB Surrogate % % % % % % % %
13C-Di-PCB 15 84 75 102 102 95 78 79 85
13C-Tri-PCB 28 17 82 80 22 28 38 24 55
13C-Tetra-PCB 52 42 83 82 59 78 73 77 83
13C-Tetra-PCB 70 55 82 84 57 79 73 79 82
13C-Tetra-PCB 81 90 92 118 138 125 86 87 107
13C-Tetra-PCB 77 85 84 114 134 118 85 82 104
13C-Penta-PCB 95 50 80 82 52 75 66 72 80
13C-Penta-PCB 101 71 90 94 65 90 85 87 92
13C-Penta-PCB 123 79 94 97 68 95 85 88 93
13C-Penta-PCB 118 76 92 95 66 91 84 87 90
13C-Penta-PCB 105 27 85 79 20 22 38 14 46
13C-Hexa-PCB 153 75 85 89 64 84 76 80 85
13C-Hexa-PCB 138 78 89 92 60 85 78 83 88
13C-Hexa-PCB 167 76 86 88 62 84 76 81 86
13C-Hexa-PCB 156 75 86 88 56 82 72 80 86
13C-Hexa-PCB 157 80 91 92 57 84 70 83 90
13C-Hepta-PCB 180 84 91 94 69 89 80 85 91
13C-Hepta-PCB 170 78 84 88 55 78 66 78 85
13C-Octa-PCB 202 76 80 85 62 79 72 76 80
13C-Nona-PCB 208 99 97 98 96 96 96 96 96
                All but PCBs 15, 81, 77 and partially 28 and 105, were in Basic Alumina Fraction 1
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in this study.  However, replicate analyses were done through time for up to five or six 
multiple toenail samples from individual A over an extended year and from two samples 
from individual C for part of a year (Tables 23-25).    
Table 23.  Blank-Subtracted Concentrations (ng/g-nail) of Organochlorine Pesticides in 
Multiple Toenail Samples from Two Individuals 
 
Table 24.  Blank-Subtracted Concentrations (ng/g-nail) of PBDEs in Multiple Toenail 
Samples from Two Individuals 
 
TOENAIL SAMPLES
6T-2 7T-2 15T-4 16T-4 17T-4 20T-4 21T-4
Date Sampled: Jan 2006 Mar 2006 Oct 2006 Feb 2007 May 2007 Jan 2009 Apr 2009
Sample Submitter A A A A A C C
Mass (g): 0.192 0.190 0.340 0.295 0.159 n=5 0.196 0.322 n = 2
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g MEAN SD ng/g ng/g MEAN SD
Pentachloroanisole 1.33 0.88 0.16 0.38 0.34 0.62 0.48 0.16 0.24 0.20 0.05
beta-HCH 0.03 0.06 0.11 0.16 0.24 0.12 0.08 0.18 0.12 0.15 0.05
Chlordanes:
trans-Chlordane 8.45 5.85 3.68 4.45 6.53 5.79 1.86 4.25 4.41 4.33 0.11
cis-Chlordane 5.18 3.55 2.40 2.81 4.18 3.62 1.10 1.86 1.96 1.91 0.07
trans-Nonachlor 4.53 3.23 1.92 2.27 3.47 3.08 1.03 1.32 1.57 1.44 0.18
DDT Series:
o,p'-DDE --- --- --- 0.13 0.11 0.12 0.02
p,p'-DDE 0.62 0.49 0.79 1.14 1.07 0.82 0.28 2.81 2.89 2.85 0.06
o,p'-DDT --- --- --- 0.64 0.39 0.51 0.17
p,p'-DDT --- --- --- --- --- 0.89 1.04 0.97 0.11
---     Not Detected or not detected above method blank
TOENAIL SAMPLES
Sample No. - Set: 3T-1 6T-2 7T-2 15T-4 16T-4 17T-4 20T-4 21T-4
Date Sampled: Nov 2005 Jan 2006 Mar 2006 Oct 2006 Feb 2007 May 2007 Jan 2009 Apr 2009
Sample Submitter A A A A A A C C
Mass (g): 0.187 0.192 0.190 n = 3 0.340 0.295 0.159 n = 2, 3, 5 or 6 0.196 0.322 n = 2
ANALYTE NAME MEAN SD ng/g ng/g ng/g MEAN SD ng/g ng/g MEAN SD
tri-BDE 28 0.335 0.31 0.43 0.36 0.06 0.13 0.22 0.33 0.29 0.10 0.36 0.34 0.35 0.01
tetra-BDE 47 8.19 8.0 8.7 8.30 0.36 --- 9.92 --- --- 5.0
penta-BDE 100 1.02 0.95 0.94 0.97 0.04 --- --- --- --- ---
penta-BDE 99 6.32 7.63 8.12 7.36 0.93 2.77 7.31 2.63 5.80 2.47 0.43 3.74 2.09 2.34
penta-BDE 85 0.17 0.26 0.22 0.06 0.21 0.29 0.32 0.25 0.06 0.18 0.28 0.23 0.07
hexa-BDE 153 1.31 2.17 1.89 1.79 0.44 1.16 2.50 1.87 1.82 0.51 0.16 0.33 0.25 0.12
hexa-BDE 139 0.06 0.09 0.07 0.07 0.02 0.03 0.05 0.04 0.01
hepta-BDE 183 0.04 0.07 --- 0.05 0.02 --- 0.03
deca-BDE 209 0.53 2.28 3.51 2.11 1.50 3.28 2.98 3.13 0.21
---   Not Detected at Specified Detection Limit or < [Blank Avg + 3SD]
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Replicated analyses from individual A were from sets 1, 2, and 4 and the two samples 
from individual C from set 4.  In Table 23, p,p’-DDE was the only compound listed that 
was quantitated with a 13C-surrogate, resulting in a mean 0.82 ng/g-nail, sd 0.28, n=5 in 
individual A and 2.85 ng/g, sd 0.06, n=2 for individual C.  Using concentrations of trans-
nonachlor as indicator for chlordanes, the two samples from individual C were very 
similar (mean 1.44 ng/g-nail, sd 0.18, n=2) but the five samples from individual A varied 
more (mean 3.08 ng/g, sd 1.03, n=5), which may indicate that exposures for individual A 
varied more during the extended year than for individual C’s partial year. 
 PBDEs overall were best analyzed in sets 1 and 2 of individual A samples that 
were not affected by slight contamination in Proteinase K enzyme used in set 4 (Table 
24).  PBDEs 47, 99, and especially 100 were measured consistently (mean 8.30 ng/g-nail, 
sd 0.36; mean 7.36 ng/g-nail, sd 0.93; mean 0.97 ng/g-nail, sd 0.04, n=3, respectively).  
In set 4 for samples from both individuals, elevated blank concentrations of PBDEs 47, 
100, and to some extent 99 eliminated those congeners.  Several minor PBDEs (28, 85, 
and especially 153) were unaffected and could be the best biomonitoring indicators.  
Measurements throughout all sets for individual A samples were PBDE 28, mean 0.29 
ng/g-nail, sd 0.10, n=6; PBDE 85, mean 0.25 ng/g, sd 0.06, n=5; and PBDE 153, mean 
1.82 ng/g, sd 0.51, n=6. 
 For PCBs in individuals A and C, concentrations (ng/g-nail) with mean and 
standard deviation from two samples each are shown for half of the 52 congeners and 
for homolog quantitation (Table 25).  Not included in Table 25 was sample 17T-4 for 
individual A with relatively high PCBs in the soap wash sample 17W-4 that indicated 
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Table 25.  Blank-Subtracted Concentrations (ng/g-nail) of Selected PCBs in Multiple 
Toenail Samples from Two Individuals 
 
exogenous or lab contamination of PCBs.  Although nearly all concentrations of PCB 
congeners in samples from individuals A and C were < 1 ng/g-nail, standard deviations 
were remarkably low (usually within ± 0.1 ng/g).  All PCB congeners were quantitated 
TOENAIL SAMPLES
15T-4 16T-4 20T-4 21T-4
Date Sampled: Oct 2006 Feb 2007 Jan 2009 Apr 2009
Sample Submitter A A C C
Mass (g): 0.340 0.295 0.196 0.322
ANALYTE NAME ng/g ng/g MEAN SD ng/g ng/g MEAN SD
Tetra-PCB 52 * 0.08 0.18 0.13 0.07 0.28 0.33 0.31 0.04
Tetra-PCB 49 0.08 0.11 0.10 0.02 0.13 0.21 0.17 0.06
Tetra-PCB 44 0.11 0.13 0.12 0.01 0.16 0.28 0.22 0.08
Tetra-PCB 74 0.13 0.16 0.15 0.02 0.24 0.26 0.25 0.02
Tetra-PCB 70 * 0.29 0.24 0.26 0.03 0.60 0.70 0.65 0.07
Tetra-PCB 66 0.17 0.18 0.17 0.01 0.37 0.45 0.41 0.05
Penta-PCB 95 * 0.14 0.19 0.17 0.04 0.65 0.83 0.74 0.13
Penta-PCB 101 * 0.39 0.34 0.37 0.03 1.04 1.36 1.20 0.23
Penta-PCB 99 0.15 0.14 0.14 0.01 0.36 0.47 0.42 0.08
Penta-PCB 97 0.17 0.11 0.14 0.04 0.35 0.50 0.43 0.10
Penta-PCB 87 0.29 0.16 0.22 0.09 0.55 0.89 0.72 0.24
Penta-PCB 110 0.39 0.21 0.30 0.12 0.57 1.25 0.91 0.47
Penta-PCB 118 * 0.74 0.23 0.49 0.36 0.93 1.39 1.16 0.32
Hexa-PCB 135 0.07 0.04 0.05 0.02 0.18 0.28 0.23 0.07
Hexa-PCB 153 */168 0.32 0.20 0.26 0.08 0.50 0.74 0.62 0.17
Hexa-PCB 138 */158 0.31 0.13 0.22 0.12 0.45 0.65 0.55 0.14
Hexa-PCB 156 * 0.03 0.05 0.04 0.02 0.09 0.11 0.10 0.01
Hepta-PCB 187 0.13 0.09 0.11 0.03 0.24 0.30 0.27 0.04
Hepta-PCB 183 0.06 0.03 0.04 0.02 0.11 0.13 0.12 0.01
Hepta-PCB 180 */193 0.12 0.10 0.11 0.01 0.16 0.20 0.18 0.03
Hepta-PCB 170 * 0.12 0.11 0.11 0.01 0.19 0.19 0.19 0.00
Octa-PCB 199 0.11 0.09 0.10 0.01 0.12 0.13 0.13 0.00
SUM: 52 PCB congeners 6.6 4.1 5.4 1.8 10.4 16.6 13.5 4.4
*   Denotes Quantitation with same 13C-PCB congener
HOMOLOG Quantitation:
SUM of Trichloro-PCBs 0.61 0.27 0.44 0.24 --- 1.80 1.80 ---
SUM of Tetrachloro-PCBs 0.82 1.15 0.98 0.23 3.61 2.97 3.29 0.46
SUM of Pentachloro-PCBs 2.33 2.14 2.24 0.13 6.82 10.8 8.81 2.83
SUM of Hexachloro-PCBs 0.44 0.50 0.47 0.04 2.71 3.98 3.34 0.89
SUM of Heptachloro-PCBs 0.58 0.14 0.36 0.31 0.74 1.00 0.87 0.19
SUM of Octachloro-PCBs 0.89 0.10 0.50 0.56 0.13 0.04 0.09 0.07
Homolog SUM Tri-Octa-PCBs 5.7 4.3 4.98 0.96 14.0 20.6 17.3 4.65
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based on a 13C-PCB surrogate, but only 10 of the 25 congeners shown in Table 25 had 
the identical congener surrogate. 
Summary 
 Because of the importance of eliminating possible exogenous superficial nail 
contamination, the analytical results showed the need for a preliminary soap wash 
before a second soap wash and rinses that would be saved for analysis.  Although it 
seemed tedious at the time, also analyzing a soap wash and rinse blank sample with 
each nail set provided valuable quality assurance that no apparent contamination arose 
from the soap wash and Fisher water rinses. 
 Though an added expense, stable-labeled 13C-surrogates spiked at low ng 
amounts provided ultimate quality assurance for analyte recoveries, typically above 
50%, throughout the method for each and every sample and facilitated accurate and 
consistent analyses by GC/HRMS.  For example, p,p’-DDE was consistently measured in 
several sets of individual A toenail samples because fluctuations in surrogate recovery 
inherently corrected for the same fluctuations for native p,p’-DDE.  Having sufficient 
number of 13C-surrogates of PBDE and especially PCB congeners, including those more 
transient and “episodic,” was extremely valuable.  Quality assurance, method sensitivity 
and selectivity were also enhanced by using GC/HRMS combined with high performance 
narrow bore capillary columns for sharper peaks with higher signal/noise and superior 
separation of close-eluting compounds and isomers.  Detection limits for analytes using 
GC/HRMS needed to be and were far below 1 ng/g with limits as low as 0.003 ng/g for 
all dioxin-like PCBs including 77 and 81.  In the majority of cases, extremely low 
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concentrations were consistently measurable in method blanks to compute a 99% 
confidence interval of 3 standard deviations added to the average method blank for 
optimum blank-correction concentrations in samples.  
 Even with the best of GC and HRMS, the method benefitted and relied on the 
miniature GPC for consistent lipid removal and accurate percent lipid measurements, 
with single use, no carryover from any other sample.  Cleanup with just the 0.5 g basic 
alumina glass SPE of the methylated polar phenolic extract was relatively good and 
would have been better with a normal GPC eluate.  Methylation with iodomethane did 
not appear to contribute any significant artifacts to interfere with searching for 
unknown compounds.  Iodomethane may not have been ideal for all targeted 
compounds; diazomethane could have been tried if artifacts were minor.  Overall, lab 
background was minimized effectively by using high purity, flash-sized basic alumina 
straight from the jar (heated) into a flash chromatography column that was solvent-
rinsed and dried with high purity nitrogen and pressurized high purity nitrogen during 
use.    
 Concerning the important early part of toenail sample preparation, hand 
grinding toenails, digestion, and dissolution were very slow tedious steps in the method.  
A miniature mill with individual stainless steel vessels that can be thoroughly cleaned for 
reuse could break down the nails to much smaller pieces with much more surface area 
accessible for digestion.  The reagent, dithiothreitol, a strong reducing agent with 
sonication was apparently effective to at least partially digest the nail keratin without 
reacting with too many target compounds, but probably reduced the acidic phthalate 
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metabolites.  Proteinase K enzyme was also somewhat successful but it took a number 
of days and the enzyme supplied to us had detectable PBDEs that compromised some of 
the PBDE concentrations in the sample set 4.  Unless a different lot or supplier will not 
have any measurable contamination, use of Proteinase K is not recommended. 
 Measuring several targeted analytes was challenging and troublesome.  
Bisphenol A in method blanks was variable and too high to distinguish BPA in toenails 
from blanks or soap washes and recoveries of the surrogate of tetrabromobisphenol A 
were consistently < 10%.  Phthalate metabolites would best be analyzed directly with an 
LC/MS/MS system, possibly after the GPC step, to determine whether they can be found 
in toenail extracts. 
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CHAPTER 4.  RESULTS AND DISCUSSION – TOENAILS AS 
BIOMONITORING MATRIX 
There is general agreement that collecting toenail clippings for human toenail 
samples in any human biomonitoring program is non-invasive compared with biopsies 
of human adipose or breast tissue, collecting blood or breast milk samples at a medical 
lab or clinic, or collecting multiple urine samples during an entire 24-hour period for 
certain compounds with short-half lives or metabolites.  Therefore, to further evaluate 
toenail clippings as a suitable biomonitoring matrix to assess human exposure to 
environmental organic compounds, results of the analyses of toenail samples is 
compared with extant data from various other human matrices.  Comparisons of 
quantitative biomonitoring data of targeted compounds includes persistent 
organochlorine pesticides, PCB congeners with varying degrees of persistency in 
humans, moderately persistent PBDE flame retardants, two synthetic musk fragrances, 
Galaxolide and Tonalide, and a compound with a very short biological half-life, triclosan. 
Biomonitoring of persistent organochlorine pesticides 
Blank-subtracted, lipid-based concentrations of persistent organochlorine 
pesticides in toenail samples from this study (Table 26) are compared to extant 
literature lipid-based data of the pesticides in serum samples by CDC of those older than 
age 20,2 adipose tissue from the former EPA program, National Human Adipose Tissue 
Survey,7 and in both hair and serum samples from 10 volunteers from Harvard 
University (Table 27).34  Concentrations in Tables 26 and 27 were all tabulated in units of 
ng/g-lipid.  The percent lipid in each toenail sample was isolated using the flash GPC 
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Table 26.  Lipid-Based Concentrations (ng/g lipid) of Organochlorine Pesticides in Nails 
 
Table 27.  Concentrations (ng/g lipid) of Organochlorine Pesticides in Serum, Tissue, and 
Hair Samples from Extant Data 
 
TOENAIL SAMPLES
6T-2 7T-2 15T-4 16T-4 17T-4 18T-4 20T-4 21T-4 22T-4
Date Sampled:  Jan 2006 Mar 2006 Oct 2006 Feb 2007 May 2007 Jan 2010 Jan 2009 Apr 2009 Nov 2007
Sample Submitter A A A A A B C C D
Mass (g): 0.192 0.190 0.340 0.295 0.159 0.0655 0.196 0.322 0.189
Lipid (%): 1.31 0.87 1.16 1.29 1.63 1.23 1.03 1.22 1.23
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g
Hexachlorobenzene 23 22 --- --- --- --- --- --- ---
Pentachloroanisole 101 101 14 29 21 38 16 19 ---
Methyl (ether) Triclosan 24 30 154 15 4 --- --- --- ---
gamma-HCH (Lindane) --- --- 4 --- 8 --- --- --- 13
beta-HCH 2 7 9 12 15 --- 18 10 17
Dieldrin --- --- --- --- --- 56 --- 20 ---
Chlordanes:
Oxychlordane --- --- --- 7 --- 31 13 7 11
Heptachlor Epoxide 14 15 6 7 5 --- 7 7 ---
trans-Chlordane 645 673 317 345 401 578 412 361 48
cis-Chlordane 396 408 207 218 256 371 181 161 27
trans-Nonachlor 346 372 166 176 213 334 128 129 26
cis-Nonachlor 15 36 14 14 24 56 29 20 18
DDE and DDTs:
o,p'-DDE --- --- --- --- --- --- 13 9 ---
p,p'-DDE 48 56 68 88 66 46 273 237 106
o,p'-DDT --- --- --- --- --- --- 62 32 ---
p,p'-DDT --- --- --- --- --- --- 86 86 108
            ---   Not Detected or not (detected) above method blank average + 3 STD
SERUM SERUM ADIPOSE HAIR HAIR:SERUM
n~=1380 > Age 20 n=407 n=10 n=10
Date Sampled: 2003-4 2003-4 1983 2003 2003
Sample Submitter CDC CDC NHATS Altshul et al. Altshul et al.
Geometric 95th Geometric Median
Mean Percentile Mean 1.8% Lipid HAIR:SERUM
ANALYTE NAME ng/g ng/g ng/g ng/g RATIO
Hexachlorobenzene 15.5 29.0 31 28 1.1
Pentachloroanisole
Methyl (ether) Triclosan
gamma-HCH (Lindane) --- < 8 ---
beta-HCH 7.9 62.2 100
Dieldrin --- 19.5 60
Chlordanes:
Oxychlordane 10.6 39.2 90 NM << 1
Heptachlor Epoxide --- 20.6 90
trans-Chlordane
cis-Chlordane
trans-Nonachlor 16.9 74.7 120 36 1.2
cis-Nonachlor
DDE and DDTs:
o,p'-DDE 41 6.2
p,p'-DDE 268 1,990 343 229 0.8
o,p'-DDT --- < 8 14 34 26
p,p'-DDT --- 20.7 294 113 12
            ---   Not Detected or not (detected) above method blank
     BLANK SPACE Denotes Not Targeted for Analysis
           NM  Not Meaningful, Some Not Detected
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cleanup step and a microbalance as described in chapter 2.  Most toenail percent lipid 
values were within a narrow range (1.03-1.31%), except for 0.87% (Sample 7T-2) and 
1.63% (Sample 17T-4).  The lowest lipid value in Sample 7T-2 was the nail sample that 
was least digested, based on the amount of residual nail fragments following extraction.  
Subsequently, extra care was used to grind nails and in Set 4, Proteinase K enzyme was 
added for more complete digestion. 
As expected, the pervasive DDT metabolite, p,p’-DDE, was detected in all toenail 
samples, even in Set 3 with its emphasis on more polar compounds.  Set 3 
concentrations of DDE were not included in Table 26 because of a potential for any DDT 
present to convert to DDE with a strong basic buffer (K2CO3).  In the five toenail samples 
collected over an extended year from individual A and analyzed in Sets  2 and 4 for non-
polar compounds, p,p’-DDE concentrations were very similar (mean 65 ng/g-lipid; sd 15, 
n=5).  Consistent and accurate p,p’-DDE values were aided by the isotope dilution 
quantitation technique (with the surrogate, 13C-p,p’-DDE).  Samples (20T-4, 21T-4, and 
22T-4) from individuals C and D had up to fourfold higher DDE concentrations and 
detectable DDT, suggestive of more recent DDT exposure.  Comparing p,p’-DDE lipid-
based concentrations with extant serum, adipose tissue, and hair lipid-based data (Table 
27), individual C toenail samples (mean 255 ng/g-lipid) nearly matched the geometric 
mean of CDC’s national serum samples (268 ng/g-lipid), adipose tissue mean from 1983 
(343 ng/g-lipid), and the median of 10 hair samples from volunteers at Harvard 
University (229 ng/g-lipid).  In toenails from the other three individuals, DDE was lower, 
ranging from 46 to 106 ng/g-lipid.  The p,p’-DDT, detected in toenail samples from 
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individuals C and D, concentrations (86, 86, and 108 ng/g-lipid) exceeded the 95th 
percentile (highest 5%) of the CDC serum samples (20.7 ng/g-lipid), nearly matched the 
median of the 10 hair samples (113 ng/g-lipid), and were only three times less than the 
geometric mean of the 1983 adipose tissue survey (Table 27).  Both hair and serum lipid-
based DDT concentrations were reported in the Harvard study of 10 donors and Altshul 
et al. (2004)34 reported that both isomers of DDT were much higher in hair than serum, 
with hair to serum ratios of 26 and 12. 
Hexachlorobenzene was found in individual A toenails (23 and 22 ng/g-lipid) in 
Set 2, but because blanks in Set 4 using Proteinase K enzyme were higher, this 
compound was only measured in individual A.  Individual A toenail concentrations of 
hexachlorobenzene fell within CDC’s geometric mean (15.5 ng/g-lipid) and 95th 
percentile (29.0 ng/g-lipid) and close to the Harvard hair median (28 ng/g-lipid), and 
mean of 1983 adipose tissue (31 ng/g-lipid).  Toenail concentrations of another 
persistent compound, beta-hexachlorocyclohexane, like hexachlorobenzene which was 
phased out of use years ago, again were low and fell within CDC’s 95th percentile.  We 
hypothesize that such compounds may arise from a long-term body burden in 
individuals arising from historic exposure; lipid-adjusted concentrations in toenails were 
very similar to CDC serum data. 
Pentachloroanisole, an environmental metabolite of pentachlorophenol 
methylated by bacteria, was detected in nearly all of the toenail samples.  
Pentachloroanisole is not a human metabolite as pentachlorophenol in human liver is 
either conjugated as a glucuronide or metabolized to tetrachlorohydroquinone.74  Like 
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pentachloroanisole, the methyl ether of the antibacterial, triclosan, can also be 
converted by bacteria.  Variable concentrations of methyl ether triclosan were found 
solely in toenails from individual A (Table 26).  As noted in Chapter 3, “free” triclosan 
itself was detected and quantitated at concentrations of 53.6 and 62.9 ng/g-wet weight 
or nearly 100 times higher on a lipid-basis in samples from the same individual (A) in Set 
3 analysis for more polar compounds.  It is possible that with small, periodic exposures 
to soaps, approximately 1% of triclosan was converted by skin bacteria to the methyl 
ether of triclosan, absorbed through the skin, and measured along with other non-polar 
compounds. 
Although not originally targeted in toenail samples and thus not detected in Set 
1 until GC/full-scan MS analysis, chlordane was subsequently detected and quantitated 
in all toenail samples analyzed in Sets 2 and 4 for nonpolar compounds (Table 26).  
Chlordane provides a good example of the use and analysis of toenail as a biomonitoring 
matrix to detect and quantify compounds not targeted that are important 
environmental organic compounds and pollutants indicative of chronic human 
exposure.  Because termites are common in Missouri, many Missouri homes or soil 
around homes were treated by a professional exterminator with chlordane before its 
ban in 1989.  Comparing concentrations of a major chlordane component, trans-
nonachlor, in toenail samples (Table 26), individual D (26 ng/g-lipid) was much lower 
than individual C (mean 129 ng/g-lipid, sd 0.7, n=2), individual B (334 ng/g-lipid), or 
individual A (254 ng/g-lipid, sd 97, n=5).  Comparing with extant serum trans-nonachlor 
data (Table 23), individual D (26 ng/g-lipid) compared closely to CDC’s geometric mean 
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(16.9 ng/g-lipid) and to hair samples median (36 ng/g-lipid) from Massachusetts. The 
higher values from Missouri may reflect the fact that termites and termite treatment is 
less prevalent in the colder northeast.  The trans-nonachlor concentrations of all toenail 
samples measured in this study exceeded the CDC 95th percentile serum concentrations, 
those in hair from Massachusetts, and were slightly above the mean for 1983 adipose 
tissue samples.  In contrast, for the metabolite, oxychlordane, toenail concentrations 
were much lower when detected (7 to 31 ng/g-lipid) and was detected in individual A in 
only one of five toenail samples near the detection limit (7 ng/g-lipid).  Compared with 
extant oxychlordane data, toenail sample concentrations, when detected, were all less 
than the CDC 95th percentile (39.2 ng/g-lipid) and, except for individual B, were very 
close to the CDC geometric mean for serum (10.6 ng/g-lipid).  Our nail results for 
oxychlordane are consistent with the Harvard hair/serum data where the metabolite 
was very low or not detected in most hair samples but was consistently measured in 
serum samples which resulted in a very low (<< 1) but not consistently measurable 
hair/serum ratio.34  
A plausible explanation for hair containing higher amounts of transient 
compounds like DDT and much lower amounts of metabolites (formed within the body) 
like oxychlordane is important because of similar tendencies shown for toenail results 
thus far.  Altshul et al. (2004)34 reasoned that hair (like toenails) is able to “sequester”34 
or incorporate within its cells some of the less persistent compounds in blood that 
people are chronically exposed to before a certain amount of a compound is partially 
metabolized (e.g. chlordane to oxychlordane) in the liver and incorporated into adipose 
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tissue.  With the example of chlordanes in the toenail samples, the majority of 
oxychlordane would be expected to form within an individual’s liver as a metabolite and 
is, therefore, less likely to be in a steady state.  During the slow growth process of hair 
and toenails, hair and toenails may integrate frequent exposures and partial 
sequestering resulting in proportionately higher concentrations of parent compounds 
and proportionately lower concentrations of metabolites.   
Biomonitoring PCB congeners 
 Lipid-based concentrations (ng/g-lipid) of various PCB congeners in Set 4 toenails 
are compared with extant data from serum, tissue, and hair samples in Table 28.  PCBs 
were quantitated two ways -- by specific individual congener peaks (or occasional 
doublets of two co-eluting congeners or isomers not distinguished by mass 
spectrometry) and by homolog groups (having the same number of chlorines).   Results 
of this tally are given at the bottom of Table 28.  Homolog group quantitation is the 
most complete tally of “total PCBs” and a check to determine whether the number of 
individual congeners targeted with quantitative calibration standards constituted a 
similar total for PCBs or whether additional congeners should have been included.  In 
Table 28, PCB totals from both quantitation methods compared well, indicating that 
there were few other PCB congeners present and detected that were not already among 
the individuals targeted.  In every toenail sample analyzed in Set 4, penta-PCBs 
comprised the highest concentrations of any homolog group. 
Looking further at PCB concentrations in Table 28, the two samples from 
individual C (20T-4 and 21T-4) are quite consistent even though one nail mass (0.196 g) 
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was nearly half the mass of the 21T-4 (0.322 g).  Sample 22T-4 from individual D had 
considerably more PCBs than all other toenail samples.  Toenail samples from individual 
A (15T-4 through 17T-4) generally had consistent concentrations for the first two 
samples (Table 25, previous chapter).  However, sample 17T-4 had higher PCBs that 
were also in the toenail soap wash (17W-4), indicating exogenous PCB contamination, 
which would have been proportionately more significant because of the smaller mass 
sample size (0.159 g) of 17T-4.  For this reason, results for sample 17T-4 are not listed in 
Table 28. 
 Toenail lipid-based (ng/g-lipid) PCB congener concentrations listed in Table 28 
are compared with lipid-based extant data of the CDC Fourth National serum-based 
Biomonitoring Study,2 breast tissue from a Canadian women’s study of 213 benign and 
217 cancerous tissue samples,75 and median hair concentrations matched with the 
hair/serum ratio of the 10 donors from Harvard University from 2003.34  In this study 
and the CDC study, toenail PCB concentrations were determined by GC/HRMS often 
using the identical congener 13C-PCB surrogate, whose recovery through the entire 
method self-corrected the value for the native PCB congener.  For the higher 
chlorinated, hepta-nona-PCBs, extant breast tissue geometric mean concentrations 
generally matched the highest (95th) percentile for CDC serum samples.  Toenail 
concentrations of the higher chlorinated, hepta-nona-PCBs generally fell within the 
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Table 28.  Lipid-Based Concentrations (ng/g-lipid) of PCBs in Toenails, Extant Serum, 
Tissue, and Hair Samples 
  
TOENAIL SAMPLES SERUM BREAST TISSUE HAIR H:S RATIO
15T-4 16T-4 18T-4 20T-4 21T-4 22T-4 n=1300 Benign n=213 n=10 n=10
Date Sampled:  Oct 2006 Feb 2007 Jan 2010 Jan 2009 Apr 2009 Nov 2007 > Age 20 Cancer n=217 2003 2003
Sample Submitter  A A B C C D CDC 2003-4 Aronson et al. Altshul et al.
Mass (g):  0.340 0.295 0.0655 0.196 0.322 0.189 Geo. 95th 1995-1997 Median HAIR/
Lipid (%):  1.16 1.29 1.23 1.03 1.22 1.23 Mean % Tile Geo. Mean 1.8% Lipid SERUM
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g Bng/g , Cng/g ng/g RATIO
Di-PCB 15 * 5 4 --- --- 2 28
 <  Tri-PCB 18  > 12 --- --- --- 7 --- 24
 <  Tri-PCB 31  >  -28 * 27 16 13 24 48 56 5 11 68 9
Tri-PCB 33 29 7 9 11 52 47 32
 <  Tetra-PCB 52 *  > 7 14 --- 27 27 120 3 7 77 51
 <  Tetra-PCB 49  > 7 8 --- 13 17 44 1 3 21
 <  Tetra-PCB 44  > 9 10 --- 16 23 92 2 5 54
Tetra-PCB 41 7 10 --- 9 11 75 27
Tetra-PCB 74 12 12 14 23 22 88 5 24 17 2
 <  Tetra-PCB 70 *  > 25 18 47 59 58 371 65
Tetra-PCB 66 14 14 22 36 37 148 1 4 56
Tetra-PCB 60 5 6 5 7 7 53 20
Tetra-PCB 81 * 0.3 0.4 1.3 0.7 0.5 1.0 --- 0.01
Tetra-PCB 77 * 0.8 0.2 --- 2 2 16
 < << Penta-PCB 95 * >> > 12 15 53 63 68 481
 <<  Penta-PCB 84  >> 2 5 --- 11 10 152 67
 <  Penta-PCB 101 *  > 34 27 96 101 111 835 2 6 136 50
 [  Penta-PCB 99  ] 13 11 24 35 39 296 5 19 18 , 20  23 3
 <  Penta-PCB 97  > 14 9 31 34 41 319 35
 <  Penta-PCB 87  > 25 12 55 54 73 572 1 3 47
Penta-PCB 85 7 3 9 10 20 163
 << Penta-PCB 110  >> 34 17 65 56 102 1,180 1 4 136
Penta-PCB 123 * 3 --- 5 2 5 35
 [  Penta-PCB 118 *  ] 64 18 101 90 114 811 7 34 25 , 30 72 3
 [  Penta-PCB 105 *  ] 37 --- 47 42 146 306 1 7 6  ,  7 25 10
 <<  Hexa-PCB 135  >> 6 3 25 17 23 134 36
 [  Hexa-PCB 153 */168 ] 27 16 43 48 61 319 24 101 98 , 105 222 2
 <  Hexa-PCB 141  > 9 3 15 19 21 115 85
Hexa-PCB 137 3 --- 3 6 8 45
 [  Hexa-PCB 138 */158 ] 26 10 57 44 53 267 18 77 67 , 74 198 3
Hexa-PCB 129 3 1 6 5 8 48
 [  Hexa-PCB 128  ] 2 --- --- 5 4 10 --- 1
 [  Hexa-PCB 167 *  ] 8 --- --- 2 3 15 1 4 3.8
 [  Hexa-PCB 156 *  ] 2 4 15 9 9 37 3 17 17 , 19 8.5
Hexa-PCB 157 * 2 1 7 2 2 9 1 4
 [  Hepta-PCB 178  ] 2 1 --- 4 4 8 1 7
 [  Hepta-PCB 187  ] 11 7 17 23 24 53 5 26 24 , 26 88
 [  Hepta-PCB 183  ] 5 2 8 10 10 25 2 8 10 , 10 39
 <<  Hepta-PCB 174  >> 5 2 8 15 14 40 66
Hepta-PCB 177 4 2 5 7 8 19 1 8 31
Hepta-PCB 171 1 0.4 --- 5 3 11 16
 [  Hepta-PCB 180 */193 ] 10 8 6 16 16 21 19 88 66 , 72 71 1
 [  Hepta-PCB 170 *  ] 11 8 11 18 15 27 7 30 32 , 34 29 2
 [  Octa-PCB 202 *  ] 2 1 --- 3 4 14
 [  Octa-PCB 199  ] 9 7 9 12 11 29 4 21 13
 [  Octa-PCB 194  ] 6 5 --- 8 7 6 4 20
 [  Nona-PCB 208 *  ] 2 1 --- 3 2 10
 [  Nona-PCB 206  ] 6 4 8 5 4 7 3 14
SUM: 52 PCB congeners 568 321 842 1,011    1,357    7,557    2,640
*   Denotes Quantitation with same 13C-PCB congener
HOMOLOG Quantitation: KEY:
SUM of Tri-PCBs 52 21 19 --- 147 99    <    >  Less Persistent (2,5-ring Cl substituents)
SUM of Tetra-PCBs 70 89 47 351 243 1,112
SUM of Penta-PCBs 201 166 727 662 886 6,255  <<   >>  Less Persistent (2,3,6-ring Cl substituents)
SUM of Hexa-PCBs 38 38 262 263 326 1,859
SUM of Hepta-PCBs 50 11 72 71 82 260   [       ]  More Persistent (no vicinal H-substituents)
SUM of Octa-PCBs 77 8 --- 13 3 33
SUM Tri-Octa-PCBs 488 333 1,128 1,360 1,688 9,617
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geometric mean and highest (95th) percentile of CDC serum and near the geometric 
mean of Canadian breast tissue, but often far exceeded the CDC serum and the breast 
tissue data for the less chlorinated, tri-hexa-PCBs.  For generally all PCBs, lipid-adjusted 
toenail concentrations matched extant hair sample data.  Consistent with our nail 
measurements, the hair/serum ratios of some of the PCBs from each of the 10 donors 
were high.34  Tetrachloro-PCB 52 (2,5-  2’,5’-substituted) and pentachloro-PCB 101 
(2,4,5-  2’,5’) were both reported to be less persistent in humans because of the vicinal 
(two neighboring) hydrogen substituents at the 3 and 4 (meta, para) ring positions of at 
least one ring that are more easily attacked by the body’s Cytochrome P450 enzyme 
system for metabolism.76, 77  Yet, Altshul et al. (2004)34 reported hair/serum lipid-based 
ratios of 51 and 50 for PCBs 52 and 101, respectively.  To further evaluate data of other 
less persistent PCB congeners of similar structures (chlorines substituted at 2,5-  and 
2,3,6- both with vicinal hydrogens), those congeners in Table 28 were color and 
character coded (< > and <<  >>), respectively.  PCB congeners reported to be most 
persistent in humans (mammals) are categorized by having no vicinal hydrogens 
(especially not at meta, para positions) and were color and character coded ( [  ] ). 
 Altshul et al. (2004)34 interpreted the higher hair concentrations (than in serum) 
for less persistent PCBs by again using the term, “sequester.”  Vascularized hair (and of 
course nails) keep growing slowly and steadily and are able to “sequester” some portion 
of various compounds in the blood that the human body has been recently exposed to 
before some degree of metabolism occurs in the liver.  If chronic exposures keep 
occurring, it is possible that hair and nails can effectively integrate periodic “sequester” 
 122 
 
episodes over the long term and ultimately complement biomonitoring data from 
currently default serum samples.   
Based on PCB human exposures of GE workers at their New York facility to three 
types of PCB commercial mixtures (Aroclors 1016, 1254 and 1260) containing less 
chlorinated PCBs (Aroclor 1016) to highly chlorinated PCBs (Aroclor 1260), Brown and 
Lawton (2001)76 had access to and studied their workers’ serum PCB concentrations 
periodically enough to compute metabolic clearance rates.  Their first-order clearance 
rates varied from a rapid 10 yr-1 for trichloro-PCB 28 to a very slow 0.003 yr-1 for very 
persistent, heptachloro-PCB 18076.  Even within the so-called ‘more consistent’ group, 
there still was a “>100-fold intercongener range” in the first order rates76.  Further, they 
remarked, “Because of this, after cessation of exposure the congener distribution 
patterns will vary continuously, and resemble those listed ... at only one instant in 
time.”76 
Larry Hansen provided further insight about human exposure to PCBs and risk 
assessment of PCB congeners: 
“… pulses of exposure to more labile mixtures may contribute to 
developmental effects without leaving a residue record … humans and 
other animals are intermittently exposed to profiles of PCBs that leave 
sparse records of their presence … pulses of these labile and unexpected 
congeners would be anticipated following every fish meal, although the 
intermittent levels would not be as high and persistent as with the 
accidentally exposed workers.  In fact, such pulses of total PCB after fish 
meals have been recorded with maximum serum levels being reached in 
about 10 hr and declining rapidly to near ambient by 48 hr.”78   
 
Hansen advocated an expanded list of 97 PCB congeners that merited monitoring,78 of 
which about 80 congeners were analyzed by GC/HRMS in this toenail study.  In a later 
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book chapter, Hansen settled for 30 major “steady-state” persistent PCB congeners and 
about 18 PCBs that accumulate in exposure sources including fish but are rapidly 
metabolized by mammals so they generally are present only transiently even if at rather 
high levels.77  Specific "episodic” PCB congeners of most important concern were PCBs 
18, 52, 95, 101, 110, and 149.77 
In humans, PCB congeners can also be preferentially retained into different 
organs, which would affect achieving a “steady state” distribution that could be 
biomonitored in adipose tissue or serum.79  For example, PCB congeners with 2,3,6-
chlorine substitution including PCBs 84, 110, and 95, and/or their hydroxyl-metabolites 
preferentially bind to lung cells.78  Some of the less-chlorinated PCBs with 2,5- or 2,3,6- 
chlorine substitution are able to weaken and cross the blood-brain barrier and cause 
various neurotoxicity effects.  Four specific neurotoxicity rankings by relative potency of 
PCB congeners from Hansen78 were tallied in Table 29 corresponding to those PCBs 
found in toenail samples.  Rankings included dopamine depletion, phorbol ester binding, 
disruption in brain calcium, and ryanodine binding associated with dysregulation of 
calcium ion (Ca2+) channels signaling.  Such effects are most important in neurological 
development along with disrupting thyroid homeostasis and finally, at least a 
correlation with a chromosome duplication phenomena associated with genetic 
disorders like autism spectrum disorder.80-88  In biochemical tests with 35 different PCB 
congeners, PCB 95 (having both 2,5- and a 2,3,6-substitution) showed the strongest 
effect on ryanodine-binding that affected calcium channel control at only 145 nM.89  
Other slightly less potent PCBs with effects at doses still < 1000 nM or 1 µM included 
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Table 29.  Relative Potencies of Neurological and Dioxin-like Toxicity Reported for PCBs 
 
(Excerpted from Table 2 of Hansen, 1998) Dioxin-like
Dopamine Phorbol Brain Brain Ca++ AHH Enzyme
ANALYTE NAME Depletion Binding Calcium Channels Induction
Di-PCB 15 * 0.00 0.00
 <  Tri-PCB 18  > 0.78
 <  Tri-PCB 31  >  -28 * 0.36/0.33 -- / < 0.3 -- / 0.35
Tri-PCB 33 0.35
 <  Tetra-PCB 52 *  > 0.74 1.00 0.49 0.33
 <  Tetra-PCB 49  > 0.66
 <  Tetra-PCB 44  > 0.56
Tetra-PCB 41
Tetra-PCB 74
 <  Tetra-PCB 70 *  > 0.10
Tetra-PCB 66 0.25 0.00
Tetra-PCB 60
Tetra-PCB 81 * Strong
Tetra-PCB 77 * 0.00 0.00 0.00 Strong
 < << Penta-PCB 95 * >> > 1.00
 <<  Penta-PCB 84  >>
 <  Penta-PCB 101 *  >
 [  Penta-PCB 99  ]
 <  Penta-PCB 97  >
 <  Penta-PCB 87  >
Penta-PCB 85
 << Penta-PCB 110  >>
Penta-PCB 123 * Moderate
 [  Penta-PCB 118 *  ] < 0.3 0.36 Moderate
 [  Penta-PCB 105 *  ] 0.29 0.45 Moderate
 <<  Hexa-PCB 135  >>
 [  Hexa-PCB 153 */168 ] < 0.3 /-- 0.36 / -- 0.10 / --
 <  Hexa-PCB 141  >
Hexa-PCB 137
 [  Hexa-PCB 138 */158 ]
Hexa-PCB 129
 [  Hexa-PCB 128  ] < 0.3 0.49 Minor
 [  Hexa-PCB 167 *  ] Minor
 [  Hexa-PCB 156 *  ] < 0.3 0.44 Moderate
Hexa-PCB 157 * Moderate
 [  Hepta-PCB 178  ]
 [  Hepta-PCB 187  ]
 [  Hepta-PCB 183  ]
 <<  Hepta-PCB 174  >>
Hepta-PCB 177
Hepta-PCB 171
 [  Hepta-PCB 180 */193 ] 0.00 / -- 0.50 / --
 [  Hepta-PCB 170 *  ] KEY:
 [  Octa-PCB 202 *  ]        <    >  Less Persistent (2,5-ring Cl substituents)
 [  Octa-PCB 199  ]
 [  Octa-PCB 194  ]       <<   >>  Less Persistent (2,3,6-ring Cl substituents)
 [  Nona-PCB 208 *  ]
 [  Nona-PCB 206  ]        [       ]  More Persistent (no vicinal H-substituents)
*   Denotes Quantitation with same 13C-PCB congener
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PCBs 84, 52, 183, 187, 170, 101, 180, 18, and 110.89  Most important was their finding 
that multiple congeners generated an additive effect.89  Therefore for effective 
biomonitoring of PCB congeners, it appears to be highly beneficial to use a biological 
matrix like toenails (or hair) that retains or “sequesters” more transient but more 
potentially toxic compounds. 
Biomonitoring of moderately-persistent PBDEs 
Lipid-based concentrations of the moderately-persistent PBDEs in toenail 
samples are compared with extant sample data in Table 31.  In Table 30 in the first three 
toenail samples (3T-1, 6T-2, and 7T-2) of individual A run in Sets 1 and 2, PBDE 47 (mean 
761 ng/g-lipid, sd 208, n=3) and PBDE 99 (mean 679 ng/g-lipid, sd 222, n=3) were 
highest, followed by PBDEs 153 (164 ng/g-lipid, sd 55, n=3), PBDE 100 (mean 88 ng/g-
lipid, sd 18, n=3), PBDE 28 (mean 34 ng/g-lipid, sd 14, n=3) and PBDE 17 (mean 14 ng/g-
lipid, sd 5.8, n=3).  With Set 2 for just non-polar compounds, PBDEs 49, 85, and 154 
were also measured in each sample.  
Unfortunately, as mentioned in Chapter 3, concentrations of some PBDEs in Set 
4 toenail samples were compromised by PBDE contamination in the Proteinase K 
digesting enzyme found in both Set 4 blanks with the enzyme but not in the blank 
without the enzyme (Table 15, p.97).  Blank subtraction of Set 4 samples almost 
completely eliminated most PBDEs associated with the “penta” formulation (PBDEs 17, 
49, 47, 100, and to some extent, 99), but did not affect PBDEs 28, 85, 154, 153, 139, 138, 
183, and 209. 
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With those limitations, PBDE 153 appears to be the best PBDE biomarker for 
comparing concentrations among all toenail samples with extant data.  With all six 
toenail samples of individual A included (Table 30), the mean and standard deviation of 
PBDE 153 was 150 ± 49 ng/g-lipid.  Although only one toenail sample was available for 
comparison from individual B, concentration of PBDE 153 in individual B (175 ng/g-lipid) 
was close to the mean value from individual A (150 ng/g-lipid).  In contrast, PBDE 153 
concentrations were lower in toenails from individuals C (mean 21 ng/g-lipid) and D  
(37 ng/g-lipid). 
Extant lipid-adjusted PBDE data (Table 31) included CDC serum geometric mean 
and highest (95th) percentile,2 the mean and range in adipose tissue samples from New 
York90 and breast tissue samples from California,91 and median or mean and highest 
breast milk samples from North Carolina,92 30 breast milk samples from the 
Philippines,93 and 30 matching hair samples from the same Filipino women.93  Four 
PBDEs (28, 47, 100, and 153) were quantitated by the CDC in sufficient number of serum 
samples to compute a geometric mean for each congener.  The CDC sera geometric 
means closely matched the median lipid-based concentrations of breast milk collected 
in North Carolina.92  In a similar comparison for the higher chlorinated PCB congeners 
earlier, the CDC highest (95th) percentile for PBDEs 28, 47, 100, 99, 85, 154, and 153, 
generally matched the means of both the New York adipose tissue samples and the 
California breast tissue samples (Table 31).  PBDE concentrations in toenails from this 
study exceeded the CDC highest (95th) percentile for sera and best matched the ranges 
observed in the adipose tissue samples from New York.  Comparing PBDE  
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Table 30.  Blank-Subtracted Lipid-Based Concentrations (ng/g-lipid) of PBDEs in Toenails 
 
Table 31.  Lipid-Based Concentrations (ng/g-lipid) of PBDEs in Extant Samples 
 
TOENAIL SAMPLES
3T-1 6T-2 7T-2 15T-4 16T-4 17T-4 18T-4 20T-4 21T-4 22T-4
Date Sampled: Nov 2005  Jan 2006 Mar 2006 Oct 2006 Feb 2007 May 2007 Jan 2010 Jan 2009 Apr 2009 Nov 2007
Sample Submitter A A A A A A B C C D
Mass (g): 0.187 0.192 0.190 0.340 0.295 0.159 0.0655 0.196 0.322 0.189
Lipid (%):  1.21 1.31 0.870 1.16 1.29 1.63 1.23 1.03 1.22 1.23
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g
Tri-BDE 17 17 7 18 --- --- --- --- --- --- ---
Tri-BDE 28 28 23 50 11 17 20 13 35 28 28
Tetra-BDE 49 --- 39 86 --- --- --- --- --- --- ---
Tetra-BDE 47 677 608 997 --- 769 --- --- --- 411 ---
Tetra-BDE 66 --- 16 --- --- --- --- --- --- --- ---
Penta-BDE 100 84 72 108 --- --- --- --- --- --- ---
Penta-BDE 99 522 582 933 239 567 161 1,140 42 306 ---
Penta-BDE 85 --- 13 30 18 23 20 58 18 23 13
Hexa-BDE 154 --- 3 3 18 30 11 89 15 17 14
Hexa-BDE 153 108 165 218 100 194 115 175 16 27 37
Hexa-BDE 139 --- --- --- 5 7 4 14 3 4 8
Hexa-BDE 138 --- --- --- --- --- --- 29 13 5 ---
Hepta-BDE 183 --- --- --- 3 5 --- --- --- 2 8
Octa-BDE 197 --- --- --- --- --- --- --- --- --- 9
Nona-BDE 207 --- --- 18 --- --- --- --- --- --- ---
Nona-BDE 206 --- --- 6 --- --- --- --- --- --- ---
Deca-BDE 209 --- --- --- 46 177 215 --- 319 244 392
Bis-TriBr-PE --- --- --- 78 90 6 --- --- --- ---
            ---   Not Detected at Specified Detection Limit or < [Blank Avg + 3SD]
SERUM (US) ADIPOSE TISSUE (NY) BREAST TISSUE (CA) BREAST MILK (NC) BREAST MILK-HAIR (Philippines)
n=1960 n = 52 n = 152 n=303 n=30 MILK n=30 HAIR
Date Sampled: 2003-4 2003-4 2004 2004-6 2008 2008
Sample Submitter: CDC Johnson-Restrepo Petreas et al. Daniels et al. Malarvannan Malarvannan
Mass (g): Geo. 95th et al. CDC et al. et al.
Lipid (%):  Mean % Tile Mean Lowest Highest Mean Lowest Highest Median Highest Mean Highest Mean Highest
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g
Tri-BDE 17 --- ---
Tri-BDE 28 1.2 8.0 3.3 < 0.1 42 2 50 0.1 0.6 0.5 1.5
Tetra-BDE 49
Tetra-BDE 47 21 163 132 1.3 2,720 86 4.3 3,141 28 1,430 1.3 4.6 8.8 33
Tetra-BDE 66 --- 1.3 --- 11
Penta-BDE 100 3.9 37 68 < 1 1,850 15 0.8 442 5 188 0.2 1.0 1.0 3
Penta-BDE 99 --- 42 74 < 1 1,380 35 1.3 470 5 299 0.4 4.4 3.6 19
Penta-BDE 85 --- 4.1 6.9 < 1 153 0.5 27
Hexa-BDE 154 --- 4.2 8.3 < 1 240 3 0.2 82 0.3 13 --- 0.4 0.5 2.8
Hexa-BDE 153 5.7 66 92 < 1 3,180 20 0.8 371 6 229 0.3 1.3 1.6 8.1
Hexa-BDE 139
Hexa-BDE 138
Hepta-BDE 183 --- --- --- 15 --- 0.5 1.3 7.5
Octa-BDE 197 0.2 0.8 1 3
Nona-BDE 207 0.1 0.3 4 11
Nona-BDE 206 5 15
Deca-BDE 209 0.5 3.4 44 140
            ---   Not Detected at Specified Detection Limit or < [Blank Avg + 3SD]
     BLANK SPACE Denotes Not Targeted for Analysis
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concentrations in breast milk from both North Carolina and the Philippines, Filipino 
women had concentrations approximately 20 times lower for the same tri- to hepta-
PBDEs (Table 31).  In matching hair samples from the same Filipino women, PBDE 
concentrations were generally about five times higher than in their breast milk, possibly 
demonstrating the hair’s ability to integrate chronic exposures of PBDEs.93  The 
combined matrices study of Filipino women was the only one to also analyze for the 
highest brominated PBDEs including the transient deca-BDE 209, which was about 50 
times higher in hair than in breast milk and only slightly less than deca-BDE 209, when 
detected, in toenails from this study. 
Two minor PBDEs, PBDE 17 (2,4- 2’-substituted) and PBDE 49 (2,4- 2’,5’-), that 
were quantitated in individual A Set 2 toenail samples were not reported in any of the 
extant data in Table 31.  PBDE 17 was targeted by CDC but was rarely if ever found in 
their sera samples.2  PBDE 49 apparently was neither targeted nor reported in the 
extant data listed.  However, recent biomedical neurotoxicity testing,81, 82, 94 again with 
ryanodine binding that affects calcium ion channel regulation, showed that both minor 
PBDEs 17 and 49 are more potent modulators of the ryanodine receptors than other 
PBDEs and may add to effects already noted for certain neurotoxic PCBs like PCB 95.95    
Because toenails may integrate chronic exposures of the moderately persistent PBDEs 
including potent neurotoxic congeners, it is very important to target the entire range of 
PBDEs even for minor and more transient compounds.  This work also demonstrates 
that it is important to carefully evaluate and pre-screen any alternative reagents (such 
as Proteinase K) to avoid compromising any pertinent concentrations of PBDEs or other 
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analytes.  In individual A Set 4 samples from 2007, a relatively new flame retardant, 1,2-
bis(2,4,6-tribromophenoxy)ethane or Bis-TriBr-PE was detected and quantitated (Table 
30) because it was included in the commercial calibration standard mixture after it was 
first reported in 2005 as a new alternative brominated flame retardant.96 
Biomonitoring Synthetic Musk Fragrance Compounds After Their 
Identification 
 Two isomeric synthetic musk fragrance compounds, galaxolide and tonalide, 
were added to the analyte list along with another isomer, traseolide, in Sample Set 4 for 
biomonitoring of non-polar compounds in toenail samples.  After their tentative 
identification by GC/full-scan MS, they were later confirmed by both GC retention time 
and mass spectrum of each pure chemical standard.  Researchers described them as 
potential endocrine-disrupting compounds, and found them in adipose tissue and breast 
milk, thereby providing an impetus in this study to determine whether they could be 
detected in human toenail samples.97-100  Because traseolide was very low in human 
toenails (Table 14), lipid-adjusted concentrations were shown for only galaxolide and 
tonalide, which were lowest in individual D (3,380 and 361 ng/g-lipid, respectively), 
followed by increasingly higher concentrations for individual A, C, and B (Table 32).  For 
these two fragrance compounds, concentrations (8,960 and 1,050 ng/g-lipid, 
respectively) for the house cat were included to determine if the compounds would be 
detectable in cat nails above the levels in blanks and to contrast differing exposures to 
house cats and humans of compounds in human personal care products.  Without 
having a daily shower or personal care products applied to skin like humans in what 
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Table 32.  Blank-Subtracted Lipid-Based Concentrations (ng/g-lipid) of Musk Fragrances 
in Toenails and Extant Data 
 
could be called “therapeutic exposures,” the house cat would be primarily limited to air 
exposure and minor exposure to residual compounds on human hands when the cat 
was touched.  For nails of both individual D and the house cat that had the lowest 
concentrations of fragrances, no fragrance compounds (above relatively high blanks) 
were detected in their soap washes in contrast to their appearance in soap washes of 
nails from the other three individuals.  Soap wash concentrations for individuals A, B, 
and C ranged up to 30% of that measured in toenails from those individuals, which 
indicated some adsorption or absorption of the musk compounds likely occurred from 
direct topical application in a similar way as that reported for measuring selenium after 
nails were exposed for 5 min to selenium-containing Selsun Blue shampoo.18  The 
appearance of these compounds in the soap washes highlights the importance of 
multiple soap washes whenever targeting compounds associated with personal care 
products. 
TOENAIL SAMPLES
15T-4 16T-4 17T-4 18T-4 19T-4 20T-4 21T-4 22T-4
Date Sampled: Oct 2006 Feb 2007 May 2007 Jan 2010 Apr 2010 Jan 2009 Apr 2009 Nov 2007
Sample Submitter A A A B M-cat C C D
Lipid (%):  1.16 1.29 1.63 1.23 1.12 1.03 1.22 1.23
Mass (g): 0.340 0.295 0.159 0.0655 0.120 0.196 0.322 0.189
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g
Galaxolide (HHCB) 60,300 79,800 141,000 280,000 8,960 181,000 154,000 3,380
Tonalide (AHTN) 2,150 3,740 1,870 11,100 1,050 5,540 10,300 361
EXTANT DATA: ADIPOSE TISSUE (NY) BREAST MILK (MA) BREAST MILK (Switzerland)
n = 49 n = 39 n= 54
2003-4 2004 2004-2006
Kannan et al. Reiner et al. Schlumpf et al.
Mean Lowest Highest Mean Lowest Highest Mean Lowest Highest
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g
Galaxolide (HHCB) 178 12 798 220 < 5 917 55 6.1 310
Tonalide (AHTN) 42 < 8 134 47 < 5 144 14 4.8 29
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 Comparing lipid-based toenail concentrations with extant sample concentrations 
in adipose tissue from New York, breast milk from Massachusetts, and from Switzerland, 
even the lowest toenail concentrations observed in this work (Individual D) were higher 
than the highest tissue or human milk sample from the US.  Assuming the possibility of 
toenails integrating periodic exposures during several months of growth before being 
clipped, it appears plausible that commonly used synthetic musk compounds could be 
higher in the toenails than in other matrices.  If high concentrations are found in soap 
washes of toenails, it is likely that higher concentrations are due to the nails adsorbing 
or absorbing topically applied compounds. 
Biomonitoring of a Transient Polar Compound, Triclosan 
 The antibacterial compound, triclosan, was measured only as “free” form in the 
two toenail samples of Individual A in Set 3.  Background-subtracted concentrations in 
the toenail samples averaged 58.3 ng/g with a standard deviation of 6.6 ng/g.  
Quantitation by GC/HRMS was aided by having the 13C-labelled surrogate of triclosan to 
correct for any recovery loss or variation through Set 3.  Ordinarily, the transient 
compound triclosan has been biomonitored in urine samples as the total of free and 
deconjugated forms by the CDC.2, 101 The geometric mean and 95th percentile total 
concentrations in µg/L (ppb) extant urine data are compared with the toenail data in 
Table 33.  Also included were “total” triclosan concentrations from a post-mortem 
sampling of adipose tissue, liver, and brain from 11 cadavers from Belgium.102  Using the 
13C-triclosan surrogate, Geens et al. (2012)102 detected triclosan in the highest 
concentrations and most prevalent (10 of 11) in the liver samples (mean 2.65 ng/g; 
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Table 33.  Concentration (ng/g-wet weight) of Triclosan in Set 3 Toenails and Extant Data 
 
highest 24.8 ng/g), followed by lower concentrations in fewer (7 of 11) adipose tissue 
samples, and finally a small amount in one brain.102  Compared with extant data of 
various other matrices on a “total” basis, the “free” concentrations of triclosan in 
Individual A toenails are several times higher than the CDC geometric “total” mean and 
within seven times of the 95th percentile “total” concentration.  Triclosan in each soap 
wash of Individual A toenails (10T-3 and 11T-3) was relatively low (1.1 and 2.8 ng/g or 2-
4%, respectively) indicating low exogenous contamination although the possibility of 
toenails being directly exposed to triclosan for adsorption or absorption through some 
unlabeled personal care product cannot be ruled out.  Although only based on two 
sample detections without multiple soap washes, it is possible that more toenail 
research and analyses will show that toenails effectively integrate human periodic 
exposures to transient compounds such as triclosan. 
Several tentatively-identified compounds were also detected by GC/full-scan MS 
in Set 3 toenail samples from Individual A for polar compounds and are listed in Table 34 
with their respective Chem Abstracts numbers.  Many of the compounds appear to be 
either flavor or fragrance agents including some possibly from natural sources.  The 
substituted benzothiazole compound listed, likely originating as 6-hydroxy-2-methyl 
TOENAIL SAMPLES ADIPOSE TISSUE   -- LIVER (BELGIUM)  -- BRAIN URINE (US)
10T-3 11T-3 n = 11 n = 11 n = 11 n = 2514
Date Sampled: May 2006 Jul 2006 2002 - Post-mortem 2002 - Post-mortem 2002 2003-2004
Sample Submitter A A Geens et al. Geens et al. Geens et al. CDC CDC
Detected (7 of 11) Detected (10 of 11) Detected Geometric 95th
Mass (g): 271.5 294.3 Mean Highest Mean Highest (1 of 11) Mean Percentile
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g ng/g ng/g µg/L µg/L
Triclosan 53.6 62.9 0.61 3.92 2.65 24.8 0.23 13.0 461
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benzothiazole, is similar to 2-hydroxy-benzothiazole that was recently found in indoor 
dust samples and associated with rubber tires.103  It is not known whether the 
substituted benzothiazole found in toenails is used in the rubber pads or soles in tennis 
shoes.  Another particular compound, octocrylene, is a common UV filter used in various 
sunscreen lotions that has become a suspect endocrine disrupting compound.99, 104  As 
with the musks, these compounds may be incorporated, in part, from topical 
application. 
Table 34.  Tentatively-Identified Unsuspected Compounds by Full-scan Mass Spectra in 
Toenail Samples from Set 3 
 
House cats as possible “sentinels” of home-related pollutants for 
humans? 
 During the past decade, researchers were still studying why the flame retardant 
PBDE levels in biomonitors had increased exponentially since the 1980s, doubling every 
Tentatively-Identified Compound or GC Extract or Eluate Possible
before Methylation Time Fraction Possible Origin - Commercial Uses CAS Number Effects
Methyl-2-amino-benzoate likely as: 8.56 pH<3, methylated, In essential (Neroli) oil derived from citrus 134-20-3
Methyl-2-amino-benzoic acid DCM (Methyl Anthranilate)
4-Methoxy-benzoate likely as: 9.37 pH<3, methylated, Food additive or flavoring agent 121-98-2
4-Methoxy-benzoic acid or DCM Occurs in anise (flavoring agent) 100-09-4
4-Hydroxy-benzoic acid Natural/synthetic anti-oxidant 99-96-7
Dimethyl quinazoline 9.75 DCM, methylated Possible drug intermediate 703-63-9
Methyl 2-(dimethylamino)-benzoate likely: 9.95 pH<3, methylated, Widely sold-related to essential (Neroli) oil 10072-05-6
2-dimethylamino-benzoic acid DCM 610-16-2
Methyl 2-(methylamino)-benzoate likely as: 10.19 pH<3, methylated, Food flavor or fragrance 85-91-6
2-methylamino-benzoic acid DCM Food flavor or fragrance 119-68-6
6-Methoxy-2-Methyl-Benzothiazole or as: 15.25 DCM, methylated Widely sold 2941-72-2
(6-Hydroxy-2-Methyl-Benzothiazole) 19989-66-3
2-(acetylamino)-benzoate likely as: 16.45 pH<3, Early GPC, Food flavor or fragrance 2719-08-6
2-(acetylamino)-benzoic acid DCM, methylated Drug intermediate or fragrance 89-52-1
Benzophenone 17.44 DCM, methylated UV filter, derivatives are in sunscreen 119-61-9 Estrogenic
Anisalacetone 18.52 DCM, methylated A flavoring agent 943-88-4
2-Anilino-4-methyl-quinoline 31.95 DCM, methylated Produced, uses unknown 10562-04-6
Octocrylene 46.87 DCM, methylated UV Filter, in sun-blocking lotions 6197-30-4 Estrogenic
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five years, and why PBDE concentrations in people from the US were about 20 times 
higher than those in people from Europe.51  PBDEs were not only in adults but in new 
born children and often even higher in toddlers and young children.  Because PBDEs 
have been used in percent levels in home furnishings of mattresses, couches, and 
electronics, Stapleton et al. (2004)105 analyzed house dust and dryer lint samples from 
17 homes and found PBDEs in every sample, the total ranging from 0.8 to 30 µg/g.  
Jones-Otazo et al. (2005)50 concluded, “Inadvertent ingestion of house dust is the largest 
contributor to exposure of toddlers through to adults.”  Meanwhile, a dramatic increase 
in feline hyperthyroidism for indoor cats, possibly affected by PBDEs, prompted Dye et 
al. (2007)106 to measure PBDEs in house cat serum as a possible “sentinel” for human 
exposure.  Although they did not also measure PBDEs in humans living with the cats, 
they found total PBDEs in their 23 cat samples ranged 20- to 100-fold greater than 
median PBDE levels in US adults reported by others.106  Lacking a way to measure lipid in 
the small cat serum samples without sacrificing part of their sample, they reported total 
PBDEs averaged 4.3 ng/mL-blood for young cats, 10.5 ng/mL for older cats without 
hyperthyroidism, and 12.7 ng/mL for cats with hyperthyroidism.106  Assuming lipid in cat 
serum is < 1%, total PBDEs in lipid-adjusted concentrations likely approached or 
exceeded 1000 ng/g-lipid.  However, there was too much variability in their small 
number of samples to directly associate total PBDEs with hyperthyroidism. 
 Within the past year, researchers of cats in California,107 Pakistan,108 and 
Sweden109 have reported PBDEs in cat serum.  Their lipid-based PBDE concentrations 
are compared with one cat toenail sample in this study (Table 35).  Although we 
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Table 35.  Lipid-Based Concentrations (ng/g-lipid) of PBDEs in Cat Toenails and Extant 
Cat Serum 
 
analyzed only one sample, cat toenail PBDE concentrations detected above the blanks 
compare closely to the mean concentrations found in the serum of cats from 
California.107  
 Penta-BDE 99 was highest in the cat toenail sample, consistent with that 
reported in all PBDE-cat-related studies, and sufficiently high to exceed the increased 
blank level for PBDE 99 (but not for PBDE 47) in Set 4 toenail samples.  In humans and 
Toenails SERUM from CA House Cats SERUM - Pakistan House Cats SERUM
19T-4 n = 26 n = 20 Pool of 16
Date Sampled: Apr 2010 2008-2010 2012 SWEDEN
Sample Submitter M-cat Guo et al. (2012) Ali et al. (2013) Norrgran et al.
Mass (g): 0.120 Cats w/Hyper-
Lipid (%):  1.12 Mean Lowest Highest Mean Lowest Highest thryoidism
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g
Tri-BDE 17 --- 0.9 --- 4.6
Tri-BDE 28 17 4.5 0.4 47.5
Tetra-BDE 49 ---
Tetra-BDE 47 --- 830 49.3 4,941 28 < 0.5 525 250
Tetra-BDE 66 --- 2.2 --- 12.9
Penta-BDE 100 --- 93 7.8 826 Est.  25
Penta-BDE 99 1,910 1,884 176 13,554 36 < 0.4 665 450
Penta-BDE 85 71 21 0.7 126
Hexa-BDE 154 174 155 13.1 1,046 1.8 < 0.2 16 Est.  40
Hexa-BDE 153 311 293 21.2 1,695 3.9 0.35 45 Est.  80
Hexa-BDE 139 41
Hexa-BDE 138 40
Hepta-BDE 183 17 20 3 74.4 Est.  30
Octa-BDE 197 4 29 4.5 153
Nona-BDE 207 --- 122 13.2 1,391
Nona-BDE 206 --- 20 --- 318
Deca-BDE 209 283 961 23.2 14,276 500
Bis-TriBr-PE --- 1.6 < 1 9
          Est.   Estimated from Figure 1 in Norrgran et al. (2012).
            ---   Not Detected at Specified Detection Limit or < [Blank Avg + 3SD]
     BLANK SPACE Denotes Not Targeted for Analysis
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many other animals, PBDE 99 is typically lower, more transient and more readily 
metabolized.  PBDE 153 (311 ng/g-lipid) in the cat toenail sample compared closely to 
the California cat serum mean (293 ng/g-lipid). 
In Table 36, extant lipid-adjusted concentrations of several POPs pesticides from 
the California and Pakistan cat studies were compared with the single cat toenail sample 
from this work.  Oxychlordane and p,p’-DDE were again both relatively low in the cat 
toenail compared with that in serum from California cats, perhaps in a similar way as 
previously discussed for human toenails.  In the context of a “sentinel,” the higher 
Table 36.  Lipid-Based Concentrations (ng/g lipid) of Pesticides in Cat Toenails and Extant 
Cat Serum 
 
TOENAILS SERUM from CA House Cats SERUM - Pakistan House Cats
19T-4 n = 26 n = 20
Date Sampled: Apr 2010 2008-2010 2012
Sample Submitter M-cat Guo et al. (2012) Ali et al. (2013)
Mass (g): 0.120
Lipid (%): 1.12 Mean Lowest Highest Mean Lowest Highest
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g ng/g ng/g
Hexachlorobenzene --- 7.0 4.0 14.1 3.7 <  2 6.9
Pentachloroanisole 85
Methyl (ether) Triclosan ---
gamma-HCH (Lindane) 13
beta-HCH --- 0.3 --- 2.6
Dieldrin ---
Chlordanes:
Oxychlordane 23 111 --- 2,108
Heptachlor Epoxide 28
trans-Chlordane 1,210
cis-Chlordane 734
trans-Nonachlor 846 318 --- 6,315
cis-Nonachlor 71
DDE and DDTs:
o,p'-DDE ---
p,p'-DDE 60 530 83           1,746 282 <  1 2,150
o,p'-DDT --- 0.03 --- 0.5
p,p'-DDT --- 58 --- 365
            ---   Not Detected or not (detected) above method blank
     BLANK SPACE Denotes Not Targeted for Analysis
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chlordane concentrations in the cat toenail indicate exposure in the home to chlordane. 
Because extant lipid-adjusted concentrations of PCB congeners were available for 
comparison from the California cats study, comparison was made with concentrations of 
the majority of PCB congeners found in the one cat toenail (Table 33).  Concentrations 
of the most persistent and higher-chlorinated PCB congeners in the cat toenail are 
within the range of that found in California cat serum samples.  However, the more 
transient PCB congeners in mammals were detected and noticeably higher in the one 
cat toenail than in the CA cat serum samples.  In this work, based on the example with 
chlordanes and PBDEs, if PCBs had been used in the home construction, it is likely that a 
cat would be a possible “sentinel” to indicate PCB exposure in its toenails. 
Summary 
Our hypothesis that the toenail offers a non-invasive biomonitoring sampling 
matrix for measuring chronic environmental organic pollutant exposure has been shown 
to be valid and even advantageous for compounds that are chronically exposed but 
transient and less likely to be effectively measured in traditional serum samples.  
Toenail samples are easy to collect, can be stored for years at room temperature, and 
are safe to ship or process without worry of biohazards like viruses.  A nail’s strong 
keratin structure helps shield it from most external contamination and its slow growth 
integrates chronic internal exposure from the blood stream.  Alternating 
hydrophilic/lipophilic layers within the nail plate enables incorporation of both lipophilic 
and hydrophilic organic compounds.   
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Table 37.  Lipid-Based Concentrations (ng/g-lipid) of PCBs in Cat Toenails and Extant Cat 
Serum 
 
TOENAILS SERUM from CA House Cats SERUM - Pakistan House Cats
19T-4 n = 26 n = 20
Date Sampled:  Apr 2010 2008-2010 2012
Sample Submitter  M-cat Guo et al. (2012) Ali et al. (2013)
Mass (g):  0.120
Lipid (%):  1.12 Mean Lowest Highest Mean Lowest Highest
ANALYTE NAME ng/g ng/g ng/g ng/g ng/g ng/g ng/g
 <  Tri-PCB 18  > 94
 <  Tri-PCB 31  >  -28 * 78
 <  Tetra-PCB 52 *  > 66
 <  Tetra-PCB 44  > 42
Tetra-PCB 74 38 4.1 --- 11.5
 <  Tetra-PCB 70 *  > 122
Tetra-PCB 66 56 3.8 --- 14.9
 < << Penta-PCB 95 * >> > 186
 <<  Penta-PCB 84  >> 42
 <  Penta-PCB 101 *  > 256 17 --- 41.2 6.9 1.5 25
 [  Penta-PCB 99  ] 84 17 --- 43.7
 <  Penta-PCB 97  > 87
 <  Penta-PCB 87  > 146
 << Penta-PCB 110  >> 187
 [  Penta-PCB 118 *  ] 208 18 --- 42.9 7.0 1.7 26
 [  Penta-PCB 105 *  ] 188 3.0 --- 11.3
 <<  Hexa-PCB 135  >> 34
 [  Hexa-PCB 153 */168 ] 83 49 --- 158 7.4 < 5 27
 [  Hexa-PCB 138 */158 ] 88 26 --- 91.3 10.4 3.5 33
 [  Hexa-PCB 156 *  ] 17 2.1 --- 6.8
 [  Hepta-PCB 187  ] 26 16 --- 49.6
 [  Hepta-PCB 183  ] 13 9.2 --- 65.4
 [  Hepta-PCB 180 */193 ] 9 24 --- 78.4
 [  Hepta-PCB 170 *  ] 14 4.9 --- 19.8
 [  Octa-PCB 194  ] --- 5.0 --- 16.0
SUM: 52 PCB congeners 2,502             ---   Not Detected or not (detected) above method blank
 BLANK SPACE Denotes Not Targeted for Analysis
KEY:
   <    >  Less Persistent (2,5-ring Cl substituents)
 <<   >>  Less Persistent (2,3,6-ring Cl substituents)
  [       ]  More Persistent (no vicinal H-substituents)
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Metabolites formed within the human body, e.g. oxychlordane, were remarkably 
low in toenail samples and less appropriate for toenail biomonitoring.  Toenail 
concentrations of POPs pesticides and persistent PCB congeners that are likely in steady 
state in the body, including hexachlorobenzene, beta-hexachlorocyclohexane, hepta-
nona-PCBs, and chlordanes for those living in newer homes matched geometric means 
of CDC’s latest national serum survey, but with sample mass 10-20 times less than 
serum, toenail biomonitoring analysis could be more difficult to achieve detection limits 
near < 0.1 ng/g wet weight or < 10 ng/g-lipid. 
Following the Needham speciation approach, compounds favored by toenail 
biomonitoring include those chronically or episodically exposed, including chlordanes 
associated with pre-1989 homes treated for termites, more transient pesticides (DDT), 
elusive but potentially neurotoxic tri-hexa-PCBs with chlorines 2,5- and/or 2,3,6-
substituted, PBDEs including penta-BDE 99, and, if not topically applied, triclosan.  With 
further steps to reduce method background and/or improve method recovery, it may be 
possible to monitor bisphenol A and tetrabromobisphenol A.  For biomonitoring of 
infants or young children, pooling several toenail samples from the individual might 
provide sufficient mass for optimum analysis.  Although the small mass of toenail 
clippings requires an optimized method of sample preparation with minimal lab 
contamination, no sample carryover, and sensitive analytical instrument(s), its use 
appears to be justified especially for measuring chronic exposure to elusive but 
potentially toxic compounds.  A faster and more productive analytical method should be 
possible using a mill with small, individualized stainless steel vessels to pulverize and 
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reduce pre-rinsed toenail samples to extremely small pieces with high surface area to 
enable rapid but mild digestion for subsequent extraction and cleanup.  Great care 
would be necessary to avoid any lab dust getting into the vessels or any nail powder or 
aerosol contaminating the lab or any other vessel.  Once extracted, trace-level analytical 
technique with few steps, minimal size, quality, and volume of solvents and reagents, 
high performance chromatographic columns, and instruments (GC/HRMS and 
LC/MS/MS) would suffice. 
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CHAPTER 5.  LIMITATIONS AND FUTURE RESEARCH 
Improve Toenail Digestion and Extraction 
Toenails were not fully digested or dissolved by the various mild chemical and 
biochemical reagents used and resulting concentrations of partially digested extracts 
were probably lower than if the toenail matrix was completely digested and dissolved 
for solvent extraction.  One way to improve digesting the nail is to first pulverize it into 
smaller pieces first, ideally using a commercial miniature mill grinder, such as the one 
made by Fritsch in Germany and recently used for nail and hair samples.30  For chemical 
digestion, a mild basic buffer (at or below pH 11) may help and may not break down too 
many target analytes.  Some phenolics will begin as anions, so a later pH 5 or pH 3 
extraction may be appropriate to extract any polar phenolic compounds.  Once 
digested, there is a need to avoid or minimize a resulting emulsion after digestion with 
solvent extraction as it drastically slows down the initial extraction process before 
preparing for flash GPC.  An additional centrifugation step should be tried to assess 
effectiveness.  For any future PBDE analyses with toenail samples, the results from Set 4 
using Proteinase K enzyme show the need to either find a different source of that 
enzyme that has very low background of PBDEs or avoid the use of Proteinase K entirely.  
Concerning the redox reagent DTT for use in nail digestion, it should be tested with all 
target analytes, especially those with poor method recoveries, ie. phthalate 
metabolites. 
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Target Compounds with Shorter-Half Lives whose Exposures Might be 
Integrated in Nails 
Bisphenol A is a very important compound to justify targeting and to achieve a 
consistently low lab background.  In principle, an ideal method for BPA would use a 
miniaturized method with low volumes of reagents and solvents, relatively few 
procedures exposed to lab aerosol and dust, and ideally, a choice of highly sensitive 
instruments, a GC/HRMS that will presume a methylation step and an HPLC/MS/MS 
tandem system that can measure both free BPA and the BPA-glucuronide and sulfate 
conjugated forms for a complete sum of BPA in the nail matrix.  In that same group, 
include tetrabromobisphenol A to evaluate and optimize better method recoveries.  
Chlorinated and brominated BPA compounds could also be included because the 
chlorinated BPAs and BPA were reported in adipose tissue of women from Spain.110  
Brominated BPAs were identified in trace (µg/L) levels in local Culligan commercial 
bottled water.111  If lab background of BPA for toenail samples can only be reduced 
partially, that may necessitate pooling two or three dates of toenail clippings from the 
same person to double or triple the sample mass (to 0.5-1 g) in order to overcome the 
lab background limitations. 
 If targeted, phthalate metabolites should be analyzed with a relatively modern 
HPLC/MS/MS.  Any future method for phthalate metabolites in nail samples will also 
have to optimize the purity of the deconjugating enzyme to avoid possible lab 
background of phthalates being then incidentally and unintentionally converted to the 
phthalate metabolite and causing false positives. 
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 With the use of an HPLC/MS/MS operated in negative ion electrospray mode but 
with different ions and somewhat different chromatography, several new analytes could 
be targeted with a modified or separate method for certain perfluoroalkyl organic 
compounds.  For example, two of the most common compounds would complement 
very recent data reported by Chinese researchers in small biomonitoring studies using 
nail and other matrices.29, 30  The obvious two most common perfluoro-alkyl organics 
would be perflurooctane sulfonate or PFOS and perfluorooctanoic acid or PFOA.  One of 
the challenges again with these perfluorinated compounds would be to avoid lab 
background from Teflon or related perfluorinated plastic tubing, Teflon septa, and from 
other unforeseen seals or lubricating items. 
Continue to Search for and Identify Unsuspected Compounds 
 Unsuspected analytes should be considered for human biomonitoring research 
by certain broad-based GC or HPLC/full scan MS acquisition data.  Instead of GC/MS 
with EI mass spectra that match a mass spectral data base, identifying HPLC/MS data 
typically requires another MS stage after a collision cell to generate diagnostic ion 
fragments and ion losses.  Unknowns often remain unknown until accurate mass 
measurements (from a specialized HPLC/MS/MS) provide diagnostic elemental formulas 
for further identification.  With the integration of various possible exposures during two 
to three months of nail growth, it is quite possible that even polar and transient 
compounds and/or conjugated metabolites could be detected and identified by a 
thorough, broad-based type of GC/MS and/or HPLC/MS analysis. 
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Future Toenail Biomonitoring Research – Validate with a Diverse 
Population, Target Compounds with Known or Suspected Exposures, 
and Other Matrices  
Concerning any and all further toenail biomonitoring research and evaluating 
whether a toenail sample is a suitable noninvasive matrix, it is hoped that researchers 
continue in the spirit of the late Larry Needham, who effectively advocated a 
“speciation” approach to human biomonitoring for the ultimate good of society.6  
Needham’s approach advocated to find the best or suitable matrices for a specific 
chemical or, if necessary, for its metabolite.  This preliminary toenail study evaluated 
whether a variety of organic compounds of varying persistency could be measured in 
toenails at or often below 1 ng/g-nail.  This work also demonstrated that, on a lipid-
adjusted basis, some compounds either matched or exceeded concentrations measured 
in other matrices used for biomonitoring indicating some potential for integrating 
exposures. 
Future research is necessary to validate toenails as a biomonitor by testing 
samples from a diverse population of age, gender, race, body mass index, occupations, 
diets, geographic location, and other details.  Validation might also include a study with 
known or relatively controlled exposures and exposure pathways based on work, home, 
or life-style.  Timing or estimating exposures with toenails will not be very predictable 
compared with that using hair linear growth rate, but the generally lower exogenous 
contamination in toenails compared with hair should definitely be a positive factor for 
its use in biomonitoring.  Ideally, at least some compounds will be present at sufficiently 
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high concentrations for replicate analysis on the same individual’s sample, perhaps on 
each foot separately.       
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